Next Article in Journal
Cardiac Implantable Electronic Device Infections in Patients with Renal Insufficiency: A Systematic Review and Meta-Analysis
Previous Article in Journal
Autoptic Findings in Patients Treated with (VA-ECMO) after Cardiac Arrest
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Comprehensive Review of Moroccan Medicinal Plants for Diabetes Management

1
Laboratory of Life and Health Sciences, FMP, Abdelmalek Essaadi University, Tetouan 93000, Morocco
2
Centre d’Agrobiotechnologie et de Bioingénierie, Unité de Recherche Labellisée CNRST (Centre AgroBiotech-URL-CNRST-05), Équipe “Physiologie des Stress Abiotiques”, Faculté de Sciences et Tecchniques, Université Cadi Ayyad, Marrakesh 40000, Morocco
Diseases 2024, 12(10), 246; https://doi.org/10.3390/diseases12100246
Submission received: 6 September 2024 / Revised: 29 September 2024 / Accepted: 2 October 2024 / Published: 9 October 2024

Abstract

:
Moroccan flora, renowned for its diverse medicinal plant species, has long been used in traditional medicine to manage diabetes. This review synthesizes ethnobotanical surveys conducted during the last two decades. Among these plants, 10 prominent Moroccan medicinal plants are evaluated for their phytochemical composition and antidiabetic properties through both in vitro and in vivo studies. The review encompasses a comprehensive analysis of the bioactive compounds identified in these plants, including flavonoids, phenolic acids, terpenoids, and alkaloids. Phytochemical investigations revealed a broad spectrum of secondary metabolites contributing to their therapeutic efficacy. In vitro assays demonstrated the significant inhibition of key enzymes α-amylase and α-glucosidase, while in vivo studies highlighted their potential in reducing blood glucose levels and enhancing insulin secretion. Among the ten plants, notable examples include Trigonella foenum-graecum, Nigella Sativa, and Artemisia herba-alba, each showcasing distinct mechanisms of action, such as enzymatic inhibition and the modulation of glucose metabolism pathways. This review underscores the necessity for further chemical, pharmacological, and clinical research to validate the antidiabetic efficacy of these plants and their active compounds, with a view toward their potential integration into therapeutic practices.

1. Introduction

Diabetes is a chronic, multifactorial condition that is growing rapidly and affects millions of people worldwide [1]. In non-industrialized nations, 80% of cases are predicted to occur by 2025; this pandemic, which is mostly caused by type 2 diabetes (T2D), represents a disproportionately large social and economic cost [2]. It is estimated that the number of people with diabetes will reach 783 million by 2045 [3]. In Morocco, it represents a major public health problem, with an estimated prevalence of 6.6% and 10% of the population over 20 and 50 years, respectively [4]. The etiology of this metabolic disorder is either the insufficient pancreatic production of insulin or resistance to the effects of insulin [5]. According to the World Health Organization [6], common symptoms include excessive appetite (polyphagia), frequent urination (polyuria), thirst (polydipsia), weight loss, exhaustion, hazy eyesight, and sluggish wound healing.
Dietary and lifestyle factors, including obesity, physical inactivity and a diet high in glycemic index and low in fiber, are well-established contributors to the development of T2D [7]. Moreover, a number of problems, such as oxidative stress, activation of the polyol pathway, and an increased risk of cardiovascular disease, peripheral neuropathy, nephropathy, retinopathy, and other microvascular and macrovascular complications, can result from chronic hyperglycemia, a hallmark of uncontrolled diabetes [7,8].
Conventional treatment, such as dietary changes, insulin therapy, and oral hypoglycemic drugs, are commonly used in combination for diabetes management. However, alternative therapy options are being investigated, but oral hypoglycemic medications are expensive and can cause side effects such as skin rashes, nausea, liver issues, and heart failure [9]. Herbal medicine has emerged as a promising complementary or alternative therapy for diabetes management [10].
Phytotherapy is an integral part of Moroccan culture, where people have endogenous knowledge passed down from generation to generation. Traditional Moroccan medicine draws on its Islamic, Arab-Berber and European components, and is used to treat a wide range of illnesses. The use of medicinal plants to treat diabetes is common practice in different regions of Morocco, not least because of the prohibitive costs of modern treatments and the limited accessibility of modern medicines [11]. This review aims to identify and analyze the medicinal plants used in Morocco to treat diabetes, based on ethnopharmacological surveys carried out over the last twenty years, and to valorize this traditional knowledge for the potential production of improved medicines.

2. Methodology

Scientific databases of peer-reviewed academic literature, such as Scopus, Web of Science, Google Scholar, PubMed, Science-direct and Medline, were used to collect relevant research about Moroccan medicinal plants used in the treatment of diabetes published from January 2004 to July 2024. Different keywords were used such as “Ethnobotanical studies”, “Ethnobotanical survey”, “medicinal plants used in diabetes management”, “antidiabetic medicinal plants”, and “Moroccan medicinal plants and diabetes”. A literature search was conducted regarding the in vitro and in vivo assessment of the biological activity of Moroccan medicinal plants used in diabetes management. We reviewed collected data on the explored Moroccan regions (Fez, Meknes, Ksar Elkebir, Taza, Rabat-Salé-Kénitra, High Atlas Central, Tangier-Tetouan, Safi and Essaouira, Beni-Mellal-Khenifra, Casablanca-Settat, Errachidia, Al Haouz-Rhamn, Tan-Tan, Laayoune Boujdour Sakia El Hamra, Izarene, Middle atlas, Sidi Slimane, Chtouka Ait Baha and Tiznit, Moroccan Rif, Taroudant, Oriental Morocco (Oujda), Central Plateau, Guelmim, Agadir and Ouezzane). In this review, we screened a large volume of literature (824 articles) but focused on studies published between January 2004 and July 2024 that met the following inclusion criteria:
-
Ethnobotanical surveys (38) of Moroccan medicinal plants used in diabetes management;
-
Publications related specifically to in vitro (30) and in vivo (97), or both (8), studies of the 10 most widely used Moroccan antidiabetic medicinal plants;
-
Studies published in peer-reviewed journals;
-
Research works that included clear experimental methods and statistical analyses.

3. Results

3.1. Traditional Uses and Plant Sources

Medicinal plants have traditionally been the main means of management of diabetes mellitus, which is the most common non-communicable disease. Moroccan local communities have developed a variety of herbal techniques used to manage diabetes. A total of 344 medicinal plants belonging to 79 families were highlighted in ethnobotanical surveys as traditional antidiabetic treatments in Morocco (Table 1, Figure 1). Among the families, Asteraceae, known as Compositae, showed the highest number of plants, followed by Leguminosae (Fabaceae), Lamiaceae, Poaceae (Graminaceae), Apiaceae, Brassicaceae, and Rosaceae (Figure 1). The Asteraceae family was the most frequently used in traditional Moroccan medicine, aligning with findings from other countries [12,13,14]. Asteraceae is recognized as the world’s largest flowering plant family, known for its medicinal properties [15]. Historical records document the traditional medicinal uses of various Asteraceae species, and several bioactive compounds within these plants have been studied for their potential health benefits [16].
Some medicinal species have been reported for the first time as antidiabetic remedies in Morocco. The distribution of species used in diabetes management varies from one region to another (Figure 2) [17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54]. Al Haouz-Rhamna had the highest number of Moroccan medicinal plant species used in diabetes management, followed by the High Atlas Central region, Tan-Tan, Rabat-Sale-Kenitra, Beni Mellal-Khenifra, Taza, Safi and Essaouira, Fez-Meknes, Middle Atlas, and Chtouka ait Baha and Tiznit (Figure 3). Some plants species are concentrated only in the southern region, especially in Tan-Tan, such as Opophytum theurkauffii, Searsia albida, Calotropis procera, Hyphaene thebaica, Artemisia reptans, Cichorium intybus, Saussurea costus, Nasturtium officinale, Capparis decidua, Maerua crassifolia, Silene vivianii, Atriplex halimus, Cynomorium coccinum, Cyperus rotundus, Ephedra alata, Ricinus communis, Acacia nilotica, Acacia Senegal, Arachis hypogaea, Ononis natrix, Ononis tournefortii, Vicia sativa, Vigna radiate, Musa paradisiaca, Eucalyptus camaldulensis, Limonium sinuatum, Cynodon dactylon, Panicum turgidum, Polypogon monspeliensis, Emex spinose, Chaenomeles sinensis, Rubia tinctorum, Datura stramonium, and Nardostachys jatamansi [19,52].
Table 1. Moroccan medicinal plants used in the treatment of diabetes.
Table 1. Moroccan medicinal plants used in the treatment of diabetes.
Family NameScientific NameLocal Name(s)Region(s)Used Part(s)Mode(s) of UseCitation NumberReferences
AizoaceaeOpophytum theurkauffii Maire L.âfzûLLeaves/FruitsDec/Pow 1[19]
AlliaceaeAllium cepa L.Bassla/AzalimA-L, N-Q, TBulbs/Seeds/RootsPow/Raw 22[17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,51]
Allium sativum L.Touma/TiskertA-L, O-QBulbs/RootsRaw/Mac/Dec19[18,19,21,24,25,26,27,29,30,31,32,33,34,35,36,37,38,39,51]
Allium ampeloprasum var. porrumBorro/LeborrouDBulbs/StemsRaw/Ing with water2[28,32]
AloeaceaeAloe vera (L.) Burm. f.Sebbar/Ssabra/SiberD, F, H, K, L, TPulps/LeavesRaw/Pow7[19,21,22,30,32,39,51]
AmaranthaceaeAnabasis aretioides Moq. & Coss. ex BungeChajra ma yeharrekha rih/SallaK, LAerial partsDec 2[19,21]
Beta vulgaris L.LbarbaRSeeds Inf 1[45]
Spinacia oleracea L.SabanikhDLeavesNd1[51]
AnacardiaceaePistacia atlantica Desf.Btem/Igg/DrouC, Q, HFruitsInf/Dec3[25,41,44]
Pistacia lentiscus L.Trou/Tidekt/DrouD, E, F, K, N, OLeaves/Gums/BarksRaw/Inf/Dec6[21,23,24,34,39,51]
Searsia albida (Schousb.) MoffettZewaya/anaffisLFruitsPow 1[19]
ApiaceaeAmmodaucus leucotrichus Coss.Kamoun soufiL, K, H, PSeeds Inf/Dec4[19,21,26,30]
Ammi majus L.Atrilal/Trilal/Rjel l’aghrabeVWhole plantInf1[49]
Ammi visnaga (L.) Lam.Bachnikha/BarghanisseA, C-E, G, I-K, N-P, TInflorescences/Fruits/SeedsDec/Mac/Ing/Inf15[17,18,20,21,22,23,24,26,29,32,33,34,35,37,51]
Anethum foeniculum L.Shamrah/FennelCNdNd1[33]
Apium graveolens L.KrafessA, C, D, H, P, WSeeds/Aerial partsInf/Dec/Mac6[26,29,30,32,33,52]
Carum carvi L.LkarwyaA, C-E, G-L, QSeedsDec/Pow/Inf15[17,18,19,21,25,27,29,30,32,33,34,35,37,41,51]
Coriandrum sativum L.KosborA-E, G-K, O, P, T, WSeeds/LeavesInf/Dec/Ing16[17,20,21,22,26,28,29,30,31,32,33,34,35,37,51,52]
Cuminum cyminum L.KamounC, D, F, K, LSeedsPow/Ing6[19,21,32,33,39,51]
Daucus carota L.KhizouK, L, ORootsJui/Puree3[19,21,24]
Eryngium ilicifolium Lam.Tasnant/IglifinQStems and leavesDec/Pow 1[25]
Ferula communis L.L-kelḫ/Uffāl/TaggweltG, RFruits/Roots/Flowers/LeavesDec/Pow/Inf2[35,45]
Foeniculum vulgare Mill.Nafaa/Hebet hlawaA, C-E, G-L, P, Q, W, XSeeds/FruitsDec/Inf 17[17,18,19,21,25,26,27,29,30,32,34,35,37,41,51,52,53]
Pastinaca sativa L.Left lmahfourH, I, QRootsRaw 4[25,27,30,37]
Petroselinum crispum (Mill.) FussMaadnoussA-D, K, I, H, L, P, WSeeds/LeavesInf/Dec/Raw 11[19,21,26,27,29,30,31,32,33,37,52]
Petroselinum sativum HoffmMԑadnūs/ImẓiGAerial parts/Whole plantsJui/Dec1[35]
Pimpinella anisum L.Habbat hlawaC-E, G-I, K, L, P, Q, TSeedsDec/Inf/Pow/Ing13[19,21,22,25,26,27,28,30,32,33,34,35,37]
Ptychotis verticillata DubyNounkhaOAerial partsInf1[24]
Ridolfia segetum (L.) MorisTebchE, K, RSeedsPow 3[21,34,45]
ApocynaceaeApteranthes europaea (Guss.) Murb.Oukan iddanQStemsDec/Inf/Raw 1[25]
Calotropis procera (Aiton) Dryand.TurjaLLeavesPow 1[19]
Caralluma europaea (Guss.) N.E.Br.DaghmousA, B, D, E, K, H, P, S, VAerial parts/Leaves/Rackets/RootsMac/Jui/Pow/Dec/Inf/Per10[21,26,29,30,31,32,34,44,46,49]
Nerium oleander L.Defla/AliliA, C-L, N, P, Q, S, T, W, YLeavesDec/Inf/Mac/Fum 23[17,18,19,21,22,23,25,26,27,32,33,34,35,36,37,39,41,44,46,48,50,51,52]
Periploca laevigata subsp. Angustifolia (Labill.) Markgr.AsllifQ, SFruits/LeavesDec2[25,46]
ArecaceaeChamaerops humilis L.Dum/Tiguezden C-E, H, K, O, YLeaves/Fruits/RootsRaw/Dec/Inf/Pow 7[21,24,30,32,33,34,50]
Hyphaene thebaica (L.) Mart.Dum/karurLFruitsPow 1[19]
Phoenix dactylifera L.Tmar/NkhilE-H, K, L, P, JFruits/Seeds/Leaves/Pulps/Roots Raw/Dec/Pow/Inf/Vin8[17,19,21,26,30,34,35,39]
AristolochiaceaeAristolochia baetica L.Tiswik nigrane/BerztemSRoots/ResinsPow 1[46]
Aristolochia longa subsp. Fontanesii Boiss. & Reut.BerztemA, G, H, K, L, TSeedsPow/Dec6[18,19,21,22,30,35]
AsparagaceaeAgave americana L.Ssabra/SayberKLeavesDec1[21]
Asparagus albus L.Sekkum/AzzuE, OYoung sprouts/RootsRaw/Dec2[24,34]
Asparagus officinalis L.SaklaimVStemsCoo in steamer, or water1[49]
AsteraceaeAchillea odorata L.ElqorteE, KLeaves and flowersInf2[21,34]
Achillea santolinoides Lag.Chouihiya, El-qorteECapitulumInf1[34]
Anacyclus pyrethrum (L.) Lag.Iguntas/Tagundecht/TakntistORoots/Leaves Inf/Pow 1[24]
Antennaria dioica (L.) GaertnOuden elfarKLeavesDec1[21]
Anvillea garcinii subsp. Radiata (Coss. & Durieu) NegdL, TLeaves/RootsPow/Dec2[19,47]
Artemisia abrotanum L.ChihKAerial parts Dec1[21]
Artemisia absinthium L.ChibaA-F, H, I, K, J, O, N, P, VAerial parts/Stems/LeavesInf17[17,18,20,21,23,26,27,29,30,31,32,33,34,37,39,49,51]
Artemisia arborescens (Vaill.) L.Šība/Šība šmaymiyaFAerial parts/LeavesInf1[35]
Artemisia atlantica Coss. & DurieuChih ourikaKAerial partsInf1[21]
Artemisia campestris L.Chihi khorayssEWhole plantInf1[34]
Artemisia herba-alba AssoIzri/Chih dwidiA, C-E, G-L, N-Q, S, T, WStems/leaves/RootsDec/Inf/Pow 23[17,18,19,20,21,22,23,25,26,27,28,29,30,32,33,34,35,37,41,46,48,51,52]
Artemisia herba alba Assac.,ChihNAerial parts/LeavesDec/Inf/Pow 1[23]
Artemisia mesatlantica MaireChih elkhryassiE, KWhole plant/Aerial partsDec2[21,34,48]
Artemisia reptans C. Sm. ex LinkChihiyaLLeavesDec1[19]
Atractylis gummifera Salzm. ex L.Addād/Ddād,GRootsInf1[35]
Calendula arvensis Bieb.,Jemra AzwiwelC, RFlowers/StemsInf/Dec2[41,45]
Centaurea maroccana BalBejjaae nhal/NogguirD, KFlowersInf2[21,51]
Chamaemelum mixtum (L.) AlloniHellalaDFlowersInf1[32]
Chamaemelum nobile (L.) All.BabounjA, D, E, H, K, TLeaves/Flowering topsDec/Inf6[21,22,29,30,32,34]
Chrysanthemum coronarium L.HmessouEFlowersInf1[34]
Cichorium intybus L.BuaggadLRoots Inf 1[19]
Cladanthus arabicus (L.) Cass.TaafsE, KFlowersInf2[21,34]
Cladanthus scariosus (Ball) Oberpr. & VogtArzgi/irzgiSFlowersDec1[46]
Cynara cardunculus L.Kharchouf/TagguaA, D, E, K, H, J, P, T, LAerial parts/StemsPow/Dec/Inf10[17,18,19,21,22,26,30,32,34,47]
Cynara cardunculus subsp. scolymus (L.)LqoqD, E, Q, TRoots/InflorescencesDec/Inf4[25,32,34,47]
Cynara humilis L.Ṭimṭa/Ḥekk/ḪeršūfGRootsDec/Pou1[35]
Dittrichia viscosa (L.) GreuterTerehla/BagramanB-D, E, K, O, SLeaves/Stems/FruitsDec/Inf8[21,24,31,33,34,41,46,51]
Echinops spinosissimus TurraTaskraQ, S, TFlowersDec3[22,25,46]
Helianthus annuus L.NouaratchamessR, HRoots/SeedsPow/Inf2[44,45]
Inula conyza (Griess.) DC.TerrehlaKRootsDec1[21]
Inula helenium L.Terrehla damnatiyaKLeaves/FlowerDec1[21]
Lactuca sativa L.Khes/LkhossE, K, H, P, RLeavesRaw/Inf5[21,26,30,34,45]
Launaea arborescens (Batt.) Murb.Iferskel/MoulbnaK, Q, LStems/Leaves/Roots FlowersPow/Dec/Inf3[19,21,25]
Matricaria chamomilla L.Mansania/LbabounjC, E, K, H, I, NLeaves/FlowersDec/Inf7[21,23,27,33,34,37,41]
Pallenis spinosa (L.) Cass.Nugd/NougedE, KAerial parts/Whole plantDec/Inf2[21,34]
Saussurea costus (Falc.) LipschitzQist HindiWStemsPow 1[52]
Scolymus hispanicus L.Gurnina/TaghdiutD, E, K, O, SStems/Leaves/Roots Raw/Dec/Inf5[21,24,34,46,51]
Scorzonera undulata VahlTamtlaQFlowersRaw 1[25]
Seriphidium herba-albaChihXNdNd1[53]
Sonchus arvensis L.Kettan elhench/TifafE, H, TLeavesInf/Dec3[22,30,34]
Sonchus asper (L.) HillTifafRWhole plantsDec1[45]
Sonchus tenerrimus L.TifafL, RLeavesDec2 [19,45]
Stevia rebaudiana Willd.SteviaD, FLeavesInf/Pow 2[39,51]
Silybum marianum L.Chouka DLeaves/FruitsNd1[51]
Tanacetum vulgare L.LbalssamE, K, RStems/LeavesInf3[21,34,45]
Taraxacum campylodes G.E. HaglundLhandba/ChladaC, KFlowers/Roots/LeavesDec/Pow 2[21,41]
Warionia saharae Benthem ex Benth. & Coss.AfssasQ, L, JLeavesInf/Pow 3[19,25,38]
BerberidaceaeBerberis vulgaris subsp. Australis (Boiss.) HeywoodArghis/AtizarD, E, G, C, KLeafy stem/Barks/FruitsDec5[21,33,34,35,51]
BrassicaceaeAnastatica hierochuntica L.Chajarat Maryem/lkemchaE, L, O, R, WStems/LeavesPow/Inf5[19,24,34,45,52]
Brassica napus L.LeftL, HRhizomesJui2[19,30]
Brassica nigra (L.) K. KochElkhardelKFlowersPow/Inf1[21]
Brassica oleracea L.Krunb mkawar/MelfufC-E, H, K, L, O, P, RAerial parts/FruitsRaw/Mac/Pou9[19,21,24,26,30,32,33,34,45]
Brassica rapa L.Left beldiD, E, K, ORoots/LeavesDec/Inf5[21,24,34,48,51]
Diplotaxis pitardiana MaireKerkaz/ElharraK, LFlowersPow 2[19,21]
Eruca vesicaria (L.) Cav.Ljerjir/Al girjirD, E, H, LAerial partsJui/Pow 3[19,30,34,51]
Lepidium sativum L.Hab errechad A-L, P, WSeedsMac/Pow/Dec/Inf18[17,18,19,21,26,27,28,29,30,31,32,33,34,35,37,39,41,51,52]
Nasturtium officinale R.Br.GernunesLLeaves/stemsMac1[19]
Ptilotrichum spinosum (L.) Boiss.AguerbazOLeaves/stemsDec1[24]
Raphanus raphanistrum subsp. sativus (L.)LfjelA, D, E, K, H, I, Q, L, PRoots/BulbsRaw/Inf/Mac10[19,21,25,26,27,29,32,34,37,51]
BurseraceaeBoswellia sacra Flueck.Louban Dakar/SalabaneD, EResins/FruitsInf/Ing/Dec2[32,34]
Commiphora myrrha (Nees) Engl.LmorraAResinsDec 1[29]
BuxaceaeBuxus balearica Lam.Azazer/lbakousK, OLeavesDec2[21,24]
Buxus sempervirens L.LbeksALeavesDec1[18]
CactaceaeOpuntia ficus indica (L.) Mill.Lhndia/AknariA-D, F-H, J, K, L, O-Q, TStems/Roots/Flowers/Seeds/FruitsDec/Jui/Pow/Inf/Raw/Oil18[17,19,20,21,22,24,25,26,27,29,30,31,32,33,35,39,41,51]
CapparaceaeCapparis decidua (Forssk.) Edgew.IgninLFruitsPow 1[19]
Capparis spinosa L.Kabar/TaylulutA, C-E, G, K, J, L, N, O, S, WAerial parts/Fruits/RootsPow/Dec/Inf12[17,18,19,21,23,24,34,35,41,46,51,52]
Maerua crassifolia Forssk.Atil/Sedra lkhadraLLeavesPow/Dec1[19]
CaryophyllaceaeHerniaria glabra var. hirsuta (L.) KuntzeHrasset lehjerGAerial partsDec/Pow 1[35]
Paronychia argentea Lam.Tahidourt n’imksaoumSLeafy stemsInf1[46]
Silene vivianii Steud.Gern lebzalLStemsRaw 1[19]
Corrigiola telephiifolia Pourr.Sergina/Tasergint/Bakur al barbarC, K, H, O, VRoots Pow 5[21,24,30,33,49]
CannabaceaeCannabis sativa L.Al lkifFSeeds/Leaves/FlowersPow 1[39]
CistaceaeCistus albidus L.BoutourOLeavesDec1[24]
Cistus creticus L.IrgelK, Q, SLeavesDec/Pow 3[21,25,46]
Cistus laurifolius L.AgullidE, K, SSeeds/FlowersPow 3[21,34,46]
Cistus salviifolius L.Irgel/TirgeltD, K, QLeaves/SeedsDec/Pow 3[21,25,51]
Cistus ladanifer L.TouzaltELeavesDec1[34]
ChenopodiaceaeAtriplex halimus L.LegtefLLeavesPow/Dec/Mac1[19]
Chenopodium ambrosioides L.MkhinzaA-C, E, G-J, WLeaves/Aerial partsInf/Mac10[27,29,30,31,35,37,38,41,42,52]
Hammada scoparia (Pomel) IljinAssay/RremtQ, MSeeds/Leaves Dec2[25,54]
Salsola tetragona DelileLaarad L, JLeaves and fruitsPow 2[19,43]
Suaeda mollis Dest.,AdeghmousJAerial partsIn meals1[43]
ColchicaceaeAndrocymbium gramineum (Cav.) J.F. Macbr.Temrate leghrabKBulbsInf1[21]
ConvolvulaceaeIpomoea batatas (L.)Batata hlouwaARootsRaw 1[29]
CucurbitaceaeBryonia dioica Jacq.TerbounaEStems/FruitsDec1[34]
Citrullus colocynthis (L.) Schrad.Aferziz/lhdejA, C-E, G, H, K, L, M, O-SSeeds/FruitsDec/Cat/Pow/Ing15[18,19,21,24,25,26,28,30,32,33,34,35,45,46,54]
Citrullus vulgaris Schard.DellahELeavesInf/Mac1[34]
Cucumis sativus L.LkhiarA, B, D, E, G-I, K, L, O-Q FruitsRaw/Mac/Pow/Jui13[19,21,24,25,26,27,29,30,31,32,34,35,37]
Cucumis melo var. flexuosus L.FeqousAFruitsRaw 1[29]
Cucurbita maxima DuchesneGaraa lhamraE, H, LLeaves/SeedsDec/Pow 3[19,30,34]
Cucurbita pepo L.Takhsait/curjtD, F, K, H, L, O, N, Q, RFruitsRaw/Dec/Coo10[19,21,23,24,27,30,32,39,45,51]
CupressaceaeJuniperus phoenicea L.Araar finiquiA, D, E, K, L, O, RLeaves/Aerial parts/Fruits/BarksPow/Dec Mac8[18,19,21,24,32,34,45,51]
Juniperus thurifera LTawaytOLeavesDec1[24]
Juniperus oxycedrus L.L arâar chriniELeavesMac1[34]
Tetraclinis articulata (Vahl) Mast.AraarC, F, K, G-I, K, N, P, T, V, WLeaves/Aerial parts/FruitsInf/Mac/Pow/Dec13[21,22,23,26,27,30,33,35,37,39,41,49,52]
CynomoriaceaeCynomorium coccineum L.TertutLStemsPow 1[19]
CyperaceaeBolboschoenus maritimus (L.) PallaSsmarKSeedsDec1[21]
Cyperus longus L.Arouk, esaadERootsMac1[34]
Cyperus rotundus L.TaraLLeavesPow 1[19]
DracaenaceaeDracaena draco subsp. ajgal Benabid & CuzinAjgalQStems/LeavesDec1[25]
EphedraceaeEphedra alata Decne.ChdidaLLeafy stemDec/Pow 1[19]
Ephedra altissima Desf.Tougel arganH, QStems/Leaves/whole plantDec2[25,27]
Ephedra fragilis Desf.AmaterSLeafy stemDec1[46]
EquisetaceaeEquisetum ramosissimum DesfDayl laawdEStemsDec1[34]
EricaceaeArbutus unedo L.Sasnu/BarnnouC-E, G, H, N, OLeaves/Roots/FruitsDec/Inf6[23,24,27,34,35,41,51]
Vaccinium myrtillus L.OleikDFruits Nd1[51]
EuphorbiaceaeEuphorbia officinarum subsp. echinus (Hook. f. & Coss.) VindtTikiout/zakoumE, K, L, O, QFruits/Stems/LeavesMac/Dec/Pow/Jui5[19,20,21,25,34]
Euphorbia officinarum L.Tikiout/DaghmoussD, H, Q, WStems/LeavesPow [25,30,51,52]
Euphorbia peplis L.HllibaE, RWhole plantInf2[34,45]
Euphorbia resinifera O. BergTikiwtA, C, E, H, O, SLeavesA drop latex in a glass of water7[18,24,27,33,34,41,46]
Mercurialis annua L.Hurriga elmalssaD, E, K, LLeafy stem/Whole plantInf/Dec/Jui4[19,21,32,34]
Ricinus communis L.Awriwer/LkharwaaLSeedsPou1[19]
FagaceaeQuercus coccifera L.ElqermezKLeavesDec1[21]
Quercus suber L.BellouteA, B, DFruits Dec/Raw 3[29,31,32]
Quercus ilex L.Bellout, KerrouchC, EBarks/LeavesDec2[33,34]
GentianaceaeCentaurium erythraea RafnQusset elhayya/Ahchlaf ntawrraC, D, G, K, N, OFlowering/Aerial partsInf/Dec/Pow 7[21,23,24,33,35,41,51]
Centaurium spicatum (L.) FritschGosset lhayyaEStems/FlowersInf1[34]
GeraniaceaePelargonium odoratissimum L.M’atarchaXLeaves Dec1[53]
Pelargonium roseum Willd.LaatterchaELeavesInf1[34]
IridaceaeCrocus sativus L.Zaafran lhorD, E, G, H, LStigmas/FlowersInf/Dec/Mac 5[19,30,32,34,35]
JuglandaceaeJuglans regia L.Swak/GargaaC, D, E, G, K, L, O, SLeaves/Barks/Seeds/FlowersInf/Dec/Raw 8[19,21,24,32,33,34,35,46]
JuncaceaeJuncus maritimus Lam.SsemarK, LFruits/StemsDec2[19,21]
LamiaceaeAjuga iva (L.) Schreb.Timerna nzenkhad/ChndkouraA, C-E, G-I, K, L, N, P, Q, S, TStems/Leaves/Whole plantPow/Dec/Inf 15[18,19,21,22,23,25,26,27,33,34,35,37,40,41,46]
Ballota hirsuta BenthMerrou elhrami/MerrouE, KLeafy stemDec/Inf2[21,34]
Calamintha officinalis Moench.MantaA, C, E, F, IAerial plants/Whole plant/Leaves/Stems/FlowersDec/Inf5[29,34,37,39,41]
Calamintha nepeta subsp. Spruneri (Boiss.) NymanNdCNdNd1[33]
Calamintha alpina L.Fliyyo dial berrDLeavesDec1[28]
Clinopodium alpinum (L.) KuntzeZiitraD, LLeavesDec2[19,28]
Clinopodium nepeta subsp. glandulosum (Req.) GovaertsMantaN, TAerial partsInf/Dec2[22,23]
Lavandula angustifolia MillElkhzama zerqa/Elkhzama FassiyaD, G, H, K, WAerial parts/Leafy stemInf/Dec/Pow 6[21,30,32,35,51,52]
Lavandula dentata L.Timzeria/Lakhzama/JaadaE, G, K, N, QStems/Leaves/Whole plantDec/Pow/Inf/Raw/Pou5[21,23,25,34,35]
Lavandula maroccana Murb.IgazioenE, Q, SStems/Leaves/FlowersDec/Inf3[25,34,46]
Lavandula multifida LKhilt lkheyl/KohaylaE, G, LLeaves/Inflorescence/StemsDec/Inf3[19,34,35]
Lavandula stoechas L.Imzeria/Tikenkert/LhalhalA, C, E, F, G, K, L, O, P, QLeaves/FlowersDec/Inf10[19,21,24,25,26,29,33,34,35,39]
Marrubium vulgare L.Mriwt/IfziA, C, D, G-I, K, L, N-R, T, WLeaves/Aerial partsDec/Inf/Pow 21[18,19,20,21,22,23,24,25,26,27,28,29,30,32,33,35,37,41,45,51,52]
Mentha pulegium L.FliouA, C, D, F, G, K, L, O, Q, TLeaves/Aerial partsDec/Inf12[18,19,21,22,24,25,28,29,32,33,35,39]
Mentha piperita L.NaanaaDLeaves/Aerial partsNd1[51]
Melissa officinalis L.Naanaa trunjELeavesInf1[34]
Mentha spicata L.Nanaa/LiqamaD, E, K, LLeaves/Leafy stemInf/Dec4[19,21,32,34]
Mentha suaveolens Ehrh.Mersita TimijjaD, ELeaves/Whole plantInf3[28,32,34]
Ocimum basilicum L.LahbaqD, E, G, H, K, OStems/Whole plant/LeavesInf6[21,24,30,34,35,51]
Origanum compactum Benth.Azukenni/Zaater/Zaatar tadlawiA-D, E, F, H, I, K, L, N, O, TStems/Leaves/Aerial partsDec/Inf/Pow/Mac13[19,21,22,23,24,29,30,31,33,34,37,39,51]
Origanum elongatum (Bonnet) Emb. &MaireZaaterD, GLeaves/Aerial plantsInf3[28,32,35]
Origanum majorana L.BerdedouchD, H, LLeavesPow/Inf4[19,30,32,51]
Origanum vulgare L.ZaatarC, PLeavesInf2[26,33]
Rosmarinus officinalis L.AzirA-I, K, L, N, O, Q, R, T, V, WLeaves/Stems/Aerial plantsPow/Dec/Inf/Mac22[18,19,21,22,23,24,25,28,29,30,31,32,33,34,35,37,39,41,45,49,51,52]
Salvia officinalis L.SalmiaA, C-E, G-I, K, L, O-T, V-XLeaves/Aerial partsDec/Inf/Mac24[18,19,20,21,22,24,25,26,27,28,29,30,32,33,34,35,37,41,45,46,49,51,52,53]
Salvia hispanica L.ChiaDSeedsNd1[51]
Teucrium polium L.Tawerart/Flyou lbour/jaaidiaA, E, H, Q, SLeaves/Whole plantDec/Pow 5[18,25,30,34,46]
Thymus broussonetii Boiss.ZietraC, D, EStems/Leaves/FlowersInf/Mac/Dec3[28,34,41]
Thymus algeriensis Boiss. & Reut.Aduchen/Azukni/ZaitraG, OStems/LeavesDec/Inf2[24,35]
Thymus maroccanus Ball.TazoukennitE, WLeaves/FlowersInf/Mac2[34,52]
Thymus munbyanus Boiss. & ReutAduchen/Azukni/ZaitraOStems/LeavesDec/Inf1[24]
Thymus satureioides Coss.Asserkna/ZiitraD, E, K, QLeavesInf/Dec/Pow/Mac4[21,25,32,34]
Thymus vulgaris L.Aduchen/Azukni/ZaitraA, D-G, K, O, QLeaves/Aerial plantsDec/Inf8[21,24,25,29,34,35,39,51]
Thymus zygis L.Aduchen/Azukni/ZaitraG, OStems/LeavesDec/Inf2[24,35]
LauraceaeCinnamomum cassia (L.) J. PreslQarfaA, C-E, H, K, O, TBarksDec/Inf8[18,21,22,24,30,33,34,51]
Cinnamomum verum J. PreslDar essini/KarfaA, B, D, G, I, K, L, WBarksMac/Inf/Dec/Pow 9[19,21,28,29,31,32,35,37,52]
Laurus nobilis L.Ourak sidna moussa/RandB, D, E, F, I, H, K, PLeavesInf/Dec8[21,26,30,31,34,37,39,51]
Persea americana Mill.LavocaA, D, H, L, OSeeds/Fruits/LeavesPow/Ing/Raw 7[18,19,20,28,30,32,51]
LeguminosaeAcacia gummifera Willd.TelhERootsDec1[34]
Acacia nilotica (L.) DelileAmur/SllahaLFruitsPow 1[19]
Acacia senegal (L.) Willd.LaalekLGumsPow 1[19]
Acacia tortilis (Forssk.) HayneTelh/Tadoute/AmrādG, K, L, MRoots/Fruits/LeavesDec/Pow 4[19,21,35,54]
Acacia albida DelileChok TelhK, RRootsDec2[21,45]
Anagyris foetida L.Ful gnawaE, LSeeds/LeavesPow/Inf2[19,34]
Arachis hypogaea L.Lgerta/KawkawD, LSeedsPow 2[19,51]
Cassia absus L.El habba sawdaeESeedsPow 1[34]
Cassia fistula L.ḫyār šambârGFruitsDec1[35]
Ceratonia siliqua L.Tikida/LkharoubA, C-E, G-I, K, L, P, QLeaves/Seeds/FruitsDec/Inf/Pow/Raw 14[19,21,25,26,27,28,29,32,33,34,35,37,41,51]
Cicer arietinum L.LhemmesA, D, E, H, LSeedsDec/Pow/Inf4[19,27,29,34,51]
Cytisus battandieri MaireAkhamelelCLeavesDec1[41]
Glycine max (L.) Merr.SojaA, C-H J, P, Q, S, WSeedsMac/Raw/Inf/Dec/Pow 14[17,25,26,27,29,30,32,34,35,39,41,46,51,52]
Glycyrrhiza glabra LArk soussD, E, F, IBarks/Roots/StemsInf/Pow /Raw 6[28,32,34,37,39,51]
Lupinus albus L.Tirms/Foul gnawaA, C-E, G, H, K, L, OSeedsPow/Inf/Dec12[18,19,20,21,27,29,32,33,34,35,41,51]
Lupinus angustifolius L.Ibawn dekoukG, K, Q, SSeedsPow /Dec4[21,25,35,46]
Lupinus luteus L.Kikel/SemqalaE, KSeedsDec 2[21,34]
Lupinus pilosus L.Rjel DjajaRSeedsInf 1[45]
Medicago sativa L.FassaB, D, E, K, H, I, L, O, PAerial parts/Seeds/LeavesInf/Mac/Coo/Pow 9[19,21,24,26,27,31,34,37,51]
Ononis natrix L.Hennet regLLeavesDec1[19]
Ononis tournefortii Coss.AfezdadLLeavesDec1[19]
Phaseolus aureus Roxb.SojaRSeedsDec1[45]
Phaseolus vulgaris L.LubyaD, E, K, L, O, RFruits/SeedsDec/Pow/Jui/Raw/Ing7[19,20,21,24,32,34,45]
Retama monosperma (L.) Boiss.RtamERoots/LeavesDec/Inf1[34]
Retama raetam (Forssk.) WebbRtam/AllugG, KRoots/Leaves/Aerial plantsDec/Pow 2[21,35]
Retama sphaerocarpa (L.) Boiss.RtemJRootsDec1[17]
Senna alexandrina Mill.SenamekiDLeavesNd1[51]
Trigonella foenum-graecum L.Lhelba/TifidasA-L, N, O, P, Q, S, T, WSeedsDec/Inf/Mac/Pow 25[17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,37,39,41,46,51,52]
Vicia faba L.Ful/FoulA, D, LSeedsPow 3[19,29,32]
Vicia sativa L.Ayn larnabLSeedsPow 1[19]
Vigna radiata (L.) R.WilczekSojaLSeedsPow 1[19]
Vigna unguiculata (L.) WalpFul gnawaG, KSeedsDec/Pow/Mac2[21,35]
Urginea maritima (L.) BakerBssallansalCLeavesDec1[41]
LinaceaeLinum usitatissimum L.Zariat elkattanA-I, K, L, O, Q, R, TSeedsDec/Pow/Inf17[19,21,22,24,25,28,29,30,31,32,33,34,35,37,39,45,51]
LythraceaeLawsonia inermis L.LhennaF, K, GLeavesDec/Cat/Pow/Inf3[21,35,39]
Punica granatum L.RmanA-G, I-L, O, Q, T Pericarps/Barks/Fruits/LeavesDec/Inf/Pow 16[17,18,19,21,22,24,25,29,31,32,33,34,35,37,39,51]
MalvaceaeAbelmoschus esculentus (L.) MoenchLmloukhiaB, D, E, OFruits/FlowersMac/Inf/Raw 5[24,28,31,32,34]
Hibiscus sabdariffa L.Karkadi/BissamC-E, K, L, SCalyces/Leaves/FlowersInf6[19,21,33,34,46,51]
MoraceaeFicus abelii MiqKarmous, ChrihaRLeavesDec1[45]
Ficus carica L.Tazart/Lkarmous/Karma/chriha/ElbakurA-K, O, Q, R, TFruits/LeavesDec/Inf/Raw/Mac18[17,21,22,24,25,27,29,30,31,32,33,34,35,37,39,41,45,51]
Ficus dottata Gasp.Karmous, ChrihaRFruitsOther1[45]
Morus alba L.Tut lbariA, D, G, K, O, R LeavesInf6[18,21,24,35,45,51]
Morus nigra L.Šejrat t-tūtGLeavesInf1[35]
MoringaceaeMoringa oleifera Lam.MoringaDLeavesNd1[51]
MusaceaeMusa paradisiaca L.BananLLeavesDec1[19]
MyristicaceaeMyristica fragrans Houtt.LgouzaC, QSeedsPow 2[25,41]
MyrtaceaeEucalyptus camaldulensis Dehnh.CalitusLLeavesDec1[19]
Eucalyptus globulus Labill.CalitusA, C-E-I, K, N, O, TLeaves/Fruits/StemsDec/Inf/Pow 13[21,22,23,24,27,29,33,34,35,37,39,41,51]
Eugenia caryophyllata ThunbQronfelC-ECloves/Leaves/FlowersMac/Inf/Pow/Dec4[33,34,41,51]
Jasminum fruticans L.YasminELeaves/FlowersMac/Inf1[34]
Myrtus communis L.RihaneA, C-K, N, OLeaves/Fruits/FlowersDec/Inf/Mas/Pow 14[17,21,23,24,27,29,30,32,33,34,35,37,39,41]
Syzygium aromaticum (L.) Merr. & L. M. PerryKranfalA, D, K, H, I, L, N, QFruits/Cloves/SeedsInf/Dec/Pow/Mac9[18,19,21,23,25,27,28,32,37]
NitrariaceaePeganum harmala L.LharmelC, E, G, I, H, J, K, O, TSeedsInf/Pow/Mac9[17,21,22,24,30,34,35,37,41]
OleaceaeFraxinus angustifolia VahlTouzaltOLeavesInf1[24]
Fraxinus excelsior var.acuminata SchurLsān Eṭ-Ṭîr/Lsān L’uṣfūr/Ḥebb DerdārGFruits/Stems/BarksDec/Inf/Pow 1[35]
Olea europaea L.Jbouj/Azmour/ZitounA-H, J, K, L, O, P, Q, S, T, W, XLeaves/Fruits/FlowersDec/Inf/Mac/Pow/Oil24[17,18,19,20,21,22,24,25,26,27,28,29,30,31,32,33,34,35,39,40,46,48,51,52,53]
Olea europaea subsp. maroccana (Greuter & Burdet) Zitūn/ZebbūjGLeaves/FruitsDec/Oil1[35]
Olea europea subsp. europaea var. sylvestris (Mill) Lehr,JebboujILeavesDec1[37]
Olea oleaster Hoffm.& Link.ZabboujELeaves/FlowersInf 1[34]
PapaveraceaeFumaria officinalis L.Hachichat assebyaneE, K, RRoots/LeavesDec/Inf3[21,34,45]
Papaver rhoeas L.BelaamanA, C, H, I, Q, SSeedsPow 6[25,27,29,37,41,46]
Plantago ovata Forssk.KatounaC, DSeedsInf 2[41,51]
PedaliaceaeSesamum indicum L.JanjlanA, D-J, L, N, Q, WSeedsPow/Inf/Dec12[17,19,23,25,27,29,32,34,35,37,39,52]
PlantaginaceaeGlobularia alypum L.Ayen lerneb/TaselghaA, C, E-H, K, L, O, S, TFlowers/Leaves/StemsInf/Dec/Pou12[18,19,20,21,22,24,30,33,34,35,39,46]
Globularia repens Lam.Ain lernabPLeavesDec1[26]
PlumbaginaceaeLimonium sinuatum (L.) Mill.LgarsaLLeavesDec1[19]
PoaceaeAvena sativa L.KhortalD, E, K, OSeedsPow/Inf/Dec5[21,24,32,34,51]
Avena sterilis L.Waskone/KhortalE, SSeedsPow/Dec2[34,46]
Castellia tuberculosa (Moris) BorZwan lmkarkebE, KSeedsDec2[21,34]
Cynodon dactylon (L.) Pers.NjemLRootsDec1[19]
Hordeum vulgare L.Chair/ZraaD-F, K, L, QAerial parts/Seeds/Whole plantInf/Pow /Mac/Dec7[19,21,25,32,34,39,51]
Lolium perenne L.Eziwane/ZouaneD, E, S, WSeedsDec/Inf4[34,46,51,52]
Lolium multiflorum Lam.ZwaneASeedsPow 1[29]
Lolium rigidum GaudinZwanDSeedsInf/Ing1[32]
Panicum miliaceum L.TafssoutE, KSeedsDec 2[21,34]
Panicum turgidum Forssk.Umm rekbaLStemsDec/Pow 1[19]
Pennisetum glaucum (L.) R.Br.IllanD, K, L, QSeedsInf/Pow 4[19,21,25,51]
Phalaris canariensis L.ZouanE, K, H, N, O, QSeeds/FruitsPow/Inf/Dec7[20,21,23,24,25,27,34]
Phalaris paradoxa L.Zwan/Senbūlt l-fār/TigurraminGSeedsPow/Dec1[35]
Polypogon monspeliensis (L.) DesfTuggaLFruitsRaw 1[19]
Sorghum bicolor (L.) MoenchBachnaO, TSeedsInf/Dec2[22,24]
Triticum durum Desf.Zraa/LkamhD, E, F, KSeedsDec/Inf4[21,34,39,51]
Triticum aestivum L.ZraaD, FSeedsMac2[32,39]
Triticum turgidum L.ZraaCNdNd1[33]
Zea mays L.Lahyat AdraC, H, N, SStigmasPow 4[23,27,33,46]
PolygonaceaeEmex spinosa (L.) Campd.LhenzabLLeaves/BulbsPow1[19]
Portulaca oleracea L.RejlaE, K, Q, R, SAerial parts/Whole plantDec/Coo5[21,25,34,45,46]
RanunculaceaeNigella Sativa L.SanoujA-L, N, O, Q, S, T, WSeeds/FruitsInf/Dec/Pow/Ing40[17,18,19,20,21,22,23,24,25,27,28,29,30,31,32,33,34,35,37,39,41,46,51,52]
ResedaceaeReseda lanceolata Lag.Rġūwa/L-Ḫrūf/IslīḫGSeeds/LeavesDec/Pow/Inf1[35]
RhamnaceaeZiziphus lotus (L.) Lam.Nbeg/Azouggar/ssdraA-D, E, G-L, Q, S, TLeaves/Fruits/Roots Dec/Pow/Inf17[17,18,19,21,22,25,27,29,30,31,33,34,35,37,41,46,51]
Ziziphus jujube MillZafzoufCLeavesDec1[41]
RosaceaeCydonia oblonga Mill.SferjelJFruitsRaw 1[17]
Chaenomeles sinensis (Dum.Cours.) KoehneSferjelLRootsDec1[19]
Crataegus monogyna Jacq.Za’zûr/Zu’rûrCNdNd1[33]
Eriobotrya japonica (Thunb.) Lindl.MzahD, F, H, O, TLeaves/FruitsInf/Dec/Raw/Jui5[22,24,30,32,39]
Fragaria vesca L.Fraiz berriCFruitsRaw 1[33]
Malus communis (L.) Poir.EtefahD, E, G, S, RFruitsJui/Raw/Vin4[32,35,45,46,48]
Prunus armeniaca L.Luz elharE, KSeedsDec2[21,34]
Prunus dulcis (Mill.) D.A. WebbLouz imrzig/Louz morrA-G, J, K, L, N, Q, S, TSeeds/Leaves/FruitsRaw/Dec/Pow 16[17,19,21,22,23,25,28,29,31,32,33,34,35,39,41,46,51]
Prunus cerasus L.Red cherryD, FSeeds/FruitsJui/Raw 2[39,51]
Rubus fruticosus var. vulgaris (Weihe & NeesLaalig/TouteD, KLeavesPow/Inf 2[21,32]
Rubus fruticosus var. ulmifolius, (Schott)Laallik/TabghaELeaves/FruitsInf1[34]
RubiaceaeRubia tinctorum L.FowwaLRootsPow 1[19]
Coffea arabica L.QahwaD, CSeedsInf/Dec3[32,33,51]
RutaceaeCitrus medica var. limon L.Lhamed beldîD, E, G, KFruits/Flowers/LeavesJui/Inf/Mac/Raw/Dec5[21,32,34,35,51]
Citrus paradisi Macfad.Pamblamus/RenjD-F, H, KFruitsJui/Raw 5[21,30,32,34,39]
Citrus sinensis (L.) OsbeckLimunF, L, PFruitsRaw /Jui3[19,26,39]
Citrus aurantium L.Larenj/Zenbue/trunjA, C, E, J, H, K, L, N, OLeaves/Fruits/FlowersJui/Inf/Dec9[17,18,19,20,21,23,30,34,41]
Ruta graveolens L.LfijelE, K, LRootsDec/Inf3[19,21,34]
Ruta chalepensis L.Fjīla/L-Fījel/ĀwermiGAerial partsDec/Pow 1[35]
Ruta montana L.Lfijel/IwermiA, E, J, K, N, O, TStems/LeavesDec/Inf/Pow 7[17,18,21,22,23,24,34]
SalicaceaeSalix alba L.Salef lmaD, E, JLeavesDec3[17,48,51]
Salvadoraceae Salvadora persica L.SiwakDBarksMac1[32]
SantalaceaeViscum album LLenjbarTSeedsInf1[22]
SapotaceaeArgania spinosa (L.) SkeelsArganB-D, F-H, K, L, O, Q, S, TSeeds/Fruits/LeavesRaw /Pow/Ing/Oil15[19,20,21,22,24,25,28,30,31,32,33,35,39,46,51]
SchisandraceaeIllicium verum Hook. f.BadianaKFruitsDec1[21]
SolanaceaeCapsicum annuum L.Felfel Hârr/soudaniaC, E, L, N, OFruitsRaw 5[19,23,24,33,34]
Datura stramonium L.Sdag jmel/MetalLSeedsDec1[19]
Lycopersicon esculentum Mill.MatichaE, K, LFruitsRaw 3[19,21,34]
Nicotiana tabacum L.NefhaNLeavesDec1[23]
Solanum melongena L.BdenjalDFruitsRaw/Dec/Inf1[32]
Withania frutescens (L.) PauquyTirnetELeavesInf1[34]
TaxaceaeTaxus baccata L.Guelguem/AguelguimtE, KRootsDec2[21,34]
TheaceaeCamellia sinensis (L.) KuntzeAttayD, E, G-I, K, L, P, Q, TLeaves/SeedsInf/Dec11[19,21,22,25,26,27,32,34,35,37,51]
ThymelaeaceaeThymelaea hirsuta (L.) Endl.MetnanE, G, KLeafy stem/LeavesPow/Inf3[21,34,35]
Thymelaea tartonraira (L.) All.TalazaztJLeavesDec1[17]
Thymelaea virgata (Desf.) Endl.MetnanE, KLeafy stemDec2[21,34]
Aquilaria malaccensis LamTaghristeD, WBarksInf/Dec/Mac2[32,52]
UrticaceaeUrtica dioica L.Taznagt/Tigzenin/LhrigaC, D, G, H, J, K, N, Q, S, TStems/LeavesDec/Inf11[17,21,22,23,25,27,30,35,41,46,51]
Urtica pilulifera L.Hurriga/TisrakmazOLeavesDec1[24]
Urtica urens L.TikzintE, ILeaves/StemsPow/Dec2[34,37]
Urtica membranacea Poir. ex SavignyḤurrayga/MalssāGLeaves/Aerial partsPou/Dec1[35]
ValerianaceaeNardostachys jatamansi (D. Don) DC.Underground partWUnderground partsInf1[52]
VerbenaceaeAloysia citriodora PalauAlwiza/LouizaE, D, L, N, O, TLeavesDec/Inf6[19,20,22,23,32,34]
Verbena officinalis L.AlwizaB, D, I, HLeavesDec/Inf4[28,30,31,37]
VitaceaeVitis vinifera L.Dalya/Zbib/Kerma/AdiliteE, J, K, LLeavesDec4[17,19,21,34]
XanthorrhoeaceaeAsphodelus microcarpus Salzm. & Viv.Lberwag/blaluz/TaziaE, K, LTubersRaw/Dec3[19,21,34]
Asphodelus tenuifolius Cav.Lehyat al aatrus/Tazya/LberiwigaKLeavesDec1[21]
ZingiberaceaeZingiber officinale Roscoe.SekinjbirA, C-E, H-J, L, N, TRhizomesDec/Inf/Pow /Mac12[17,19,22,23,28,29,30,32,33,34,37,51]
Curcuma longa L.KharqumD, IStems/RhizomesInf4[28,32,37,51]
ZygophyllaceaeTetraena gaetula (Emb. & Maire) Beier & ThulinAagaiaA, J, K, L, N, O, QLeaves/Roots/SeedsPow/Inf/Dec7[17,18,19,21,23,24,25]
Zygophyllum gaetulum Emb. &MaireAagayaA, GAerial parts/LeavesDec/Inf2[29,35]
Regions: A, Fez; Meknes. B, Ksar Elkebir. C, Taza. D, Rabat-Sale-Kenitra. E, High Atlas Central. F, Tangier-Tetouan. G, Safi and Essaouira. H, Beni-Mellal-Khenifra. I, Casablanca-Settat. J, Errachidia. K, Al Haouz-Rhamna. L, Tan-Tan. M, Laayoune Boujdour Sakia El Hamra. N, Izarene. O, Middle Atlas. P, Sidi Slimane. Q, Chtouka Ait Baha and Tiznit. R, Moroccan Rif. S, Taroudant. T, Oriental Morocco (Oujda). V, Central Plateau. W, Guelmim. X, Agadir. Y, Ouezzane. Mode(s) of use: Dec: Decoction. Pow: Powder. Mac: Maceration. Inf: Infusion. Ing: Ingestion. Jui: Juice. Fum: Fumigation. Coo: Cooking/Cooked. Per: Perfusion. Pou: Poultice. Cat: Cataplasm. Mas: Mastication. Vin: Vinegar.
The majority of Moroccan medicinal plants reported during the last two centuries to treat diabetes grow spontaneously (56%), while a significant portion are cultivated (34%), some are imported (5%), some are endemic and some are either spontaneous or cultivated (3%) (Table 2, Figure 4).
The survey of the ethnobotanical literature showed that different plant parts are used to treat diabetes in Morocco, such as aerial parts (10%), leaves (47%), roots (14%), fruits (19%), flowers/inflorescence (12%), leafy stems/stems (17%), barks (4%), whole plant (5%), bulbs (2%), seeds (22%), resins (1%) and gums (0.6%) (Figure 5). Moreover, different preparation methods are used to treat diabetes in Morocco, such as decoction (62%), infusion (49%), powder (36%), maceration (13%), raw (14%), ingestion (3%), vinegar (0.6%), poultice (2%), oil (1%), cooked (1%), cataplasm (0.6%), fumigation (0.3%), etc. (Figure 6).
Moroccan traditional medicine incorporates a wide array of plant species for managing diabetes. While some plants are well-documented in the scientific literature, others remain under-studied or unknown. This categorization helps highlight the need for further research, especially on lesser-known and unknown species, to ensure their safe and effective use in diabetes management.

3.1.1. Antidiabetic Plants Well-Known in Pharmacological Literature of Diabetes

Several plant species have been extensively studied for their antidiabetic properties. They are frequently used in traditional medicine and supported by scientific studies. Among 344 plants species, 100 species belonging to 45 families are considered well-known antidiabetic plants. The most represented families are Lamiaceae, Asteraceae, Leguminosae, and Poaceae. The Lamiaceae family is the most frequently used in traditional Moroccan medicine. Fourteen species were reported as used in traditional antidiabetic treatment in the literature, including Ajuga iva, Marrubium vulgare, Mentha piperita, Melissa officinalis, Mentha spicata, Ocimum basilicum, Origanum majorana, Rosmarinus officinalis, Salvia officinalis, Salvia hispanica, Teucrium polium, Thymus satureioides, Thymus vulgaris, and Thymus zygis. The leaves of these medicinal plants are the most commonly used parts to treat diabetes in Morocco. The modes of use vary by region, but infusion and decoction are the most common forms [18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,37,39,40,41,45,46,49,51,52,53].
The Leguminosae family has been reported as the second most rich source of Moroccan traditional species used for diabetes management. This family includes thirteen medicinal species, such as Acacia nilotica, Acacia albida, Anagyris foetida, Cassia fistula, Cicer arietinum, Glycine max, Glycyrrhiza glabra, Lupinus albus, Medicago sativa, Phaseolus vulgaris, Trigonella foenum-graecum, Vigna radiata, and Vigna unguiculata. Different parts of these plants, such as seeds, roots, fruits, leaves, stems, aerial parts and barks, are used. The mode of preparation differs by region, but most patients use species from this family after decoction, infusion, maceration, or as a powder [17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,37,39,41,45,46,51,52]. Medicinal plants belonging to the Asteraceae family have also been highlighted as a rich source of remedies used for diabetes management. Seven well-known antidiabetic plants belonging to this family are reported, including Phoenix dactylifera, Artemisia herba-alba Asso, Cichorium intybus, Helianthus annuus, Matricaria chamomilla, Stevia rebaudiana, and Silybum marianum. The parts used are mainly leaves and roots, prepared by infusion or decoction, or consumed as a powder [17,18,19,20,21,22,23,25,26,27,28,29,30,32,33,34,35,37,39,41,44,45,46,48,51,52].
Another rich family, Poaceae, is reported as having antidiabetic agents in different Moroccan regions. Five species are included in this family, such as Cynodon dactylon, Hordeum vulgare, Pennisetum glaucum, Sorghum bicolor, and Triticum aestivum. The seeds of the three last species are prepared by infusion, decoction, and maceration, or taken as a powder. Meanwhile, different parts (aerial parts, seeds, and the whole plant) of Hordeum vulgare are prepared using different methods, whereas the roots of Cynodon dactylon are used after decoction [19,21,22,24,25,32,34,39,51]. The Cucurbitaceae, Lauraceae, and Myrtaceae families (four species each) have been reported as antidiabetic medicinal plants by Moroccan patients. Plants belonging to the Cucurbitaceae family include Citrullus colocynthis, Cucumis sativus, Cucurbita maxima, and Cucurbita pepo. Their fruits are prepared using various methods such as raw, decoction, powder, juice, ingestion, maceration, cooking or cataplasm [18,19,21,23,24,25,26,27,28,29,30,31,32,33,34,35,37,39,45,46,51,54]. Four species have also been reported in the Lauraceae family as well-known antidiabetic plants, including Cinnamomum cassia, Cinnamomum verum, Laurus nobilis, and Persea americana. Different parts of these species, such as barks, leaves, seeds and fruits, are used by diabetic patients. The preparation method most commonly used by these patients is infusion [18,19,20,21,22,24,26,28,29,30,31,32,33,34,35,37,39,51,52]. Four species, including Eucalyptus camaldulensis, Eucalyptus globulus, Myrtus communis, and Syzygium aromaticum, have also been reported in the Myrtaceae family as well-known antidiabetic species used by Moroccan patients from different regions. The leaves of these species are prepared using different methods to treat diabetes [17,18,19,20,21,22,23,24,25,27,28,29,30,32,33,34,35,37,39,41,51]. Plants from the Brassicaceae family have been reported in the treatment of diabetes in Morocco for a long time. The plants used are Brassica oleracea, Brassica rapa, and Lepidium sativum. The aerial parts, fruits, roots, leaves and seeds of these species are prepared in various ways by Moroccan diabetic patients [17,18,19,21,24,26,27,28,29,30,31,32,33,34,35,37,39,41,45,48,51,52].
Ten families, each presented by two plant species, are pillars of traditional Moroccan medicine in the management of diabetes. Allium cepa and Allium sativum from the Alliaceae family are globally recognized for their antidiabetic properties. The bulbs are typically consumed raw or cooked. Additionally, they are prepared via decoction or maceration for medicinal use. Garlic can also be consumed as a powder or supplement in the form of capsules [17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,39,51]. The leaves of Calotropis procera and Nerium oleander (Apocynaceae) are used. Traditionally, N. oleander leaves are prepared as a decoction, though careful dosage is necessary due to the plant’s toxicity. Calotropis procera is used as a powder for its antidiabetic properties [17,18,19,21,22,23,25,26,27,32,33,34,35,36,37,39,41,44,46,48,50,51,52]. The Capparaceae family is also represented by two species, Capparis decoctionidua and Capparis spinosa. The fruits of the first species are consumed as a powder, whereas different parts of the second species are prepared after decoction and infusion, or as a powder [17,18,19,21,23,24,34,35,41,46,51,52]. The Ericaceae family, with Arbutus unedo and Vaccinium myrtillus, offers its leaves and fruits, used in infusion or decoction [23,24,27,34,35,41,51]. The Lythraceae family includes Lawsonia inermis and Punica granatum, with leaves and fruit rinds used via different methods [17,18,19,21,22,24,25,29,31,32,33,34,35,37,39,51]. In the Malvaceae family, Hibiscus sabdariffa calyces are consumed as a tea, and Abelmoschus esculentus fruits and flowers are used in infusion and maceration or as a powder [19,21,24,28,31,32,33,34,46,51]. The Moraceae family, with Ficus carica and Morus alba, provides its fruits and leaves, which are used in infusion [17,18,21,22,24,25,27,29,30,31,32,33,34,35,37,39,41,45,51]. The Rosaceae family includes Cydonia oblonga fruits and Eriobotrya japonica leaves and fruits, typically used raw or prepared by infusion or decoction [17,22,24,30,32,39]. The Rutaceae family, represented by Citrus sinensis and Citrus aurantium, is used in combination with lemon juice, and C. aurantium leaves are used in infusion or decoction [17,18,19,20,21,23,26,30,34,39,41]. Finally, the Zingiberaceae family, featuring Zingiber officinale and Curcuma longa, provides its rhizomes used in powder or decoction, often added to food for their antidiabetic effects [17,19,22,23,28,29,30,32,33,34,37,51].
Several plant families are represented by a single species traditionally known for its antidiabetic properties. The Aloeaceae family is represented by Aloe vera; the gel from leaves is consumed raw or as a powder [19,21,22,30,32,39,51]. In the Anacardiaceae family, Pistacia atlantica fruits are used in infusion or decoction [25,41,44]. The Apiaceae family includes Foeniculum vulgare, with seeds and fruits consumed as an infusion or incorporated into meals [17,18,19,21,25,26,27,29,30,32,34,35,37,41,51,52,53]. The Cactaceae family is represented by Opuntia ficus-indica, where the stems, roots, flowers, seeds and fruit are consumed raw or prepared by decoction and infusion or as an oil [17,19,20,21,22,24,25,26,27,29,30,31,32,33,35,39,41,51]. In the Cannabaceae family, Cannabis sativa seeds and leaves are consumed as a powder by diabetic patients from Tangier and Tetouan regions [39]. The Convolvulaceae family includes Ipomoea batatas; its roots are used in dietary preparations [29]. In the Cyperaceae family, Cyperus rotundus leaves are consumed by diabetic patients from Tan-Tan as a powder [19]. The Euphorbiaceae family is represented by Ricinus communis, with the seeds prepared in a poultice [19]. The Gentianaceae family includes Centaurium erythraea, the whole plant of whch is used in decoction or infusion [21,23,24,33,35,41,51]. In the Iridaceae family, Crocus sativus stigmas and flowers are prepared as an infusion, or via decoction or maceration [19,30,32,34,35]. The Juglandaceae family is represented by Juglans regia, with leaves used in decoction [19,21,24,32,33,34,35,46]. The Linaceae family includes Linum usitatissimum, the seeds of which are consumed via infusion and decoction, or in food [19,21,22,24,25,28,29,30,31,32,33,34,35,37,39,45,51]. The Moringaceae family is represented by Moringa oleifera, with leaves prepared as teas or powder [51]. The leaves of Musa paradisiaca (Musaceae) are used in decoction or cooked dishes [19]. In the Myristicaceae family, Myristica fragrans seeds are consumed in powdered form [25,41]. The seeds of Peganum harmala (Nitrariaceae) are prepared using various methods [17,21,22,24,30,34,35,37,41]. The Oleaceae family includes Olea europaea, with leaves prepared via infusion [17,18,19,20,21,22,24,25,26,27,28,29,30,31,32,33,34,35,39,40,46,48,51,52,53]. The Polygonaceae family is represented by Portulaca oleracea, the whole plants of which are used in decoction [21,25,34,45,46]. In the Ranunculaceae family, Nigella sativa seeds are consumed powdered, after decoction via ingestion or in infusions [17,18,19,20,21,22,23,24,25,27,28,29,30,31,32,33,34,35,37,39,41,46,51,52]. The roasted seeds of Coffea arabica (Rubiaceae) are used in infusion or decoction [32,33,51]. The seeds of Viscum album (Santalaceae) are also used in infusion [22]. The Sapotaceae family includes Argania spinosa, with seeds, fruits and leaves used crude, after ingestion, or as an oil in cooking [19,20,21,22,24,25,28,30,31,32,33,35,39,46,51]. In the Solanaceae family, Datura stramonium seeds are used in decoction [19]. The Theaceae family includes Camellia sinensis, with leaves and seeds prepared as infusions or decoctions [19,21,22,25,26,27,32,34,35,37,51]. The Urticaceae family is represented by Urtica dioica, the leaves of which are prepared by decoction or infusion [17,21,22,23,25,27,30,35,41,46,51]. Finally, the leaves of Vitis vinifera (Vitaceae) are used in decoction [17,19,21,34].

3.1.2. Antidiabetic Plants Little Known in Pharmacological Literature on Diabetes

The exploration of little-known antidiabetic plants is gaining momentum as traditional herbal remedies are being increasingly recognized for their potential benefits in managing diabetes. This category encompasses 124 species, and their uses are recognized in Moroccan traditional medicine.
The Asteraceae family is notable for its diverse members. Among its eighteen species are Anacyclus pyrethrum, Artemisia absinthium, Artemisia arborescens, Artemisia campestris, Artemisia mesatlantica, Atractylis gummifera, Calendula arvensis, Chamaemelum nobile, Chrysanthemum coronarium, Cynara cardunculus, Dittrichia viscosa, Lactuca sativa, Pallenis spinose, Saussurea costus, Scorzonera undulata, Sonchus arvensis, Sonchus asper, and Warionia saharae. Different parts of these plants are used via infusion or decoction by diabetic patients from different Moroccan regions [17,18,19,20,21,22,23,24,25,26,27,29,30,31,32,33,34,35,37,38,39,41,45,46,47,48,49,51,52].
Within the Apiaceae family, fourteen species present significant antidiabetic potential. This family includes Ammodaucus leucotrichus, Ammi visnaga, Apium graveolens, Carum carvi, Coriandrum sativum, Cuminum cyminum, Daucus carota, Ferula communis, Pastinaca sativa, Petroselinum crispum, Petroselinum sativum, Pimpinella anisum, Ptychotis verticillata, and Ridolfia segetum. The seeds of these species are mainly employed in infusion to enhance digestion and blood sugar levels [17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,37,39,41,45,51,52].
The Leguminosae family encompasses a wide variety of plants renowned for their medicinal properties and nutritional value. Among these, nine noteworthy species are utilized in traditional medicine, particularly in the treatment of various ailments, including diabetes. These species include Acacia Senegal, Acacia tortilis, Arachis hypogaea, Ceratonia siliqua, Ononis natrix, Phaseolus aureus, Retama raetam, Senna alexandrina, and Vicia faba. Their different parts—gums, roots, fruits, leaves, seeds, and aerial parts—are used in various preparations such as decoctions, infusions, powders, and raw forms. These traditional practices not only highlight the versatility of these plants, but also their importance in herbal medicine and nutrition [19,21,25,26,27,28,29,32,33,34,35,37,41,45,51,54]. The Lamiaceae family contains eight species, Calamintha officinalis, Lavandula multifida, Lavandula stoechas, Mentha pulegium, Mentha suaveolens, Origanum compactum, Origanum vulgare, and Thymus algeriensis. Their leaves are mainly prepared by decoction or infusion [18,19,21,22,23,24,25,26,28,29,30,31,32,33,34,35,37,39,41,51].
The Rosaceae family is a diverse group of flowering plants that includes many well-known fruit-bearing species, some of which have significant medicinal applications. Among these, Chaenomeles sinensis, Crataegus monogyna, Malus communis, Prunus armeniaca, Prunus dulcis, and Prunus cerasus stand out for their health benefits, various parts of which are used in traditional preparations. Their fruits are often consumed raw or juiced to aid digestion and provide a rich source of vitamins. Each species offers unique health benefits by use of its various parts—roots, fruits, seeds, and leaves—prepared in forms such as juices, raw, wines, decoction, and powder [17,19,21,22,23,25,28,29,31,32,33,34,35,39,41,45,46,48,51]. The Poaceae and Solanaceae families each include five species of interest. The Poaceae family includes Avena sativa, Panicum miliaceum, Phalaris canariensis, Triticum turgidum, and Zea mays. The seeds of these species are consumed after decoction or infusion, or as a powder. Z. mays kernels are used in various dishes, while A. sativa is commonly consumed as a porridge, helping to regulate blood sugar levels [20,21,23,24,25,27,32,33,34,46,51]. From the Solanaceae family, Capsicum annuum, Lycopersicon esculentum, Nicotiana tabacum, Solanum melongena, and Withania frutescens are little-known antidiabetic plants. S. melongena is valued for its low carbohydrate content and is used in various culinary preparations. The fruits and leaves of species belonging to this family are consumed raw, or after decoction or infusion [19,21,23,24,33,34].
Among the Brassicaceae, Cistaceae, and Rutaceae families, four species are noteworthy. Brassicaceae is represented by Brassica napus, Brassica nigra, Eruca vesicaria, and Nasturtium officinale, which are used in five Moroccan regions as antidiabetic agents. Rhizomes of B. napus are consumed as a juice [19,30], whereas flowers of B. nigra are commonly used after infusion or as a powder [21]. The aerial parts of E. vesicaria are consumed as a juice or powdered [19,30,34,51]. Leaves and/or stems of N. officinale are used after maceration by diabetic patients of the Tan-Tan region [19]. The plants of the Cistaceae family include Cistus creticus, Cistus laurifolius, Cistus salviifolius, and Cistus ladanifer. The leaves of these species are used by Moroccan patients after decoction or as a powder [21,25,34,46,51]. The Rutaceae family is represented by Citrus paradisi, Ruta graveolens, Ruta chalepensis, and Ruta montana. Different parts of these species, such as leaves, stems and aerial parts, are commonly prepared by decoction or infusion, or as a powder [17,18,19,21,22,23,24,34,35]. Aditionnally, fruits of C. paradisi are consumed raw or as a juice [21,30,32,34,39].
In the Amaranthaceae, Cucurbitaceae, Cupressaceae, and Fagaceae families, three species are rarely discussed in the pharmacological literature on diabetes, but are widely used by different Moroccan regions. Plants from the Amaranthaceae family are represented by Anabasis aretioides, Beta vulgaris and Spinacia oleracea. The aerial parts and seeds of these species are used after decoction and infusion, respectively [19,21,45,51]. Bryonia dioica, Citrullus vulgaris, and Cucumis melo var. flexuosus are part of the Cucurbitaceae family. Fruits of these species are commonly consumed raw or after decoction, whereas their leaves are prepared by infusion or macertaion [29,34]. The Cupressaceae family includes Juniperus phoenicea, Juniperus oxycedrus, and Tetraclinis articulata. Their leaves are mainly used after decoction or infusion, or as macerations or powders [18,19,21,22,23,24,26,27,30,32,33,34,35,37,39,41,45,49,51,52]. Furthermore, the Fagaceae family is represented by Quercus coccifera, Quercus suber, and Quercus ilex. Their leaves, fruits and barks are commonly prepared by decoction [21,29,31,32,33,34].
Several families, including Arecaceae, Asparagaceae, Burseraceae, Caryophyllaceae, Chenopodiaceae, Oleaceae, Papaveraceae, Rhamnaceae, and Thymelaeaceae, feature two antidiabetic species little known in the pharmacological context of diabetes. Plants belonging to Arecaceae include Chamaerops humilis and Hyphaene thebaica. Different parts of C. humilis are used raw, powdered, or after decoction or infusion [21,24,30,32,33,34,50], whereas fruits of H. thebaica are used as a powder by diabetic patients in the Tan-Tan region [19]. The Asparagaceae family includes Agave americana and Asparagus officinalis. The leaves of the first species are consumed after decoction by diabetic patients in the Al Haouz-Rhamna region [21], whereas stems of A. officinalis are used by patients from Central Plateau regions after cooling in a steamer, or in water [49]. The Burseraceae family includes Boswellia sacra and Commiphora myrrha species that are known for their resins and fruits, used mostly after decoction or infusion and via ingestion [29,32,34]. Plants of the Caryophyllaceae family include Paronychia argentea and Corrigiola telephiifolia. The leafy stem of the first species is prepared by infusion, whereas the second’s roots are used as a powder [21,24,30,33,46,49]. Atriplex halimus and Chenopodium ambrosioides are two antidiabetic species belonging to the Chenopodiaceae family, cited as little-known in the pharmacological context of diabetes. The leaves of these species are commonly used as macerations [19,27,29,30,31,35,37,38,41,42,52]. Moreover, the leaves of the species Fraxinus angustifolia and Olea oleaster, belonging to the Oleaceae family, are commonly prepared by infusion [24,34]. Two antidiabetic species belonging to the Papaveraceae family, Fumaria officinalis and Plantago ovata, are used after the infusion or decoction of their leaves, seeds or roots [21,34,41,45,51]. Another important antidiabetic family, Rhamnaceae, is represented by Ziziphus lotus and Ziziphus jujube species. Their leaves, fruits, and roots are commonly used after decoction or infusion or as a powder [17,18,19,21,22,25,27,29,30,31,33,34,35,37,41,46,51]. Leaves of Thymelaea hirsute and Thymelaea tartonraira (Thymelaeaceae) are used after decoction by diabetic patients from the Errachidia region, whereas in other regions (Al Haouz-Rhamna, High Atlas Central, and Safi-Essaouira regions), patients use them after infusion or as a powder [17,21,34,35].
Seventeen plant families are represented by only one antidiabetic species that is little known in the pharmacological context of diabetes, but traditionally known for its antidiabetic properties. The Anacardiaceae family is represented by Pistacia atlantica; different parts of the plant are used after decoction or infusion, or raw [21,23,24,34,39,51]. In the Apocynaceae family, different parts of Caralluma europaea are also employed by diabetic patients through different methods [21,26,29,30,31,32,34,44,46,49]. The Buxaceae family includes Buxus sempervirens, with leaves consumed after decoction [18]. Ephedraceae are represented by Ephedra alata, the leafy stem of which is prepared by decoction or consumed as a powder [19]. In the Euphorbiaceae family, Euphorbia resinifera leaves are consumed by dropping latex in a glass of water [18,24,27,33,34,41,46]. The Gentianaceae family includes Centaurium spicatum, the stems and flowers of which are used after infusion [34]. In the Geraniaceae family, the leaves of Pelargonium odoratissimum are commonly used after decoction by diabetic patients from the Agadir region [53]. The Myrtaceae family is represented by Eugenia caryophyllata. Different parts of this species are prepared using various methods, such as decoction, infusion, maceration, or powdering [33,34,41,51]. Different Moroccan regions use Sesamum indicum species (Pedaliaceae) to treat diabetes, especially after decoction, infusion, or powdering [17,19,23,25,27,29,32,34,35,37,39,52]. The Plantaginaceae family is also an important family used in different Moroccan regions as an antidiabetic. Globularia alypum is little discussed in the literature as anantidiabetic agent; however, different parts of this species are used after decoction or infusion, or as a poultice [18,19,20,21,22,24,30,33,34,35,39,46]. In the Polygonaceae family, Emex spinosa leaves and bulbs are used mainly as a powder [19]. Barks of the Salvadora persica species (Salvadoraceae) are used after maceration by diabetic patients from the Rabat-Sale-Kenitra region [32]. In the Schisandraceae family, Illicium verum fruits are prepared by decoction by patients in the Al Haouz-Rhamna region [21]. These patients also consume the leaves of Asphodelus tenuifolius (Xanthorrhoeaceae) after decoction. Moreover, the underground parts of the Nardostachys jatamansi species (Valerianaceae) are commonly consumed after infusion by diabetic patients from Guelmim [52]. In the Verbenaceae family, Verbena officinalis leaves are consumed in different Moroccan regions after decoction and infusion [28,30,31,37]. The family Zygophyllaceae includes Zygophyllum gaetulum, the aerial parts and leaves of which are prepared by decoction and infusion [29,35].
These lesser-known antidiabetic plants demonstrate the richness of traditional herbal medicine. Their unique properties, parts used, and preparation methods reveal their potential use in supporting blood sugar management. As interest in herbal remedies continues to grow, further research is warranted to validate their traditional uses and explore their roles in modern diabetes management.

3.1.3. Antidiabetic Plants Unknown in Pharmacological Literature of Diabetes

This part presents a selection of 120 plants traditionally used by Moroccan diabetic patients over the last two decades, but which remain unrecognized in the pharmacological literature. The Asteraceae family is one of the largest plant families, and several species are traditionally used for managing diabetes by Moroccan patients. Twenty-three plants species are reported in Moroccan folklore, including Achillea odorata, Achillea santolinoides, Antennaria dioica, Anvillea garcinii subsp. Radiata, Artemisia abrotanum, Artemisia atlantica, Artemisia herba alba Assac, Artemisia reptans, Centaurea maroccana, Chamaemelum mixtum, Cladanthus arabicus, Cladanthus scariosus, Cynara cardunculus subsp. scolymus, Cynara humilis, Echinops spinosissimus, Inula conyza, Inula helenium, Launaea arborescens, Scolymus hispanicus, Seriphidium herba-alba, Sonchus tenerrimus, Tanacetum vulgare, and Taraxacum campylodes. Different parts of these species are commonly used to treat diabetes after decoction or infusion [19,21,22,23,24,25,32,34,35,41,45,46,47,51,53]. Aromatic herbs from the Lamiaceae family are often used in Moroccan herbal medicine for treating diabetes. This family is represented by Ballota hirsuta, Calamintha nepeta subsp. Spruneri, Calamintha alpina, Clinopodium alpinum, Kuntze Clinopodium nepeta subsp. glandulosum, Lavandula angustifolia, Lavandula dentata, Lavandula maroccana, Origanum elongatum, Thymus broussonetii, Thymus maroccanus, and Thymus munbyanus. Different parts of these plants are used, especially the leaves, stems, aerial parts and flowers, prepared mainly by decoction or infusion [19,21,22,23,24,25,28,30,32,33,34,35,41,46,51,52]. Leguminous plants are often included in the diet and traditional medicinal practices of Morocco, contributing to blood sugar control. Eleven species have been reported as antidiabetic plants, including Acacia gummifera, Cassia absus, Cytisus battandieri, Lupinus angustifolius, Lupinus luteus, Lupinus pilosus, Ononis tournefortii, Retama monosperma, Retama sphaerocarpa, Vicia sativa, and Urginea maritima. The parts used are seeds, leaves and roots, prepared by decoction or infusion or consumed as a powder [17,19,21,25,34,35,41,45,46].
Grasses, widely used as food sources, are also used in traditional medicine for their potential to help regulate blood sugar. Poaceae is also considered a rich family, including Avena sterilis, Castellia tuberculosa, Lolium perenne, Lolium multiflorum, Lolium rigidum, Panicum turgidum, Phalaris paradoxa, Polypogon monspeliensis, and Triticum durum. Their seeds are used through various methods, such as decoction, infusion or ingestion, or consumed raw by diabetic patients [19,21,29,32,34,35,39,46,51,52]. Brassicaceae and Euphorbiaceae families are represented by four species each. These families are known for both edible and medicinal plants, several of which are used traditionally by Moroccan diabetics. In the Brassicaceae family, leaves and stems of Anastatica hierochuntica and Ptilotrichum spinosum species are prepared by decoction, infusion or powdering in different Moroccan regions [19,24,34,45,52], whereas the flowers of Diplotaxis pitardiana are consumed as a powder by diabetic patients from Al Haouz-Rhamna and Tan-Tan [19,21]. Aditionnally, diabetic patients from different Moroccan regions use the bulbs and roots of Raphanus raphanistrum subsp. sativus, prepared by infusion, maceration, or consumed raw [19,21,25,26,27,29,32,34,37,51]. The Euphorbiaceae family is represented by Euphorbia officinarum subsp. echinus, Euphorbia officinarum, Euphorbia peplis, and Mercurialis annua. The stems and leaves of these plants are commonly used after decoction, or as a powder [19,20,21,25,30,32,34,45,51,52].
Several families, including Apiaceae, Chenopodiaceae, Moraceae, Oleaceae, Rosaceae, and Urticaceae, are represented by three species each. These families contain several species traditionally used by Moroccan diabetic patients. Plants from the poaceae family are represented by Ammi majus, Anethum foeniculum, and Eryngium ilicifolium. These plants are used by diabetic patients from the Central plateau, Taza and Chtouka Ait Baha and Tiznit regions, respectively. The whole plants of these species are used after decoction, infusion, or as a powder [25,33,49]. Aditionnally, Hammada scoparia, Salsola tetragona, and Suaeda mollis are described in the Chenopodiaceae family. The leaves or seeds of the first species are used after decoction, while the second one’s leaves and fruits are consumed as a powder [19,25,43,54]. Morover, the aerial parts of the third species are consumed in meals [43]. The Moraceae family includes Ficus abelii, Ficus dottata, and Morus nigra. Their leaves are prepared by decoction or infusion [35,45]. Plants from the Oleaceae family include Fraxinus excelsior var. acuminata, Olea europaea subsp. maroccana, and Olea europea subsp. europaea var. sylvestris. Their leaves, fruits, stems and barks are used mainly in decoctions [35,37]. Fragaria vesca, Rubus fruticosus var. vulgaris, and Rubus fruticosus var. ulmifolius are described in the Rosaceae family. The fruits and leaves of these species are are used after infusion, as a powder, or raw [21,32,33,34]. Three species, including Urtica pilulifera, Urtica urens, and Urtica membranacea, have also been reported in the Urticaceae family as antidiabetic species by Moroccan patients from different regions. Their leaves are prepared mainly by decoction [24,34,35,37].
Various families, such as Apocynaceae, Aristolochiaceae, Caryophyllaceae, Cyperaceae, Ephedraceae, and Thymelaeaceae, are represented by two species each. These families contain a range of species with unexplored antidiabetic potential but that are used in Moroccan traditional medicine. Plants of the Apocynaceae family include Apteranthes europaea and Periploca laevigata subsp. Angustifolia. The leaves, fruits and stems of these plants are mostly used after decoction [25,46]. Aristolochia baetica and Aristolochia longa subsp. Fontanesii are two species belong to the Aristolochiaceae family and known for their roots, resins and seeds, used as powders or after decoction [18,19,21,22,30,35,46]. Plants belonging to the Caryophyllaceae family include Herniaria glabra var. hirsute and Silene vivianii. The parts of these species that are used are aerial parts and stems, respectively prepared by decoction/powdering or consumed raw [19,35]. Plants belonging to the Cyperaceae family include Bolboschoenus maritimus and Cyperus longus. The seeds and roots are used after decoction and maceration, respectively, by diabetic patiens from the Al Haouz-Rhamna and High Atlas regions [21,34]. In the Ephedraceae family, the leafy stems of Ephedra altissima and Ephedra fragilis are used after decoction by Moroccan patients from the Beni-Mellal-Khenifra, Chtouka Ait Baha and Tiznit, and Taroudant regions [25,27,46]. Thymelaeaceae plants, such as Thymelaea virgate and Aquilaria malaccensis, are reported only in four regions (Al Haouz-Rhamna, Rabat, High Atlas Central, and Guelmim) for use as antidiabetic agents. Their leafy stems and barks are mostly used after decoction by diabetic patients [21,34,35,52].
Several other families contribute to traditional diabetes management in Morocco. These families are represented by one species each. People in Sahara (Tan-Tan) use the leaves of Limonium sinuatum (Plumbaginaceae) after decoction of the stems, whereas stems of Cynomorium coccinum (Cynomoriaceae) and roots of Rubia tinctorum (Rubiaceae) are used as a powder to treat diabetes [19]. Opophytum theurkauffii (Aizoaceae) and Searsia albida (Anacardiaceae) are also used, where the leaves and fruits are consumed as a powder or after decoction [19]. The leaves of Maerua crassifolia (Capparaceae) have been used by patients after decoction or as a powder [19].
The Alliaceae family includes Allium ampeloprasum var. porrum, the bulbs and stems of which are used raw, or ingested with water [28,32]. Moreover, diabetic patients from the Middle and High Atlas regions use Asparagus albus (Asparagaceae) young sprouts and roots after decoction, or raw [24,34]. Berberis vulgaris subsp. Australis (Berberidaceae) has also been described as used by Moroccan diabetic patients, especially in Al Haouz-Rhamna, High Atlas Central, Taza, Safi and Essaouira. Fruits, barks, and leafy stems of this species are used after decoction [21,33,34,35,51]. Plants from the Buxaceae family are also known as antidiabetic remedies, especially the Buxus balearica species. The leaves of these species are prepared by decoction [21,24]. The Cistaceae plants include Cistus albidus, and diabetic patients from the Middle Atlas region use the leaves of this plant after decoction [24]. Patients from this region also use Juniperus thurifera (Cupressaceae) leaves after decoction as an antidiabetic agent. Moreover, the bulbs of Androcymbium gramineum (Colchicaceae) are prepared by infusion by diabetic patients from Al Haouz-Rhamna [21].
Additionally, Dracaena draco subsp. ajgal is the only species of the Dracaenaceae family used in the treatment of diabetes by Moroccan patients from Chtouka Ait Baha and Tiznit. The stems and leaves are prepared by decoction to treat diabetes [25]. The family of Equisetaceae is represented by Equisetum ramosissimum, which has been used in the High Atlas Central region as an antidiabetic remedy. The patients use its stems after decoction [34]. Patients from this region also use Pelargonium roseum (Geraniaceae) leaves after infusion. The Myrtaceae family is represented by Jasminum fruticans species, where the flowers and leaves are prepared by infusion or macerations [34]. Juncus maritimus is the only species of the Juncaceae family that has been reportedly used by diabetic patients from Al Haouz-Rhamna and Tan-Tan in traditional medicine [19,21]. These studies describe how the stems and fruits of this species are prepared by decoction to treat diabetes. In the Papaveraceae family, Papaver rhoeas seeds are used as a powder by Moroccan diabetic patients from different regions [25,27,29,37,41,46]. Globularia repens (Plantaginaceae) species are used after decoction by patients from the Sidi Slimane region [26].
Recently, Reseda lanceolata (Resedaceae) has been reported for the first time to be used as an antidiabetic treatment by patients from the Safi and Essaouira regions. Its seeds and leaves are used as a powder, after infusion or via decoction [35]. Citrus medica var. limon belongs to the Rutaceae family. The leaves and fruits of these species are prepared by decoction, infusion, macerations, juicing or raw [21,32,34,35,51]. Salix alba (Salicaceae) has been reported to be used as a medicinal plant to treat diabetes. The leaves of this species are prepared by decoction [17,48,51]. Furthermore, Taxus baccata (Taxaceae) is a very important species known by people from the Al Haouz-Rhamna and High Atlas Central regions to be used as a traditional antidiabetic plant. People from these regions use the plant’s roots after decoction to treat diabetes [21,34]. The leaves of Aloysia citriodora (Verbenaceae) are commonly prepared via decoction or infusion [19,20,22,23,32,34]. Tubers of the Asphodelus microcarpus species are used after decoction or raw [19,21,34]. The Zygophyllaceae family, including Tetraena gaetula, have been used in different Moroccan regions by diabetic patients. The leaves, roots and seeds of this species are used by diabetic patients as a powder or after infusion or decoction [17,18,19,21,23,24,25].
These species reflect the rich cultural heritage of Moroccan herbal medicine, and may hold untapped potential for diabetes management. However, scientific research is required to confirm their efficacy and safety.

3.2. Overview of Diabetes in Morocco

In Morocco, diabetes continues to be a serious public health concern. An estimated 2.3 million individuals in the nation, aged 20 to 79, had diabetes as of 2024 [55]. This translates to an approximate 9.8% prevalence rate, with 40.2% of the population with diabetes being undiagnosed [55]. Regional variations in prevalence are notable, with higher rates observed in urban regions as a result of urbanization and lifestyle modifications.
Most cases of diabetes are type 2, which is closely linked to lifestyle factors and obesity. According to a recent study, 21.7% of Moroccans are obese, while 55.1% of them are overweight [56]. These, along with additional comorbidities including dyslipidemia and hypertension, greatly increase the burden of diabetes. There are about 43,000 instances of type 1 diabetes in children and adolescents (ages 0–19) [57]. The main causes of morbidity and death are still diabetes-related complications, such as retinopathy, neuropathy, nephropathy, and cardiovascular disorders. Diabetes is associated with high fatality rates; the condition is responsible for over 31,434 fatalities every year [58]. Among the 344 plants species used in diabetes management in Morocco during the last two decades, 49 were used for diabetes type 1, 79 plants were used for diabetes type 2, 12 plants were used for gestational diabetes mellitus, and 65 species were used for both types. Moreover, nine plants were used for diabetes type 1, diabetes type 2 and gestational diabetes mellitus, seven plants were used for both diabetes type 2 and gestational diabetes mellitus, and only one species was used for both diabetes type 1 and gestational diabetes mellitus (Table 3).
The Moroccan healthcare system continues to face challenges in managing this growing epidemic. Although there have been efforts to increase diabetes awareness and screening, a significant proportion of the population remains undiagnosed. The government has implemented various national plans to combat diabetes, including improving access to healthcare and promoting lifestyle changes [59,60,61]. However, access to insulin and other medications remains a challenge, particularly in rural areas. Moreover, the economic impact of diabetes is substantial, with a significant portion of healthcare expenditure dedicated to managing chronic non-communicable diseases like diabetes. The move towards universal health coverage aims to alleviate some of these burdens, but more comprehensive strategies are needed to address the underlying risk factors and ensure equitable access to care across the country.

3.3. Phytochemical Composition of Antidiabetic Medicinal Plants

Based on ethnobotanical survey carried out during the last two centuries, the medicinal species most widely recommended for use in diabetes management are T. foenum-graecum (19 regions), N. oleander, R. officinalis, S. officinalis, O. europaea, and N. sativa (18 regions), A. cepa and A. herba-alba Asso (17 regions), A. sativum, M. vulgare, L. usitatissimum, and F. carica (15 regions), C. sativum, F. vulgare, A. absinthium, L. sativum, O. ficus indica, C. colocynthis, and P. granatum (14 regions), O. compactum, A. iva, and P. dulcis (13 regions), A. visnaga, C. sativus, T. articulata, G. max, M. communis, S. indicum, Z. lotus, and A. spinosa (12 regions), C. carvi, P. anisum, C. spinosa, C. siliqua, E. globulus, and G. alypum (11 regions), P. crispum, L. stoechas, M. pulegium, C. sinensis, and Z. officinale (10 regions), and C. europaea, C. cardunculus, B. oleracea, R. raphanistrum subsp. sativus, C. ambrosoides, L. albu, P. harmala, C. aurantium, and U. dioica (9 regions). These findings corroborate with those reported in a previous review [62,63], which highlighted that T. foenum-graecum was the most useful plants species used in diabetes management in different Moroccan regions. This species is also most commonly recommended for use in other countries, such as southern Italy, India, Bangladesh and China [64,65,66,67].
Several studies have been conducted to find natural alternatives for the treatment of type 2 diabetes. The most effective potential medications are the secondary metabolites found in medicinal plants, such as terpenoids, flavonoids, phenolic acids, and alkaloids. In this section, the results of phytochemical, in vivo and in vitro studies are reported, but only for the most useful medicinal plants (first ten species) (Figure 7).

3.3.1. Trigonella foenum-graecum

This is an age-old adaptable legume, with a long history spanning the Eastern Mediterranean and the Indian subcontinent. Originally grown as a forage crop, this aromatic herb has become a mainstay in many different cuisines around the world, valued for its usage in stews, curries, and syrups [68]. Fenugreek is known for its medicinal properties and has been used in traditional therapeutic techniques for ages, in addition to its culinary uses.
The total carbohydrates in dried fenugreek seeds range from 52% to 58% on average. This includes 24.6–47.6% total dietary fiber, 4.2% accessible carbohydrates, 3.7% starch, 23% crude protein, 8.8% moisture, 6.4% total lipids, and 3.4% ash [69,70]. On the other hand, fresh fenugreek leaves contain approximately 86% moisture, 6% carbohydrates, 4.4% proteins, 1.5% ash, 1.1% fiber, and 0.9% fat [71,72]. Fenugreek seeds have a high nutritional value, according to Bakhtiar et al. [68]. They contain 3.94% ash, 7.94% fat, 10.3% crude fiber, 35.41% protein, and 50.5% carbohydrates. According to Alu’datt et al. [73], fenugreek seed lipids are high in unsaturated fatty acids and antioxidants, such as tocopherols and phytosterols [74]. Their lipid content ranges from 4.5 to 15 g/100 g of seeds. Various phenolic chemicals have been identified in fenugreek leaves, seeds, stems, and flowers, such as total flavonoids (TF), phenolic acids, coumarins, stilbenoids, and tyrosol [75,76]. The total phenolic content (TP) varies between 6.5 and 80 mg GAE/g in the seeds; untreated seeds have lower TP and TF than leaves that have been air-dried [77,78]. The main constituents of fenugreek essential oil (EO) that contribute to its scent and medicinal qualities are neryl acetate, camphor, β-pinene, and α-selinene, among others [79,80].

3.3.2. Nerium oleander

N. oleander is a popular ornamental plant found in parks, gardens, and roadside plantings. In colder climates, it is occasionally grown inside. Oleander is dangerous despite its attractiveness, since it might be accidentally consumed. A preliminary phytochemical screening showed the presence of alkaloids, carbohydrates, cardiac glycosides, phenolics, flavonoids, tannins, cardenolides, pregnanes, triterpenes, triterpenoids, saponins, and steroids [81,82,83]. The plant accumulates these compounds across its organs, with oleandrin being the most prominent, particularly in the roots (0.34 to 0.64 mg/g dry weight), leaves (0.18 to 0.31 mg/g dry weight), and stem (0.12–0.23 mg/g dry weight) [83]. These concentrations vary according to environmental and genetic factors. The leaves also contain other major products such as cardenolides, neriin, odoroside and gentiobiosyl. Approximately 1.5% of the cardenolides in the leaves is 0.1% oleandrin, or 3-o-α-Loleadrosyl-16-acetylgitoxigenin [84]. Glucosides such as oleandrine, adigoside, and odorosides are found in the seeds, while the bark contains glucosides like rosaginoside, corteneroside, and nerioside [85]. Additionally, a variety of other pharmacologically active compounds have been identified in the plant, including rutin, oleandomycin, folinerin and rosagenin [84].
The flowers contain 1.76% total oil, with 34 compounds identified. The major components include 22.56% neriine, 11.25% digitoxigénine, 8.11% amorphane, 6.58% 1.8-cineole, 5.54% α-pinene, 5.12% calarene, 5.01% limonene, 4.84% β-phellandrene, 3.98% terpinene-4-ol, 3.22% sabinene, 2.94% isoledene, 2.56% 3-carene, 2.29% humulene, 2.01% β-pinene and 1.67% cymen-8-ol [86]. Kaempferol, chlorogenic acid, and kaempferol 3-O-β-glucopyranoside were isolated from the ethyl acetate sub-extracts of flower ethanolic extract [87]. A polysaccharide fraction was isolated from the hot water extract of flowers using ethanol precipitation, cetyltrimethyl ammonium bromide complexing, anion exchange chromatography, and gel permeation chromatography [88].
Few studies have focused on the phenolic fraction. It has been revealed that a high quantity of polyphenols is present in the leaves, with cinnamic acid being the major component. Other components include catechin, epicatechin, and chlorogenic acid. The TP content in flowers was found to be 136.54 mg GAE/g of EO. The TP contents of methanol, water, methanol:water and acetone extracts of the leaves were 4.25, 4.54, 2.08 and 4.21, respectively, and in the flowers, they were 7.15, 7.52, 6.24 and 7.13 μg GAE per 100 μg extract, respectively [89].

3.3.3. Rosmarinus officinalis

Growing widely, rosemary is a native of the Mediterranean. Both fresh and extracted leaves are used to flavor and preserve food [90]. Rosemary is characterized by its distinctive camphor scent. Its EO is primarily composed of 1,8-cineole (15–55%), αα-pinene (9.0–26%), camphor (5.0–21%), camphene (2.5–12%), beta-pinene (2.0–9.0%), borneol (1.5–5.0%), and limonene (1.5–5.0%), with the composition varying based on bioclimatic conditions and growth period [91]. The key phytochemicals in R. officinalis include rosmarin, caffeic acid, ursolic acid, carnosic acid, camphor, and carnosobetulinic acid [92]. Carnosic acid, which oxidizes into carnosol, is recognized for its photolabile, physicochemical, and thermal properties [93].
Significant rosemary chemotypes are dominated by αα-pinene, cineole, or camphor. The terpenes, including carnosol, ursolic acid, oleanolic acid, and epirosmanol, contribute to rosemary’s therapeutic potential [94]. In the EO, minor components like humulene, cedrene, and caryophyllene coexist with oxygenated compounds like caryophyllene oxide [95]. These terpenes are classified into mono-, di-, tri-, and sesquiterpenes, which are crucial for many bio-natural compounds.
The flavonoids and polyphenols in rosemary, such as luteolin, diosmin, apigenin, genkwanin, chlorogenic acid, caffeic acid, and rosmarinic acid, contribute to its antioxidant properties [96]. The rosmarinic acid, carnosol, and carnosic acid in rosemary extracts are significant antioxidants [97,98]. The extract predominantly contains carnosic acid, carnosol, ursolic acid, and rosmanol, though production levels vary [99]. The triterpenes in rosemary, such as botulin, betulinic acid, 23-hydroxybetulinic acid, ursolic acid, oleanolic acid, 3-epi-α-amyrin, and micromeric acids, are noted for their anti-inflammatory and tumor-inhibitory functions [100]. Key compounds extracted from rosemary also include diosmin, cirsimaritin, and genkwanin [101,102,103]. Rosemary’s diverse bioactive compounds underscore its value in therapeutic and medicinal applications.

3.3.4. Salvia officinalis

The EO of S. officinalis is a complex mixture of active compounds, primarily consisting of monoterpenes such as α- and β-thujone, camphor, 1,8-cineole, and borneol, along with sesquiterpenes like α-humulene and β-caryophyllene [104,105]. Among these, α- and β-thujone are typically the predominant constituents, although there is considerable chemical variability in the EOs of this plant due to factors such as genetic background, locality, environmental conditions, and the plant’s physiological stage at harvest [106,107]. Research has focused extensively on the chemical composition of its EO across different regions. For instance, a study on 25 indigenous populations in Croatia identified the EO content (1.93–3.7%), with α- β thujone and camphor being the most abundant compounds. This study also revealed three main chemotypes, dominated by α- and β-thujone and camphor/β-pinene/borneol/bornyl acetate [108]. Similarly, an analysis of 12 indigenous populations from Montenegro identified 40 oil constituents as the major components, including α-thujone (16.98–40.35%), camphor (12.75–35.37%), and 1,8-cineole (6.40–12.06%) [109].
In addition to EOs, sage hydrosols and extracts have been extensively studied for their phenolic contents. In the hydrosol headspace, oxygenated monoterpenes such as 1,8-cineole (42.9%), α-thujone (24.3%), β-thujone (14.7%), and camphor (8.9%) predominate, along with monoterpene and sesquiterpene hydrocarbons like β-pinene and β-caryophyllene [110]. The aqueous extracts of S. officinalis are particularly rich in flavone glycosides, accounting for about 40% of the total phenolic compounds, with luteolin-O-glucuronide, apigenin-O-glucuronide, and scutellarein-O-glucuronide being the most prevalent [111].
Despite variations in compound concentrations across different studies, rosmarinic acid consistently emerges as a major phenolic in S. officinalis extracts. For example, superior levels of rosmarinic acid were found in one cultivar, with 52.7 μg/mg extract, compared to 28.3 μg/mg extract in another [112,113]. Additionally, Silva et al. [113] identified up to 24 phenolic compounds in sage extracts, with cis-rosmarinic acid and luteolin-7-O-glucuronide being the most abundant. These phenolics, along with salvianolic acid and lithospermic acid, were consistently found across various extracts, highlighting the significant role of rosmarinic acid and luteolin derivatives in S. officinalis. Further research into sage’s polyphenolic profile identified 18 compounds, primarily hydroxycinnamic acid, rosmarinic acid, and luteolin derivatives. These findings align with those of earlier studies that reported rosmarinic acid and luteolin-7-O-glucuronide as the compounds of highest concentration in sage extracts, underscoring their importance in the plant’s phytochemical profile [114,115].

3.3.5. Olea europaea

Olive trees are primarily grown in Mediterranean regions, and the plant is renowned for its fruit, which holds significant economic, nutritional, and medicinal value [116,117]. The phytochemical analysis of O. europaea leaves has revealed the presence of a wide variety of compounds, including glycosides, alkaloids, phenolics, flavonoids, coumarins, anthocyanins, tannins, carbohydrates, amino acids, proteins, resins, and fats [118,119]. The leaves contain 49.8% moisture, 1.1% lipids, 7.6% protein, 37.1% carbohydrates, and 4.5% minerals [120,121]. The TP content of the leaves is 125.92 μg GAE/mg of dry extract, with TF at 18 μg CE/mg of dry extract [119]. Five subgroups of phenolics have been identified: flavones, flavonols, flavan-3-ols, oleuropeosides, and substituted phenols, with hydroxytyrosol and oleuropein being the predominant compounds [122].
The EO obtained via hydrodistillation contains several key components, including α-pinene (52.7%), β-pinene (2.46%), and other volatiles such as (E)-2-hexenol (1.26%) and (z)-3-hexanol (1.51%) [123]. Olive fruit consists of 50% moisture, 24.9% carbohydrates, 22% lipids, 1.6% protein, and 1.5% minerals [120,121]. Olive oil is enriched with polyunsaturated fatty acids, carotenoids, and tocopherols, which are essential for protecting against oxidative stress [124]. Additionally, olive oil contains volatile compounds such as isoprene, (E)-Hex-2-enal and α-copaene, and phenolic compounds including hydroxytyrosol, p-coumaric acid, quercetin, and luteolin [125]. Various studies have analyzed the TP contents of olive leaf extracts obtained using different solvents. For instance, the TP content derived using boiling water was found to be 13.39–16.51 mg caffeic acid/g dry matter, with oleuropein concentrations of 13,225–18,694 mg/kg dry matter [126]. The major phenolic compounds identified in 80% aqueous ethanolic olive leaf extracts include 919 mg/kg dry matter of hydroxytyrosol, 312 mg/kg tyrosol, 75 mg/kg caffeic acid, 524 mg/kg ferulic acid, 2406 mg/kg verbascoside, 4221 mg/kg rutin, 6003 mg/kg luteolin-7-O-glucoside, 22,708 mg/kg oleuropein, 6471 mg/kg luteolin-4-O-glucoside and 4537 mg/kg apigenin-7-O-glucoside [126]. The concentrations varied with different extraction methods, highlighting the impact of solvent choice on the yield of bioactive compounds.
The phytochemical diversity of O. europaea extends beyond the leaves. The stems and branches are rich in secondary metabolites, including triterpenoids like maslinic acid and erythrodiol, and phenolic substances like taxifolin, comselogoside, and oleuropein [127]. The fruit is notable for its valuable phenolic composition, characterized by flavonoids, secoiridoids, coumarins, phenolic acids, and triterpenoids [128,129,130]. Biophenol secoiridoids, including oleuropein, dimethyl-oleuropein, and ligstroside, along with their hydrolysis derivatives such as oleacein, oleocanthal, and hydroxytyrosol, have been isolated from olive leaves [131,132]. The leaves also contain triterpenes (e.g., maslinic acid, oleanolic acid), coumarins (e.g., scopoletin, aesculetin), alkaloids (e.g., cinchonidine, cinchonine), and chalcones (e.g., olivine-4′-O-diglucoside, olivine) [133]. The olive tree’s bioactive molecules exhibit a wide range of biological activities, including antidiabetic, antibacterial, antifungal, antioxidant, anti-inflammatory, and anticancer effects [134,135,136,137,138]. These activities are largely attributed to the high concentrations of phenolic compounds and triterpenoids found in various parts of the plant.

3.3.6. Nigella sativa

N. sativa, commonly known as “black seeds”, is widely distributed across North Africa, the Middle East, Europe, and Asia [139]. It has been traditionally used for culinary and medicinal purposes for millennia, particularly in Arab countries, the Indian subcontinent, and Europe [140]. The chemical composition of N. sativa is well documented. Subsequent studies have identified that the medicinal value of N. sativa is primarily attributed to thymoquinone (TQ) [141]. Other significant components of N. sativa include carvacrol, p-cymene, thymohydroquinone (THQ), dihydrothymoquinone (DHTQ), thymol, α-thujene, α, β- pinene, t-anethole, and γ-terpinene [141]. The EO of N. sativa contains molecules such as monoterpenoid alcohols, monoterpenes, diterpenes, sesquiterpenes, and ketones, with TQ being a predominant compound [142,143]. N. sativa seeds also contain a variety of phenolic compounds, including ferulic acid, gallic acid, vanillic acid, chlorogenic acid, quercetin, p-coumaric acid, catechin, rutin, nigelflavonoside B, apigenin, and flavone [144,145]. Various alkaloids, such as nigellicine (composed of an indazole nucleus) [146], nigellimine (an isoquinoline molecule) [147], and nigellidine (another indazole compound) [148], have been isolated. Saponins, secondary metabolites in N. sativa, exhibit a notable affinity for cell membranes due to their amphiphilic nature [149]. In different studies, several saponins have been isolated and identified in the aerial parts of the plant [145], including Kaempferol 3-O-rutinoside, nigelloside, and Flaccidoside.
In various studies, N. sativa seeds were found to contain 28.5% fat, 26.7% protein, 24.9% carbohydrates, 8.4% crude fiber, and 4.8% total ash [150,151]. They are also rich in unsaturated fatty acids, primarily linoleic acid (50–60%), oleic acid (20%), dihomolinoleic acid (10%), and eicodadienoic acid (3%). Saturated fatty acids like palmitic and stearic acids make up about 30% or less of the seed’s composition [152,153,154]. NS seeds have also been reported to contain compounds such as avenasterol-5-ene, nigellone, avenasterol-7-ene, 24-methylenecycloartanol, cholesterol, campesterol, citrostadienol, gramisterol, cycloeucalenol, lophenol, stigmastanol, obtusifoliol, stigmasterol-7-ene, butyrospermol, β-amyrin, cycloartenol, and others [155,156]. These compounds contribute to the plant’s rich phytochemical composition, which includes more than 50% terpenoids and terpenes among the identified molecules [157]. N. sativa seed oil contains sterols, with β-sitosterol as the major component (48.35–51.92%), followed by 5-avenasterol, campesterol, and stigmasterol [158,159]. N. sativa’s extensive phytochemical profile includes a variety of polyphenols, such as kaempferol and quercetin, which contribute to its antioxidant properties. For example, N. sativa seeds contain 105.55 g of dry weight polyphenols, with kaempferol and quercetin being the most abundant [160,161].

3.3.7. Allium cepa

A. cepa, commonly known as onion, is widely used as a vegetable, spice, and in traditional medicine [162]. The bulbs of onion are rich in secondary metabolites, including flavonoids, polyphenols, and steroids/triterpenoids. Notably, fifteen polyphenol compounds have been identified in bulbs, including quercetin derivatives like quercetin 3-glucoside, quercetin 4′-glucoside, and isorhamnetin derivatives [163,164,165,166]. Research has highlighted that onion extracts contain various bioactive compounds. For instance, hot 80% ethanol extraction has been reported to yield carbohydrates such as fructo-oligosaccharides [167]. Moreover, fresh leaf hydrodistillates contain allicin and various disulfides [168], while the 80% methanol extract of dry roots revealed the presence of steroid saponins such as alliospiroside A [169].
Onion skins, which are often discarded as waste, are particularly rich in carbohydrates (88.56%), and also contain protein (0.88%), ash (0.39%), and crude fiber (0.15%) [170]. The skins are a valuable source of phenolic compounds, including quercetin and its derivatives, along with flavonoids, flavanols, anthocyanins, vanillic acid, and ferulic acid. High-performance liquid chromatography has detected numerous polyphenolics in red onion skins, such as catechin, chlorogenic acid, and kaempferol, alongside anthocyanins like cyanidin 3-laminaribioside and cyanidin 3-(6″-malonylglucoside) [171].
Phenolic compounds, derived from cinnamic or benzoic acid, are responsible for the color, flavor, bitterness, and odor of plants. The concentration of these compounds varies between onion varieties, with red skins typically having the highest phenolic content (23.67 free, 12.50 esterified, and 25.45 mg GAE/g bound phenolics), followed by yellow skins (22.71 free, 10.75 esterified, and 17.96 mg GAE/g bound phenolics) [172]. Flavonoids, a significant subgroup of phenolics, are abundant in onions. These include flavonols such as quercetin and kaempferol, and anthocyanins, which contribute to the red or purple color of certain onion varieties. Quercetin derivatives, like quercetin 4′-O-glucoside and quercetin 3,4′-O-diglucoside, represent about 90% of the total flavonoid content in various Allium species, with red onions containing higher amounts than white ones. The flavonoid content in red onion skins ranges from 1.276 to 169 mg/g, compared to 0.08 mg/g in white onion skins [173,174,175]. Phenolic acids like benzoic and cinnamic acid derivatives, along with coumarins and lignans, have also been identified in onions. For example, six coumarins, including scopoletin and esculin, were reported in yellow onion bulbs, and lignans like syringaresinol have been found in onion skins [176,177].
Onion skins also contain organosulfur compounds and phenolic acids. For instance, the total organosulfur compound content in onions is 19%, with onion waste ranging from 15 to 35% [178]. Organosulfur compounds such as trans-(+)-S-1-propenyl-L-cysteine sulphoxide, and other sulfur-containing amino acids contribute to the onion’s characteristic odor and lachrymatory effect [179,180].

3.3.8. Artemisia herba-alba Asso

A. herba-alba, locally known as “Shih”, is a greenish-silver perennial herb [181]. Renowned for its medicinal properties, this plant has been widely used in traditional medicine across various cultures since ancient times [181,182,183]. EO extraction revealed the presence of fifty-four compounds, representing 94.1% of the total composition [184]. The EO is primarily constituted by 80.3% oxygenated monoterpenes, followed by 10.8% monoterpene hydrocarbons, and 0.2% oxygenated sesquiterpenes. The major compounds include 48.0% α-thujone, 13.4% β-thujone, and 13.1% camphor, with minor components such as 3.6% camphene, 1.4% γ-terpinene, 1.3% borneol, and 1.0% p-cymene [184]. In total, 27 and 10 compounds were identified, representing 96.19% of A. herba-alba EO. The major constituents were terpinen-4-ol (37.25%) and ocimene (9.37%) [185]. Amor et al. [186] also reported that oxygenated monoterpenes predominated in A. herba-alba EO extracted by hydrodistillation from the Azzemour region, Southwest Morocco, with cis- and trans-thujone, vanillyl alcohol, and nor-davanone as principal constituents. Meanwhile, EO from the Er-rachidia province in south central Morocco was characterized by chrysanthenone and camphor as the main constituents [187]. In contrast, Benabdallah et al. [188] found different dominant compounds in Algerian A. herba-alba, including β-copaene (16.22%), limonene (14.56%), and eucalyptol (14.49%).
A. herba-alba extract revealed the presence of flavonoids, terpenoids, phenols, tannins, and reducing compounds, with no detection of alkaloids, free quinines, glycosides, or saponins [189]. The RP-HPLC analysis of the aqueous extract indicated the presence of compounds belonging to flavonoids (catechin, apigenin, luteolin) and phenolic acids, with a notable concentration of caffeic acid. Apigenin was also detected in A. herba-alba samples from Egypt and Tunisia [190]. The contents of phenolic compounds, flavonoids, and tannins varied between extracts, with the aqueous extract showing the highest concentrations [189]. The TP (263.93 mg GAE/g E), TF (40.94 mg QE/g E), and total tannins (35.99 mg GAE/g E) were significantly higher in the 80% aqueous ethanolic extract than in the methanolic and distilled water extracts. The ethyl acetate extract contained the lowest values of these bioactive compounds [191]. The quantitative and qualitative differences in polyphenol content are influenced by plant origin, solvent nature, and extraction methods [192,193]. Additionally, environmental stress, such as water deficit, can induce phenolic compound synthesis [194].

3.3.9. Allium sativum

Garlic is one of the oldest horticultural crops and has been used since ancient times for both culinary and medicinal purposes [195]. Phytochemical analysis revealed that garlic bulbs are rich in sulfur-containing compounds [196], which constitute up to 82% of the total sulfur content [197]. Key compounds include thiosulfinates (e.g., allicin), sulfides (diallyl disulfide, diallyl trisulfide), vinyldithiins (2-vinyl-(4H)-1,3-dithiin, 3-vinyl-(4H)-1,2-dithiin), and ajoenes (E-ajoene, Z-ajoene) [197,198]. Allicin, derived from alliin via the allinase enzyme upon cutting or crushing garlic, is one of the main bioactive molecules, along with S-methyl cysteine-sulfoxide and S-propyl-cysteine-sulfoxide, which are responsible for garlic’s characteristic odor [198]. These sulfur compounds can further transform into other molecules such as allyl methane thiosulfinates and methyl methanethiosulfonate, depending on water content, temperature, and enzymatic activity [198].
Garlic formulations also contain other organosulfur compounds like N-acetylcysteine, S-allyl-cysteine, and S-ally-mercapto cysteine, all of which are derived from alliin [199,200]. In quantitative studies, garlic extracts have been reported to contain 65 µg/mL chlorogenic acid, 44 µg/mL p-coumaric acid, and 25 µg/mL 4-hydroxybenzoic acid [201]. The TP in garlic varies between 11.05 and 20.63 mg GAL/g DM, while TF ranges from 0.94 to 2.12 mg QE/g DM [202]. The allicin content in garlic ranges between 3.69 and 7.12 mg/g DM, and alliin ranges between 2.5 and 5.38 mg/g DM [202]. Garlic is also reported to contain a variety of other bioactive compounds, including saponins, steroids, flavonoids, phenols, tannins, and cardiac glycosides [203].

3.3.10. Marrubium vulgare

M. vulgare, native to the region between the Mediterranean Sea and Central Asia, is now widespread across all continents [204]. The plant produces trace amounts of EO, primarily composed of monoterpenes such as camphene, fenchene, p-cymol, limonene, sabinene, α-pinene, and α-terpinolene [205]. Non-volatile monoterpene derivatives like marrubic acid and sacranoside A, along with sesquiterpene lactone vulgarin, β-sitosterol, lupeol, and triterpenoids such as oleanolic acid, have been identified in M. vulgare extracts [206,207,208,209]. Diterpenes of the labdane type, including 0.12–1% marrubiin, 0.13% pre-marrubiin, and other related compounds, are the principal bitter components [210,211,212].
In terms of phenolic compounds, M. vulgare is rich in phenolic acids, cinnamic acids, and flavonoids. The total cinnamic acid derivatives are estimated at 14.09 mg/100 mg of dry material, with condensed tannins at 16.55 mg catechin/100 g [213,214]. Specific compounds include gallic, gentisic, and syringic acids; trans-cinnamic, ferulic, and p-coumaric acids; and hydroxycinnamic acid derivatives such as acteoside [215,216,217]. Flavonoid fractions contain apigenin, luteolin, chrysoeriol, and diosmetin, among others [216]. M. vulgare also accumulates marrubiin in its leaves and trichomes, with levels influenced by the plant’s developmental stage. The central diterpenoid precursor, geranylgeranyl pyrophosphate, is crucial for the biosynthesis of marrubiin and related metabolites [218,219]. Studies on M. vulgare EO reveal significant variation across regions. Major components include germacrene D, β-caryophyllene, and bicyclogermacrene, with some studies also identifying E-caryophyllene and β-bisabolene as key constituents [220,221,222,223,224,225]. Additionally, horehound extracts are rich in polyphenols (55.72 mg gallic acid equivalent/mL), flavonoids (11.01 mg catechin equivalent/mL), phenolic acids (4.33 mg caffeic acid equivalent/mL), and condensed tannins (4.46 mg delphinidin equivalent/mL) [226,227].
Moroccan medicinal plants traditionally used for diabetes management, and studied herein, contain bioactive compounds with proven antidiabetic properties (Table 4, Figure 8). For example, we can list the following:
-
Flavonoids. T. foenum-graecum, O. europeae, N. sativa, A. sativum, and A. cepa have been reported to be rich in flavonoids, including quercetin and kaempferol, which are known for their antioxidant and hypoglycemic effects;
-
Phenolic Acids. R. officinalis, S. officinalis, A. sativum, and M. vulgare contain significant amounts of phenolic acids such as rosmarinic acid, which is linked to glucose metabolism regulation and insulin sensitivity;
-
Terpenoids. Plants like T. foenum-graecum, N. oleander, O. europeae, N. sativa, A. cepa, A. herba-alba Asso, and M. vulgare have demonstrated a high content of terpenoids, which contribute to their antidiabetic and anti-inflammatory activities;
-
Alkaloids. Alkaloids have been identified in N. oleander, O. europeae, and N. sativa, which are known to influence insulin release and glucose absorption pathways.

3.4. In Vivo and In Vitro Antidiabetic Effects of Moroccan Medicinal Plants

Diabetes mellitus, a global health challenge characterized by chronic hyperglycemia due to impaired insulin secretion, insulin action, or both, is often managed with synthetic drugs that can cause significant side effects. Consequently, there is growing interest in natural alternatives, including Moroccan medicinal plants, which have been extensively studied for their antidiabetic properties [228,229]. These plants have demonstrated in vivo potential to reduce blood glucose levels, enhance insulin secretion, protect pancreatic β-cells, and stimulate glycogen biosynthesis, as evidenced by 133 manuscripts investigating their effects.
Enzymes like α-amylase, α-glucosidase, and β-glucosidase control the degradation of carbohydrates in the intestine, which raises blood glucose levels. The inhibition of these enzymes is a key strategy for managing type 2 diabetes [230,231]. Although synthetic inhibitors like acarbose are effective, they are associated with adverse effects such as digestive disorders and increased liver enzyme levels [232,233,234]. As a result, research has focused on plant-derived alternatives, including Moroccan medicinal plants rich in secondary metabolites like alkaloids, phenolic acids, flavonoids, and terpenoids, which have shown significant in vitro antidiabetic effects [230,231]. Notably, the 10 Moroccan medicinal plants most widely used, belonging to six botanical families, have been tested for their in vivo antidiabetic activity against these enzymes, with some also showing in vitro efficacy (Table 5) [235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,306,307,308,309,310,311,312,313,314,315,316,317,318,319,320,321,322,323,324,325,326,327,328,329,330,331,332,333,334,335,336,337,338,339,340,341,342,343,344,345,346,347,348,349,350,351,352,353,354,355,356,357,358,359,360,361,362,363].
Table 4. Chemical compounds of the most useful antidiabetic Moroccan medicinal plants.
Table 4. Chemical compounds of the most useful antidiabetic Moroccan medicinal plants.
Plant SpeciesUsed PartsExtract/EOGroupsCompoundsReferences
T. foenum-graecumLeaves/seeds/stems/flowersAqueous extractFlavonoidsQuercetin/kaempferol[75]
StemsAqueous extractPhenolic acidsGallic acid/caffeic acid[75,76]
SeedsEOTerpenoidsNeryl acetate/camphor/β-pinene/α-selinene [79,80]
Seeds4-hydroxyisoleucineAlkaloidsTrigonelline[243]
N. oleanderSeedsAqueous extractFlavonoidsRutin/kaempferol[84,87]
Flower/Leaves Ethanolic extractPhenolic acidsCinnamic acid/chlorogenic acid[89]
FlowersEOTerpenoidsNeriine/digitoxigenin [86]
Leaves/SeedsAqueous extractAlkaloidsOleandrin/odoroside [83,84]
R. officinalisAerial partsAqueous extractFlavonoidsLuteolin/apigenin/diosmin [96]
Aerial partsAqueous extractPhenolic acidsRosmarinic acid/caffeic acid[96]
Aerial partsEOTerpenoids1,8-cineole/α-pinene/camphor/carnosol/ursolic acid [91,93]
S. officinalisAerial partsAqueous extractFlavonoidsLuteolin/apigenin [111]
PowderAqueous extractPhenolic acidsRosmarinic acid/salvianolic acid [113,114,115]
LeavesEOTerpenoids1,8-cineole/α-β thujone/camphor[108,109]
O. europaeaFruitsOilFlavonoidsQuercetin/luteolin/apigenin [125]
LeavesOil/Aqueous extractPhenolic acidsHydroxytyrosol/oleuropein/verbascoside[126,312]
Leaves/stems/branchesAqueous extractTerpenoidsMaslinic acid/oleanolic acid [127,133]
LeavesAqueous extractAlkaloidsCinchonidine/cinchonine [133]
N. sativaSeedsAqueous extractFlavonoidsQuercetin/rutin/apigenin/catechin/nigelflavonoside B. [144,145]
SeedsAqueous extractPhenolic acidsFerulic acid/gallic acid/vanillic acid/chlorogenic acid/p-coumaric acid[144,145]
SeedsEOTerpenoidsThymoquinone/THQ/DHTQ/α-thujene/β-pinene/γ-terpinene. [141]
SeedsEthanolic extractAlkaloidsNigellicine/nigellimine/nigellidine[147,148]
A. cepaBulbsAqueous extractFlavonoidsQuercetin 3-glucoside/quercetin 4′-glucoside/isorhamnetin[163,164,165,166]
Onion skinsEthanolic extractPhenolic acidsChlorogenic acid/vanillic acid/ferulic acid[171]
RootsMethanol extractTerpenoidsAllicin/disulfides/steroid saponins (alliospiroside A) [169]
A. herba-albaAerial partsAqueous extractFlavonoidsApigenin/catechin/luteolin. [190]
Leaves/Aerial partsAqueous extractPhenolic acidsCaffeic acid/tannins[189,190]
Leaves EOTerpenoidsα- β-thujone/camphor/terpinen-4-ol/ocimene[184]
A. sativumBulbsAqueous extractFlavonoidsQuercetin (trace)[203]
BulbsAqueous extractPhenolic acidsChlorogenic acid/p-coumaric acid/4-hydroxybenzoic acid [201]
BulbsEOTerpenoidsAllicin, diallyl disulfide, diallyl trisulfide, ajoene.[197,198]
BulbsAqueous extractAlkaloidsS-allyl cysteine[198]
M. vulgareAerial partsAqueous extractFlavonoidsApigenin/luteolin/chrysoeriol/diosmetin[216]
Aerial partsAqueous extractPhenolic acidsGallic acid/gentisic acid/syringic acid/cinnamic acid/ferulic acid/p-coumaric acid[215,216,217]
Flowers/Aerial parts/LeavesEOTerpenoidsMarrubic acid/marrubiin/germacrene D/β-caryophyllene/bicyclogermacrene. [220,221,222,223,224,225]
Table 5. In vitro and in vivo studies of Moroccan medicinal plants used in diabetes management.
Table 5. In vitro and in vivo studies of Moroccan medicinal plants used in diabetes management.
FamilySpeciesExtractsParts UsedAdministrated Dose Model/Experimental MethodsKey ResultsReferences
LeguminosaeTrigonella foenum-graecumMethanolic extractSeeds 2 g/kgOral glucose tolerance test
Normal albino rats
Reduction in blood glucose[235]
Hydroalcoholic extractSeeds100 μL of extract for α-amylase/60 μL of extract for α-glucosidaseα-amylase and α-glucosidase inhibition assayHigh inhibitory activity of α-amylase and α-glucosidase[236]
Aqueous extractSeeds300 mg/kgSTZ-induced diabetic ratsIM6E demonstrated strong α-glucosidase activity and moderate α-amylase and invertase inhibition activities under in vitro conditions[237]
Ethanolic extractSeeds1 g/kgNormal and alloxan-induced diabetic ratsDecreased blood glucose to 12.40% level in alloxan-induced rats
No acute toxicity
[238]
Aqueous extractSeeds0.44/0.87/1.74 g/kg for 6 weeksSTZ-induced diabetic ratsIncreases body weight and decreases fasting blood glucose [239]
Aqueous extractSeeds2.5 g/kgNormal and alloxan induced diabetic rabbitsReduction in plasma glucose levels in the fenugreek-treated rabbits[240]
Ethanolic extractSeeds 25 g seed mucilage/rat/daySTZ-induced diabetic ratsAmelioration of the diabetic state[241]
Aqueous extractSeeds100 mg/kgSTZ-induced diabetic ratsReduced blood glucose levels
Urea levels decreased following daily intraperitoneal injection
[242]
Solution of
4-hydroxyisoleucine
Seeds50 mg/kgSingle and repeated injection STZ-induced type I diabetic ratsLevels of insulin are reduced by 65%[243]
Hydroalcoholic extractSeeds400 mg/kgSTZ-induced diabetic ratsDecreased blood glucose levels[244]
Powder Seeds 5 g of dry FSP mixed with 95 g of powdered rat feed) for 21 daysAlloxan induced diabetic ratsFSP treatment increased insulin levels in diabetic rats to nearly 80%[245]
ApocynaceaeNerium oleanderAqueous extractLeaves Nda-amylase inhibition assayBreakdown of starch to maltose, maltotriose, various oligoglucans is mediated by α-amylase enzyme followed by subsequent α-glucosidase activity to finally yield glucose[246]
PowderLeaves16 g dry leaves/kg Normal ratsInhibitory activity of α-glucosidase
Reduced the blood glucose level in maltose- and sucrose-loaded rats at very high dose of 16 g/kg
[247]
Methanolic extractLeaves200 mg/kgAlloxan induced diabetic ratsReduced blood glucose level by 73.79%
OGTT revealed increase in glucose tolerance by 65.72%
No mortality was observed in the experiment
[248]
Methanolic extractFlowersNdRats L6 myogenic cellsDecreasing the blood glucose level and inhibition of α-amylase[249]
Plant extractNd250 mg/kg for 4 weeksSTZ-induced diabetic ratsImprovement in insulin and glucose levels[250]
Ethanolic extractFlowers225 mg/kgSTZ-induced diabetic ratsDecrease glucose level[251]
PowderShoots375 μg/0.5 mL of distilled water for 12 weeksHigh-fat-diet-fed STZ-induced diabetic ratsReduced fasting blood glucose[252]
Chloroform and ethanolic extractLeaves50 mg to 5000 mg/kgAlloxan-induced diabetic ratsPrevented body weight loss in diabetic rats
No sub-acute glucose reduction
[253]
LamiaceaeRosmarinus officinalisEOLeaves250 µlα-amylase inhibition assayInhibitory activity of α-amylase[254]
Aqueous extractAerial parts100 µg/20 µL distilled waterα-glucosidase inhibition assayHigh inhibitory activity of α-glucosidase[255]
Ethanolic extractLeaves100 mg of RAEα-amylase inhibition assayInhibited amylase activity by 85%[256]
Diethyl ether and n-butanol extractLeaves800 mg/kgα-glucosidase assay
Oral glucose tolerance test
Normal and STZ-induced diabetic rats
Inhibitory activity of α-glucosidase
Decrease glucose level
Inhibited glucose intestinal transport
[257]
Ethanolic extractLeaves 20 mg/0.6 waterNormal and STZ-induced diabetic ratsStrong α-glucosidase inhibitory[258]
Powder Leaves12% for 6 weeksNormal and STZ-induced diabetic ratsReduced fasting blood glucose[259]
Ethylacetate extractNd300 mg/kgNormal and alloxan-induced diabetic ratsReduced fasting blood glucose[260]
Aqueous extractLeaves200 mg/kg for 21 daysNormal and STZ-induced diabetic ratsReduced the glucose level[261]
Aqueous extractLeaves1.11 gm/mL/dayNormal and STZ-induced diabetic ratsReduced blood glucose level
Reduced fasting plasma glucose
[262]
Aqueous extractLeaves200 mg/kg for 21 daysNormal and STZ-induced diabetic ratsReduced fasting plasma glucose[263]
Aqueous extractLeaves200 mg/kg for 21 daysNormal and STZ-induced diabetic ratsReduced fasting plasma glucose[264]
PowderLeaves5 g/100 g dietNormal and STZ-induced diabetic ratsReduced blood glucose level[265]
Aqueous extractLeaves200 mg/kg for 21 daysNormal and STZ-induced diabetic ratsIncreased serum insulin, C-peptide while decreased ALT and aspartate aminotransferase[266]
Aqueous extractLeaves200 mg/kg/daySTZ-induced diabetic ratsIncreased serum insulin level
Reduced fasting plasma glucose
[267]
Aqueous extractLeaves200 mg/kg for 21 daysSTZ-induced diabetic ratsReduced blood glucose level
Reduced antioxidant status of diabetic rats
[268]
Rosmarinic acidLeaves120–200 mg/kgSTZ-induced type 1 diabetes rats or high-fat-diet (HFD)-induced type 2 diabetes ratsDecreased plasma glucose levels and improved insulin sensitivity[269]
Rosmarinic acidLeaves577 µg/mLSTZ-induced diabetic rats
High-fat-diet-induced diabetic rats
Reduced fasting plasma glucose
Increased insulin levels without affecting liver glycogen levels
[270]
Ethanolic extractLeaves200 mg/kg for 7 daysAlloxan-induced diabetic ratsReduced fasting plasma glucose and increased serum insulin[271]
Powder Leaves20% of powder for 45 daysAlloxan-induced diabetic ratsReduced fasting plasma glucose[272]
Rosmarinic acidLeaves100–200 mg/kg for 8 weeksAlloxan-induced diabetic ratsInhibited glomerular hypertrophy, glomerular number loss and glomerulosclerosis[273]
Salvia officinalisAqueous extractAerial parts Ndα-amylase and α-glucosidase inhibition assayInhibitory activity of α-amylase and α-glucosidase [274]
EOLeaves5% to 75%α-glucosidase inhibition assayInhibitory activity of α-glucosidase[275]
Aqueous extractAerial parts50 µLα-glucosidase inhibition assayInhibitory activity of α-glucosidase[276]
Ethanolic extractLeaves0–200 µgα-glucosidase inhibition assayInhibitory activity of α-glucosidase[112]
Water and ethanolic extractNd12%α-glucosidase inhibition assayInhibitory activity of α-glucosidase[277]
Ethylacetate extractAerial parts20–300 mg/mLα-amylase and α-glucosidase inhibition assayInhibitory activity of α-amylase and α-glucosidase[278]
Methanolic extractLeaves250 and 500 mg/kg for 21 daysα-glucosidase inhibition assay
Oral glucose tolerance test
Normal and alloxan-induced diabetic rats
Inhibitory activity of α-glucosidase
Reduced postprandial blood glucose
[279]
Ethanolic extractLeaves and flowers300 mg/kgAlloxan induced diabetic ratsReduced blood glucose and cholesterol [280]
Ethanolic extractLeaves 0.2 and 0.4 g/kg for 14 daysNormal and STZ-induced diabetic ratsReduction in serum glucose and increased plasma insulin in[281]
Aqueous and ethanolic extractsLeaves100 mg/kg for 14 daysNormal and alloxan-induced diabetes
in white rats
Reduced blood glucose[282]
Water ethanol extractLeaves500 mg/kgNormal and alloxan-induced diabetic miceReduced blood glucose[283]
Aqueous extractLeaves300 mg/kg for 5 weeksNormal and alloxan-induced diabetes ratsReduced blood glucose[284]
Aqueous extractLeaves400 and 600 mg/kg for 7 daysAlloxan-induced diabetic miceReduced fasting blood glucose[285]
Methanolic extractLeaves100–500 mg/kgSTZ-induced diabetic ratsDecreased serum glucose after 3 h of administration[286]
Marrubium vulgareAqueous extractLeaves400 mg/kgα-amylase inhibition assay
Normal rats
Inhibitory activity of pancreatic α-amylase
Reduced blood glucose
[287]
Hydro-alcoholic extractLeavesNdα-amylase inhibition assay Inhibitory activity of pancreatic α-amylase [288]
Methanolic extractAerial parts500 mg/kg for 28 daysSTZ-induced diabetic ratsIncreased plasma insulin
Reduced blood glucose
[289]
Methanol, water and butanol extractWhole plant1 and 2 mg/mL for 28 daysCyclosporine A and STZ-induced diabetic ratsInduced autoimmune diabetes mellitus-type1 induced by cyclosporine A and STZ in mice[290]
Aqueous extractAerial parts100, 200 and 300 mg/kgNormal and alloxan-induced diabetes
rats
Increased plasma insulin and tissue glycogen[214]
Aqueous extractLeaves 300 mg/kgNormal and alloxan-induced diabetes ratsIncreased plasma insulin
Reduced blood glucose
[291]
Ethanolic extractWhole plant100 mg/kgNormo-glycemic ratsIncreased plasma insulin
Reduced blood glucose
[292]
Oleaceae Olea europaeaAlcoholic extractLeaves0.1, 0.25 and 0.5 g/kg for 14 daysNormal and STZ-induced diabetic ratsDecreased the serum glucose
Increased the serum insulin in diabetic rats
[293]
NdLeaves1 g/kg for 14 daysSTZ-induced diabetic ratsDecreased blood glucose level[294]
Alcoholic extractLeaves1 g/kgSingle and repeated injection STZ-induced diabetic ratsImproved glucose homeostasis through the reduction of starch digestion and absorption[295]
Aqueous extractLeaves100 and 200 mg/kgSTZ-induced diabetic ratsDecreased serum glucose level[296]
PowderLeaves6.25%STZ-induced diabetic ratsDecreased serum glucose level by 38%[297]
Ethanolic extractLeaves300 and 500 mg/kg/daySTZ-induced diabetic ratsInhibited high-glucose-induced neural damage[298]
Ethanolic extractLeaves3 and 5 mg/kgSTZ-induced diabetic ratsThymoquinone and oleuropein significantly decrease serum glucose levels[299]
Aqueous extractLeaves and fruits1 g/kgNormal and STZ-induced diabetic ratsDecreased blood glucose level at 4th week compared to the diabetic control rats[300]
PowderLeaves17.8 mg/kgSTZ-induced diabetic ratsReduced blood glucose tolerance curve[301]
Aqueous extractLeaves200 and 400 mg/kgNormal and STZ-induced diabetic ratsDecreased serum insulin level[302]
Ethanolic extractLeaves200 and 400 mg/kg for 10 weeksHFD STZ-induced diabetic ratsIncreased serum insulin level[303]
Aqueous extractLeaves1% and 3%STZ-induced diabetic ratsExerted antihyperglycemic effects via AS160 inhibition[304]
Aqueous extractLeaves1 mg/mL
200 mg/kg
α-glucosidase inhibition assay
Normal and STZ-induced diabetic rats
Strong α-glucosidase inhibitory activity
Reduced blood glucose
[305]
Ethanolic extractLeaves100 mg/kgNormal and HFD ratsReduced blood glucose and insulin levels[306]
Alcoholic extractLeaves8 and 16 mg/kgAlloxan-induced diabetic ratsDecreased serum glucose level[307]
Aqueous extractLeaves3% and 6%Alloxan-induced diabetes ratsDecreased blood glucose level[308]
Aqueous extractLeaves100–600 mg/kg Normal and alloxan-induced diabetes ratsDecreased blood glucose level
Increased plasma insulin level
[309]
Hydroethanolic extractLeaves5–20 mg/kg for 40 daysNormal and alloxan-induced type 1 diabetic ratsDecreased blood glucose level[310]
Ethanolic extractLeaves600 mg/kgAlloxan-induced diabetic rabbitsReduced blood glucose level by 20%[311]
Aqueous extractLeaves20 mg/kg for 16 weeksNormal and alloxan-induced diabetes rabbitsDecreased blood glucose level[312]
Ethanolic extractLeaves3.85 mg/mlα-glucosidase inhibition assayInhibitory activity of α-glucosidase[313]
Hydro-alcoholic extractOil 500 to 31.25 mg/mL.α-glucosidase and α-amylase inhibition assayInhibitory activity of α-glucosidase
Less inhibitory activity of α-amylase
[314]
Ethyl acetate extractStems10 µLα-amylase inhibition assayInhibitory activity of α-amylase[315]
Hydro-alcoholic extractLeaves100–600 µMα-glucosidase and α-amylase inhibition assayInhibitory activity of α-glucosidase
Less inhibitory activity of α-amylase
[134]
RanunculaceaeNigella SativaAqueous extractSeeds10–50 μLα-glucosidase inhibition assayInhibitory activity of α-glucosidase[316]
Ethanolic extractSeeds2 g/kg for 4 weeksOral glucose tolerance testHypoglycemic and hypolipidemic activity[299]
Aqueous extractSeeds2 g/kgOral glucose tolerance testImproved glucose tolerance in rats[317]
Aqueous methanol
Oil
Seeds810 mg/kg for 25 days
2.5 mL/kg for 25 days
Normal and alloxan-induced diabetes ratsAdministration of the crude methanolic extract and the oil decreased significantly the blood glucose after 10 days of treatment[318]
Methanolic extract/Oil Seeds2.5 mL/kg for 24 daysNormal and alloxan-induced diabetes rabbitsDecreased blood glucose level[319]
Ethanolic extractSeeds20 and 40% of pulverized extract (for 24 days)Normal and alloxan-induced diabetes
rats
Decreased blood glucose level[320]
Ethyl acetate fraction of Ethanolic extractSeeds200–1000 mg/kgAlloxan-induced type 2 diabetes ratsReduced blood glucose level[321]
Ethanolic extractSeeds100, 200, and 400 mg/kg for 6 weeksSTZ-induced diabetic ratsDecreased serum glucose level[322]
Methanolic extractSeeds500 mg/kgSTZ-induced types 2 diabetic ratsReduced postprandial glucose, and improved glucose tolerance in rats [323]
NdSeeds0.5–1.5 mLSTZ-induced diabetic ratsReduced serum glucose level[324]
Ethanolic extractSeeds300 and 600 mg/kg for 7 daysHFD STZ-induced diabetic ratsReduced blood glucose level[325]
Ethanolic extractSeeds100 mg/kg for 28 daysSTZ-induced diabetic ratsDecreased blood glucose level[326]
OilSeeds400 mg/kg for 4 weeksSTZ-induced diabetic hamstersDecreased blood glucose level[327]
OilSeeds2 mg/kg for 30 daysSTZ-induced diabetic ratsReduced fasting blood glucose and increased insulin levels[328]
Petroleum ether
extract
Seeds2 g/kg for 4 weeksSTZ-induced diabetic ratsThe petroleum ether extract exerted an insulin-sensitizing action [329]
Ethanolic extractSeeds Polys35–140 mg/kg for 4 weeksHFD STZ-induced types 2 diabetic ratsReduced fasting plasma glucose and increased serum insulin [330]
AlliaceaeAllium cepaEthyl alcohol extract
Quercetin
Skin1–3 mg/mLα-amylase and α-glucosidase inhibition assayInhibitory activity of α-amylase and α-glucosidase[331]
Methanolic extractSkinNdα-glucosidase inhibition assayInhibitory activity of α-glucosidase[332]
Ethanolic extractSkin30 mg/mL
0.1–0.5 mg/mL
α-amylase inhibition assay
α-glucosidase inhibition assay
Inhibitory activity of α-amylase α-glucosidase assay[333]
Aqueous extractsSkin0.01–10 mg/mLα-amylase inhibition assayInhibitory activity of α-amylase[334]
Hydroethanolic extractSkin10 µg/mLα-glucosidase inhibition assayInhibitory activity of α-glucosidase[335]
Hydromethanolic extractSkinNdα-glucosidase inhibition assayInhibitory activity of α-glucosidase[336]
EOBulbs100 mg/kg for 21 daysSTZ-induced diabetic ratsDeceased blood glucose and increase in serum insulin[337]
Ethanolic extractBulbs150 and 300 mg/kgNormal and STZ-induced diabetic ratsDecreased fasting blood glucose
Increased serum insulin levels
[338]
Ethanolic extract
Quercetin
Bulbs0.5 or 1% for 8 weeks
0.1% for 8 weeks
Oral glucose tolerance test
Normal and HFD STZ-induced diabetic rats
Improves insulin sensitivity by upregulating expressions of insulin receptor and glucose transporter[339]
Powder Bulbs 0.5 and 2% for 4 weeksNormal and HFD STZ-induced diabetic ratsSerum insulin concentrations and insulin resistance were dose-dependently increased in the onion-fed groups[340]
Aqueous extractWhole plant200–300 mg/kg for 6 weeksAlloxan-induced diabetic ratsReduced fasting blood glucose level by 75.4% at 300 mg/kg[341]
Aqueous extractBulbs 1 mL for 4 weeksNormal and alloxan-induced diabetic ratsReduced their plasma glucose levels by 70% [342]
PowderBulbs12.5% for 15 daysNormal and HFD alloxan-induced diabetic ratsReduced fasting blood glucose level[343]
Allium sativumAqueous extractBulbs 1250 µg/mLα-amylase inhibition assayInhibitory activity of α-amylase [344]
OilBulbs5–10%α-amylase inhibition assayInhibitory activity of α-amylase [346]
PolysaccharideBulbs0.5–4.0 mg/mLα-amylase and α-glucosidase inhibition assayInhibitory activity of α-amylase and α-glucosidase[347]
PowderBulbsNdConvective hot-air drying
α-amylase and α-glucosidase inhibition assay
Inhibitory activity of α-amylase and α-glucosidase [348]
Allyl methyl sulfideBulbs50–200 mg/kg for 30 daysSTZ-induced diabetic ratsReduced blood glucose level
Regulate insulin production and sensitivity in pancreatic β-cells
[349]
Ethanolic extractBulbs0.1–0.5 g/kg for 14 daysNormal and STZ-induced diabetic ratsDecreased serum glucose level[350]
Aqueous extractBulbs 500 mg/kg for 3 weeksSTZ-induced diabetic ratsDecreased serum glucose level[351]
PolysaccharideBulbs1.25–5.0 g/kg for 5 weeksSTZ-induced diabetic ratsReduced fasting blood glucose[352]
Aqueous extractBulbs 300 μL
200–400 mg/kg for 4 weeks
α-amylase inhibition assay
Oral glucose tolerance
Alloxan-induced diabetic rats
Inhibitory activity of α-amylase
Decreased serum blood glucose level
Increased plasma insulin level
[345]
Aqueous extractBulbs 0.4 g/100 g for 4 weeksNormal and alloxan-induced diabetic ratsReduced their plasma glucose levels by 68%[342]
PowderBulbs12.5% for 15 daysNormal and HFD alloxan-induced diabetic ratsReduced fasting blood glucose level[343]
AsteraceaeArtemisia herba-alba AssoEOWhole plants0.25–1 mg/mLα-amylase and α-glucosidase inhibition assayInhibitory activity of α-amylase and α-glucosidase[353]
Ethyl alcohol extractWhole plants200 µL
500–4000 mg/kg
α-amylase inhibition assay
Alloxan-induced diabetic rats
Inhibitory activity of α-amylase
Decreased plasma glucose level
[354]
Aqueous extractAerial parts0.39 g/kg for 18 weeksAlloxan-induced diabetic ratsReduced blood glucose level[355]
Aqueous extractAerial parts100–300 mg/kg for 15 daysNormal and alloxan-induced diabetic rats Reduced blood glucose level[356]
Aqueous extractAerial parts85 mg/kgSTZ-induced diabetic rabbitsReduced blood glucose level[357]
Ethyl alcohol extractAerial parts100–400 mg/kg for 14 weeksSTZ-induced diabetic ratsReduced fasting blood glucose level
Increased plasma insulin level
[358]
Aqueous extractAerial parts50 and 100 mg/kgSTZ-induced diabetic rabbitsReduced blood glucose level[359]
Aqueous extractWhole plants50–100% for 10 daysDexamethasone-induced diabetic ratsDecreased postprandial blood glucose[360]
Hydroethanolic extractAerial parts2 g/kg 18 weeksHFD-induced diabetic ratsDecreased the blood glucose level and serum insulin concentrations[361]
Aqueous extractAerial parts0.39 g/kg for 14 weeksAlloxan-induced diabetic ratsReduced fasting serum glucose level[362]
Aqueous extractAerial parts400 mg/kg for 3 weeksAlloxan-induced diabetic rabbitsReduced blood glucose level[363]

3.4.1. Trigonella foenum-graecum

Fenugreek is known to have various pharmacological effects, such as antibacterial, anticancer, antidiabetic, antioxidant, anticarcinogenic, gastric stimulant, lactation aid, and galactogogue activities. The antidiabetic effect of fenugreek was investigated widely by four studies in vitro [235,236,237,238] and eight in vivo [239,240,241,242,243,244,245,246]. An in vitro study using albino rats showed that fenugreek extract exhibited a maximum α-glucosidase-inhibitory activity at 100 μg/mL (IC50 = 57.25 μg/mL) compared to acarbose (STD). Additionally, at 320 μg/mL, the extract demonstrated dipeptidyl peptidase IV (DPP IV) inhibition (IC50 = 52.26 μg/mL) [235]. Recently, Neagu and his collaborators investigated the inhibitory effect of fenugreek seeds extract on the enzymatic activity of α-amylase and α-glucosidase. This extract showed the potent inhibition of both enzymes with IC50 = 3.22 ± 0.30 μg/mL and 11.14 ± 0.90 μg/mL, respectively [236]. Similar results were obtained in the study done by Laila et al. [237], who reported that the aqueous extract of 4th-day-germinated genotype fenugreek sprouts in the form of lyophilized powder (IM6E) also demonstrated strong α-glucosidase activity, and moderate α-amylase and invertase inhibition activities. Using the oral glucose tolerance test (OGTT), the ethanolic extract of fenugreek seeds administrated at 2 g/kg, caused a significant reduction in blood glucose levels of albino rats, which correlates with the α-glucosidase and DPP IV inhibition [239].
Fenugreek water seed extract was found to increase body weight and decrease fasting blood glucose in STZ-induced diabetic rats [239]. These findings are similar to those obtained by Abdelatif et al. [240], who observed weight gain in fenugreek-treated rabbits compared to the group that received only alloxan monohydrate. Plasma glucose levels were also reduced in the fenugreek-treated rabbits. Further, the same extract showed significant antidiabetic activity, with the most effective dose being 1 g/kg, and no acute toxicity was observed when the extract was administered orally at high doses [241]. In another study, fenugreek seed mucilage (FSM) showed antidiabetic actions in streptozotocin-induced diabetic rats (STZ), with FSM being more effective than other plants in ameliorating the diabetic state [242]. The aqueous extract of fenugreek seeds administered at 100 mg/kg significantly reduced blood glucose levels in a diabetic rat model induced by STZ. Urea levels decreased following daily intraperitoneal injection [242]. Fenugreek seed extract reduced blood glucose levels, potentially due to its high content of alkaloid trigonelline and steroidal saponins, particularly the 4-hydroxyisoleucine compound known to be insulinotropic [243]. The hydroalcoholic extract of fenugreek administered at 400 mg/kg body weight significantly decreased blood glucose levels compared to the standard drug glibenclamide [244]. Additionally, three weeks of treatment with insulin and fenugreek seed powder (FSP) separately resulted in a significant reduction in hyperglycemia in diabetic rats. FSP treatment increased insulin levels in diabetic rats to nearly 80% of the control levels [245].

3.4.2. Nerium oleander

N. oleander has various biological activities, such as antidiabetic, antibacterial, anti-inflammatory, anticancer, antinociceptive, and central nervous system-depressant. The antidiabetic activity of N. oleander has been extensively studied across different parts of the plant [246,247,248,249,250,251,252,253]. The enzyme α-amylase is crucial in the breakdown of starch into maltose, maltotriose, and various oligoglucans, which are further converted to glucose by α-glucosidase [246]. N. oleander has demonstrated inhibitory activity against α-glucosidase, as shown by Ishikawa et al. [247], who also identified chlorogenic acid as an active isolate. Additionally, Dey et al. [248] investigated the effect of a standardized hydromethanolic extract of N. oleander leaves administrated at 200 mg/kg in alloxan-induced diabetic mice. This extract showed a high inhibitory activity against α-amylase (22.63 µg/mL) with an IC50 value of 703.01 ± 56.47 mg/mL, and demonstrated significant antihyperglycemic activity, reducing blood glucose levels by 73.79% after 20 days of treatment. The OGTT results reveal a 65.72% decrease in blood glucose levels three hours post-treatment [248]. Similarly, Magdalene et al. [249] reported the concentration-dependent inhibition of α-amylase, leading to decreased blood glucose levels.
The in vivo antidiabetic potential of N. oleander was also explored by Mwafy et al. [250], who compared the effects of the extract at 250 mg/kg for four weeks on insulin and glucose levels. The results show that the plant extract improved insulin and glucose levels in STZ-induced diabetic rats. Additionally, the ethanolic extract led to a significant decrease in glucose levels and an increase in insulin levels [251]. Furthermore, the administration of N. oleander distillate at 375 μg/0.5 mL for 12 weeks to high-fat-diet (HFD)-fed STZ-induced diabetic rats increased insulin sensitivity and the normalization of insulin resistance assessed by a homeostasis model [252]. Ishikawa et al. [247] observed that a very high dose of 16 g/kg lowered blood glucose levels in maltose and sucrose-loaded rats, although it had no effect on glucose loading. Another study confirmed the antihyperglycemic effect of N. oleander extract [248]. In contrast, Sikarwar et al. [253] reported no sub-acute glucose reduction using the N. oleander aqueous extract.

3.4.3. Rosmarinus officinalis

Rosemary is well-known for its various pharmacological properties, including antidiabetic, anti-inflammatory, antidepressant, antinociceptive, antifungal, and antibacterial activities. Numerous studies have demonstrated the inhibitory effects of R. officinalis on key enzymes involved in carbohydrate metabolism, such as α-amylase and α-glucosidase. Numerous studies reported that rosemary EO or aqueous extract is a potent inhibitor of α-amylase (26.29%) and α-glucosidase (75%) [254,255]. Similarly, McCue et al. [256] demonstrated that pure rosmarinic acid extract inhibited α-amylase activity by 85%. Supporting these findings, Belmouhoub et al. [257] demonstrated that diethyl ether and n-butanol fractions of rosemary showed potent α-glucosidase inhibition, with maximum inhibition rates of 77% and 72% at 250 μg/mL, respectively. Further research by Koga et al. [258] identified a rosemary-distilled extract as a strong inhibitor of α-glucosidase, with an IC50 value between 683 and 711 μg/mL.
In vivo studies have confirmed rosemary’s antidiabetic potential through various models of diabetes. Kabubi et al. [259] demonstrated that a diet supplemented with 12% rosemary leaf powder significantly reduced fasting blood glucose (FBG) levels in diabetic animals, suggesting a hypoglycemic effect comparable to normal control groups. The study attributed this effect to the flavonoid content present in the extracts. Further evidence has been provided by Belmouhoub et al. [257], who evaluated the in vivo effects of rosemary fractions in STZ-induced diabetic rats. Their findings reveal that the n-butanol fraction significantly lowered postprandial hyperglycemia, reducing glucose levels by up to 40.77% and 28.2% with sucrose and maltose, respectively. Additionally, the OGTT revealed the maximum antihyperglycemic effect (51.65%) of the n-butanol fraction, which also significantly inhibited glucose intestinal transport.
Moreover, studies on rosemary’s hypoglycemic activity show that its extracts effectively lower glucose levels and improve insulin response. For instance, Benkhedir et al. [260] reported that an ethyl acetate extract of rosemary significantly increased serum glucose and decreased plasma insulin in diabetic control rats. Meanwhile, Khalil et al. [261] observed that the daily administration of aqueous rosmarinic acid at 200 mg/kg for three weeks reduced blood glucose levels. Similar effects were observed with aqueous rosemary extract (ARE), including significant reductions in the fasting plasma glucose (FPG) level in STZ-induced diabetic rats [262]. Supporting these findings, Alnahdi [263] demonstrated that ARE administered at 200 mg/kg/day two weeks before and three weeks after STZ injection significantly reduced FPG [264]. Furthermore, Soliman [265] showed that dried rosemary leaves (5 g/100 g diet) administered for six weeks decreased FPG level in a diabetic group. ARE also provided significant protection against pancreatic β-cell loss, leading to reduced blood glucose levels and increased insulin [266,267,268]. Further studies confirmed these findings by showing that rosmarinic acid dose-dependently decreased plasma glucose levels and improved insulin sensitivity in STZ- and HFD-induced diabetic rats [269,270]. Moreover, in alloxan-induced diabetic models, Bakırel et al. [271] and Kensara et al. [272] provided evidence of rosemary’s efficacy, demonstrating significant reductions in FPG and improvements in insulin levels, and providing renoprotective effects by inhibiting glomerular hypertrophy and glomerulosclerosis [273].

3.4.4. Salvia officinalis

S. officinalis (sage) is widely recognized for its medicinal properties, including antioxidant, antibacterial, hypoglycemic, anti-inflammatory, fungistatic, and virustatic effects, among others, due to its rich phytochemical content [281,282]. The in vitro antidiabetic potential of sage has been demonstrated in various studies. For instance, the EO of sage was found to effectively inhibit the enzymatic activities of α-amylase and α-glucosidase. Al-Mijalli et al. [274] reported that EO exhibited important enzymes inhibitory of α-amylase (IC50 = 81.91 ± 0.03 μg/mL) and α-glucosidase (IC50 = 113.17 ± 0.02 μg/mL), compared to acarbose. Similarly, EO showed the potent inhibition of α-glucosidase in a concentration-dependent manner [275]. Moreover, the aqueous extract showed the inhibition of α-glucosidase (EC50 = 71.2 ± 5.0 µg/mL) at a level four times greater than acarbose [276]. In other studies, the hydroethanolic extracts strongly inhibited α-glucosidase [112,277], while the ethyl acetate fraction exhibited the strong inhibition of both α-amylase (IC50 = 46.52 ± 2.68 mg/mL) and α-glucosidase (104.58 ± 0.06 mg/mL) [278].
In vivo studies also support the antidiabetic potential of sage. Moradabadi et al. [279] found that the oral administration of a methanolic extract of sage leaves (500 mg/kg) to alloxan-induced diabetic rats significantly reduced postprandial blood glucose levels, similarly to acarbose. The study further highlighted the short-term blood glucose reduction effects of the extract. Similarly, several authors reported that ethanolic extracts of sage leaves led to significant reductions in blood glucose levels and increased plasma insulin in diabetic rats [280,281,282,283]. These authors confirmed the hypoglycemic effects of sage, which were attributed to its bioactive compounds such as polyphenols, flavonoids, tannins, and alkaloids. Moreover, Mbiti et al. [284] investigated the hypoglycemic effects of the aqueous extracts of sage leaves in alloxan-induced diabetic mice. The results show that the oral administration of this extract significantly lowered FBG levels [284,285]. It is also reported that sage leaves possess a hypoglycemic effect on STZ-induced diabetic rats [286]. Both in vitro and in vivo studies substantiate the antidiabetic properties of sage, emphasizing its role in inhibiting key digestive enzymes and reducing blood glucose levels in diabetic models.

3.4.5. Marrubium vulgare

M. vulgare is known for its diverse medicinal properties, including hypoglycemic, vasorelaxant, analgesic, antioxidant, anti-inflammatory, vasodilator, and antihypertensive activities. The antihyperglycemic potential of M. vulgare has been well documented. Gourich et al. [287] demonstrated that the administration of M. vulgare extract effectively reduced elevated glucose levels, comparable to the effect of glibenclamide. The study also highlighted the extract’s significant inhibitory effect on pancreatic α-amylase activity, with an IC50 value of 0.081 ± 0.013 mg/mL, outperforming acarbose. This inhibition is likely due to the presence of bioactive compounds within the extract. Similar results have been observed by Aazza et al. [288], who reported that the hydro-alcoholic extract exhibited the most potent α-amylase inhibition among six studied plants.
A series of in vivo experiment were conducted on different models to determine the antidiabetic effects of M. vulgare. In studies on STZ-induced diabetic rats, the methanolic extract of the aerial parts was shown to have a beneficial effect on diabetes and its complications. Moreover, a daily oral dose of 500 mg/kg for 28 days resulted in a significant reduction in blood glucose from the second week, along with increased plasma insulin and tissue glycogen levels [289]. The study suggests that the extract’s antidiabetic effects may be linked to the stimulation of insulin release from the remaining pancreatic beta cells. Another study explored the effects of the methanol, water and butanol extracts of the whole plant on autoimmune diabetes mellitus type 1 induced by cyclosporine A and STZ in mice, demonstrating its potential therapeutic benefits [290]. In an alloxan-induced diabetic rats model, Boudjelal et al. [214] reported that aqueous extracts from the aerial parts (100, 200, and 300 mg/kg) resulted in a dose-dependent reduction in blood glucose levels—up to a 60% decrease at higher doses. Similarly, the aqueous extract of the leaf infusion improved blood glucose levels, indicating its protective effects against diabetes-related complications [291]. Vergara-Galicia et al. [292] investigated the antidiabetic activity of various ethanolic extracts of the whole plant on normoglycemic rats. The intragastric administration of the whole plant extract (100 mg/kg) significantly reduced blood glucose levels and suppressed any elevation in plasma glucose.

3.4.6. Olea europaea

O. europaea has a wide range of medicinal properties and traditional uses, including antihypertensive, antidiabetic, antioxidant, and anti-inflammatory activities. Several studies have demonstrated the antidiabetic effects of olive extracts in different models. In STZ-induced diabetic rats, alcohol extracts significantly decreased blood glucose levels at doses of 0.1, 0.25, and 0.5 g/kg administrated over 14 days, showing greater efficacy than glibenclamide [293,294]. This effect is consistent across various studies [295,296,297,298,299,300,301,302,303,304,305], suggesting a strong hypoglycemic potential. Mansour et al. [305] reported that the administration of olive extract combined with metformin significantly reduced blood glucose levels to near-normal levels, indicating its potential as an adjuvant therapy. Similarly, Wainstein et al. [295] demonstrated improved glucose homeostasis with repeated administration. Furthermore, Shudiefat et al. [304] suggested that olive extract exerted antihyperglycemic effects through AS160 inhibition, offering an alternative to metformin treatment. The antidiabetic potential of oleanolic acid, isolated from olive leaves, was also confirmed, showing a reduction in blood glucose and insulin levels in HFD mice [306]. The antidiabetic effects extend to alloxan-induced diabetic models as well. Olive leaf extracts have shown significant reductions in blood glucose in rats [307,308,309,310] and rabbits [311,312]. Al-Azzawie et al. [312] studied the hypoglycemic activity of hydroxytyrosol from olive leaves in diabetic rabbits, and found that oleuropein had significant hypoglycemic activity due to its antioxidant potential. Farah et al. [311] investigated the effects of ethanolic olive leaf extracts, with the maximum hypoglycemic activity observed at a dose of 600 mg/kg. The hypoglycemic effect of olive leaf extracts is extensively related to improvements in oxidative stress markers, further supporting its potential as a natural antidiabetic treatment [307,309,310,312].
Recent studies have focused on the α-glucosidase-inhibitory effects of olive leaf extracts (OLEs), which could help explain how they lower blood sugar and create safer, more natural antidiabetic supplement alternatives. Mansour et al. [305] reported strong α-glucosidase inhibitory activity in all studies on OLEs, with inhibition increasing with concentration. AlShaal et al. [313] observed that olive leaf extracts inhibited α-glucosidase by 81.34% at 3.85 mg/mL, with an IC50 of 0.34 ± 0.12 mg/mL. The hydroxytyrosol and oleuropein in olive leaves showed potent α-glucosidase-inhibitory effects compared to α-amylase, as demonstrated by Hadrich [134], with IC50 values of 150 µM and 400 µM, respectively. The role of phenolic compounds in OLEs was highlighted by Loizzo et al. [314], who showed that olive oil extracts were weaker inhibitors of α-amylase compared to α-glucosidase (IC50 = 258 and 184 mg/mL, respectively). Khlif et al. [315] further showed that oleanolic acid and its dimethyl derivative from olive stems were active against α-amylase enzyme, with IC50 values of 1.18 and 1.03 mg/mL, respectively. Numerous in vitro studies, such as those by Mansour [315], suggest that plant polyphenols in OLEs could inhibit carbohydrate hydrolytic enzymes by binding to the proteins, thus delaying the hydrolysis and absorption of monosaccharides.

3.4.7. Nigella sativa

N. sativa seeds and their oil possess various medicinal properties, including potent antidiabetic activity. Several studies have demonstrated the hypoglycemic effects of N. sativa in different models of diabetes. For instance, Alhodieb et al. [316] found that black seed extract inhibited α-glucosidase in a dose-dependent manner, which can be attributed to the presence of compounds like ferulic acid, rutin, and catechin. Using the oral glucose tolerance test, the aqueous and ethanolic extracts of N. sativa seeds demonstrated significant hypoglycemic and hypolipidemic effects, all without any observed toxicity [228,317].
Research on alloxan-induced diabetic rats also underscores the antidiabetic potential of N. sativa. The administration of methanolic crude extract and commercial oil of N. sativa seeds resulted in significant blood glucose reductions [318,319,320]. Similarly, Sutrisna et al. [321] found that the ethyl acetate fraction of ethanolic extract reduced blood glucose levels. In STZ-induced diabetic rats treated with N. sativa seed extract, serum glucose levels decreased considerably compared to diabetic controls [322,323,324,325,326]. Treatment for six weeks resulted in hypoglycemic effects and improved cardiovascular complications associated with diabetes (Abbasnezhad, 2019). For instance, Fararh et al. [327] and Abdelrazek et al. [328] showed that the oral administration of N. sativa oil led to a significant, consistent, and time-dependent decrease in blood glucose levels in STZ-induced diabetic hamsters. Additionally, Le et al. [329] showed that petroleum ether extract enhanced insulin signaling pathways in STZ-induced diabetic rats. In another study conducted by Dong et al. [330], they found that N. sativa seed polysaccharides significantly reduced FBG levels and increased insulin levels. These studies reveal that NS in various forms—oil, water extracts, dried seeds—exhibits substantial hypoglycemic potential, particularly in forms based on aqueous extraction.

3.4.8. Allium cepa

Recent studies have highlighted the diverse biological properties of onion, including its antihypertensive, antioxidant, antimicrobial, anti-inflammatory, and antidiabetic effects. In particular, the antidiabetic potential of onion and its extracts has been extensively investigated through both in vitro and in vivo studies. The in vitro antidiabetic potential of onion skin (OS) extract has been well documented. For instance, the extract showed significant inhibitory activity against α-glucosidase and α-amylase, with IC50 values of 1.27 mg/mL and >3.00 mg/mL, respectively [331]. Methyl alcohol extracts have also been reported to inhibit yeast α-glucosidase with an IC50 value of 0.159 mg/mL [332]. Quercetin, a key compound in onion extract, exhibited potent sucrose-inhibitory activity (IC50 = 0.11 mg/mL), suggesting its role as an active component [331]. Quercetin’s inhibition of α-glucosidase helps delay glucose absorption, aiding in the control of blood glucose levels. The ethanolic extract has also shown promising antidiabetic effects by inhibiting α-amylase and α-glucosidase activities, with inhibition increasing with concentration. At 30 µL, both the extract and the standard drug demonstrated a 75% inhibition rate, which increased to 80% at 50 µL [333]. Further research by Gois Ruivo da Silva et al. [334] revealed that 50% and 100% ethanol extracts, and 100% methanol extracts, of OS, at concentrations ranging from 0.01 to 10 mg/mL, effectively decreased α-amylase activity. Interestingly, OS extract exhibited higher inhibition than the quercetin standard, indicating that additional substances in OS may synergistically contribute to this effect. Both yellow and red OS extracts (ethanolic and aqueous) also demonstrated dose-dependent inhibitory activity against α-glucosidase (IC50 = 3.90–8.99 μg/mL) [335]. Nile et al. [336] confirmed that various extracts of red OS waste displayed enzyme-inhibitory effects against α-glucosidase (IC50 = 42.8–73.2 μg/mL), with methanol and ethanol extracts being the most effective. The study also noted that flavonoid glucosides extracted from red OS could be used to treat diabetes mellitus, hyperuricemia, and skin pigmentation disorders.
The antidiabetic effects of onion have also been observed in in vivo studies. El-Soud and Khalil [337] reported that onion EO treatment led to significant decreases in blood glucose and increases in serum insulin in STZ-induced diabetic albino rats. Similarly, red onion extract reduced FBG levels and increased serum insulin levels [338]. Jung et al. [339] explored the effects of OS extract on hyperglycemia and insulin sensitivity in HFD/STZ-induced diabetic rats. The administration of 1% OS led to a significant decrease in the incremental area under the curve and improved insulin sensitivity. The study found that 1% OS had a stronger hypoglycemic effect than pure quercetin, likely due to the presence of over 20 other flavonoids. Similarly, Islam et al. [340] demonstrated that serum insulin concentrations and insulin resistance were dose-dependently increased in onion-fed groups compared to diabetic control groups. The hypoglycemic effects of onion were further confirmed in alloxan-induced diabetic rat models, where aqueous extracts reduced FBG levels by 75.4% at 300 mg/kg [341]. Another study reported significant antihyperglycemic effects following 4 weeks of onion juice treatment [342]. Gholamali et al. [343] observed that onion consumption led to significant reductions in FBG, aligning with findings by Abouzed et al. [338] and Ozougwu et al. [341] that suggest onion acts as a hypoglycemic agent. Collectively, these studies underscore the antidiabetic potential of onion and its extracts, with phenolic compounds like quercetin and other flavonoids playing a crucial role in their efficacy.

3.4.9. Allium sativum

Commonly known as garlic, this plant is widely recognized not only as a food flavor-enhancer, but also for its medicinal properties, including its use in managing diabetes. Several studies have highlighted the significant inhibitory effects of garlic extracts on enzymes such as α-amylase and α-glucosidase, which are crucial in carbohydrate digestion. For instance, an ethanolic extract of garlic bulbs exhibited an 81.86% inhibition of α-amylase at 1250 µg/mL [344]. The inhibitory effect of garlic extract on α-amylase was also shown to be highly effective, with an IC50 of 680.54 ± 0.58 μg/mL—significantly more potent than the standard drug acarbose [345]. Moreover, a further study demonstrated that oil extracted from garlic bulbs had a stronger inhibitory activity on α-amylase than other species of the Allium genus, with an IC50 value of 3.0 ± 0.02% [346]. Yan et al. [347] also observed that polysaccharides extracted from garlic bulbs significantly inhibited both α-amylase and α-glucosidase in a dose-dependent manner, with the strongest inhibition attributed to a high uronic acid content and low molecular weight fractions. Additionally, another study investigated the effects of a convective hot-air drying method on garlic’s enzyme-inhibitory α-amylase and α-glucosidase properties [348]. These authors found that garlic’s extracted compounds could serve as functional ingredients in dietary treatments for early-stage hyperglycemia.
In vivo studies further support these findings. Sujithra et al. [349] demonstrated that doses of 50, 100, and 200 mg/kg of garlic effectively reduced blood glucose levels and regulated insulin production and sensitivity in STZ-induced diabetic rats. Similarly, the oral administration of garlic extract normalized serum glucose and insulin levels in both normal and diabetic rats, with effects that were even more notable than glibenclamide [350,351]. Moreover, the FBG in the high-dose polysaccharide group was 42% lower than in the diabetic model group, demonstrating its hypoglycemic effect [352]. Gholamali et al. [343] and El-Demerdash et al. [342] also reported that garlic consumption significantly decreased FBS in HFD alloxan-induced diabetic rats, possibly due to the actions of compounds like allyl propyl disulfide or diallyl disulfide. The aqueous extract of garlic bulbs (200 and 400 mg/kg) has been shown to increase plasma insulin. Notably, these extracts significantly reduced blood glucose levels during the OGTT, outperforming the acarbose molecule in reducing postprandial glycemia [345]. These studies suggest that garlic, due to its enzyme-inhibitory properties and hypoglycemic effects, is a promising agent for managing diabetes, particularly in the early stages of hyperglycemia.

3.4.10. Artemisia herba-alba Asso

Numerous studies have demonstrated that A. herba-alba (AHA) exhibits a wide range of biological and pharmacological effects, particularly regarding its antibacterial, antispasmodic, antidiabetic, antioxidant, leishmanicidal, and antifungal properties. Regarding its antidiabetic potential, the EO of AHA has shown strong inhibitory activity against α-amylase and α-glucosidase enzymes, with IC50 values of 1.946 and 1.754 mg/mL, respectively [353]. Similarly, Awad et al. [354] emphasized the hypoglycemic activity of AHA in vitro, noting that the 70% ethyl alcohol extract and its mucilage inhibited α-amylase activity by 11% and 2%, respectively.
Further supporting these findings, Taştekin et al. [355] observed that the aqueous extract of AHA significantly reduced blood glucose concentrations in alloxan-induced diabetic rats, an effect comparable to that of insulin and repaglinide. This hypoglycemic effect was further confirmed by Boudjelal et al. [356], who found that the oral administration (300 mg/kg) of AHA aqueous infusions resulted in a significant reduction in blood glucose levels, demonstrating more efficacy than glibenclamide [354]. These results underscore the plant’s traditional use as an antidiabetic remedy. In another study, Iriadam et al. [357] demonstrated that the oral administration of AHA aqueous extract significantly reduced blood sugar levels in both normal and diabetic rabbits, indicating its potential for broad-spectrum hypoglycemic activity. Abdallah et al. [358] also reported that ethyl alcohol extracts of AHA at various concentrations significantly decreased FBG and homocysteine levels, while enhancing plasma insulin in STZ-treated rats, with similar effects observed in studies by El-Marasy et al. [359]. Ahmad et al. [360] further corroborated these findings, showing that AHA’s aqueous extract has potent hypoglycemic effects in experimentally induced hyperglycemic rats. Complementing this, Hamza et al. [361] demonstrated that a dose of hydro-alcoholic extracts of AHA (2 g/kg), administered orally for 18 weeks, significantly lowered blood glucose levels and serum insulin concentrations in male mice fed a high-fat diet. These results align with those of previous studies on the hypoglycemic effects of AHA in diabetic rats [355,362], rabbits [363] and normal mice [361].
Based on the phytochemical and pharmacological literature reviewed in this study, the most promising antidiabetic plants include T. foenum-graecum, O. europaea, N. Sativa, A. herba-alba, and S. officinalis. These species demonstrate strong in vivo and in vitro antidiabetic effects, often attributed to their high contents of bioactive compounds such as flavonoids, terpenoids, and phenolic acids.
-
T. foenum-graecum: Numerous studies have demonstrated its hypoglycemic potential, attributed to its saponins, alkaloids, and flavonoids. Clinical trials also show its promise in improving glucose tolerance.
-
O. europaea: The leaves contain high levels of oleuropein and hydroxytyrosol, known for their antidiabetic properties. These compounds have shown potent effects in animal models of diabetes.
-
N. sativa: Thymoquinone and other phenolics demonstrate strong insulinotropic and glucose-lowering effects in vivo.
-
A. herba-alba: The plant is rich in terpenoids, particularly thujone and camphor, which have shown antidiabetic effects in animal models. Its use in North Africa is well-established, and its traditional use is supported by modern pharmacological studies.
-
S. officinalis: This plant is widely recognized for its high levels of rosmarinic acid and flavonoids, which exhibit both hypoglycemic and antioxidant properties. In vivo studies confirm its potential as an adjunct in diabetes management.
These species should be prioritized in future research, focusing on their mechanisms of action, dosage optimization, and potential synergistic effects when combined with conventional treatments.

3.5. Current Therapeutic Trajectory of Diabetes Management in Morocco

The current landscape of diabetes management in Morocco predominantly involves conventional pharmacological treatments, such as insulin and oral hypoglycemic agents (e.g., metformin, sulfonylureas), commonly prescribed for type 2 diabetes [364]. These therapies, while effective, can have significant side effects and limitations, including hypoglycemia, weight gain, and long-term cardiovascular risks [365]. As a result, the World Health Organization (WHO) has long advocated for integrating Traditional Medicine (TM) into modern healthcare, offering a more holistic, sustainable, and culturally acceptable approach to manage chronic diseases like diabetes [366].
In Morocco, traditional medicinal plants are increasingly being explored for their potential to complement standard therapies. Several plant species, including T. foenum-graecum, N. sativa, R. officinalis, and O. europaea, have demonstrated significant hypoglycemic effects in both in vitro and in vivo studies. These plants often enhance or mimic the effects of conventional treatments. For instance, T. foenum-graecum improves insulin sensitivity and secretion, while R. officinalis exhibits strong antioxidant properties that may help mitigate oxidative stress associated with diabetes.
Given the WHO’s recommendation to integrate TM into modern healthcare, these plants offer a cost-effective and culturally appropriate complement to pharmaceutical drugs. In rural Moroccan communities, patients frequently use these medicinal plants alongside conventional treatments, further underscoring their practical potential in bridging traditional knowledge with modern medicine [367]. However, structured clinical trials are essential to evaluate the safety, dosage, and interactions with modern hypoglycemic drugs of these plants, so as to ensure their safe integration into diabetes management.

3.6. Comparison with Plant-Based Management of Diabetes in the Maghreb Region

In the Maghreb region, including Algeria, Tunisia, and Libya, plant-based diabetes management shows many similarities with that in Morocco, largely due to the shared ecological and cultural contexts. Common medicinal plants used across these countries include T. foenum-graecum, N. sativa, R. officinalis, O. europeae and A. herba-alba. Despite these commonalities, local traditions and the availability of specific plants introduce variations in usage. For example, A. herba-alba is more widely studied in Morocco, while combinations of plants are frequently used in Tunisia and Algeria [368,369]. Nevertheless, Libya shows a limited number of studies compared to Morocco, but ethnobotanical research suggests that T. foenum-graecum, O. europeae, M. vulgare, S. officinalis and A. herba-alba are common across the Maghreb for their antidiabetic properties [370,371].
Fenugreek’s antidiabetic properties are well documented throughout the Maghreb. In Morocco, fenugreek has been used traditionally for its hypoglycemic effects, supported by modern research showing its ability to improve insulin sensitivity and lower blood sugar levels [235,236,237,238,239,240,241,242,243,244,245]. In Algeria, similar studies demonstrate its potential in enhancing glucose tolerance and exerting insulinotropic effects in diabetic rats [372]. In Tunisia, a study by Hachouf et al. [373] corroborated these findings, showing that fenugreek enhances insulin secretion, aligning with Moroccan and Algerian results. Fenugreek seeds contain alkaloids and flavonoids, which contribute to its hypoglycemic action across the region. N. sativa, is another plant extensively used in Maghreb traditional medicine for diabetes management. In Algeria, Houcher et al. [318] conducted in vivo studies that showed its significant hypoglycemic and insulin-sensitizing effects. Tunisian research by Ghlissi et al. [374] confirmed these results, noting that black seed not only regulates glucose metabolism, but also exerts antioxidant effects. These findings align with N. sativa’s traditional use in Morocco, and support its importance across the region in managing diabetes. Rosemary is widely used for its antidiabetic and antioxidant properties across the Maghreb. In Algeria, Benkhedir et al. [260] highlighted its significant ability to reduce hyperglycemia and improve insulin sensitivity in diabetic rats. Rosemary’s bioactive compounds, including flavonoids and phenolic acids, have been reported to lower blood glucose by stimulating insulin secretion from pancreatic cells [375]. These findings align closely with the traditional use of rosemary in Morocco for managing diabetes. Likewise, S. officinalis is used in Tunisian folk medicine, often in combination with other herbs for diabetes treatment, which reflects a region-specific approach to herbal synergy that differs from Moroccan practices [376].
The olive tree holds a significant place in the cultural and medicinal landscape of the Maghreb. In Algeria, studies show that olive leaf extracts exhibit strong hypoglycemic and antioxidant effects in diabetic rats [368]. Similar findings are reported in Tunisia, where Wannes and Marzouk [369] highlighted the ability of olive leaves to lower blood glucose levels. These effects are primarily attributed to the presence of oleuropein and other polyphenols that promote insulin sensitivity. In Morocco, olive leaves are used similarly, and the plant is widely recognized for its antidiabetic properties in traditional medicine. A. herba-alba is also well-known for its antidiabetic properties across the region. In Algeria, aqueous extracts of this plant have been shown to reduce hyperglycemia and provide antioxidant effects in diabetic rats [368]. Tunisian studies also confirm the plant’s hypoglycemic efficacy, aligning with findings in Morocco [369]. However, its use is somewhat less prominent in Tunisia and Algeria compared to Morocco, where it has been extensively studied and forms a key component of traditional diabetes treatments.
In summary, there is substantial overlap in the use of medicinal plants for diabetes management across the Maghreb, with shared reliance on species like T. foenum-graecum, N. sativa, R. officinalis, O. europaea, and A. herba-alba. The ecological similarities of these countries contribute to the commonality of plant species, while local traditions and plant availability account for regional variations. Tunisia and Algeria, for instance, use more combinations of plants, while Morocco tends to focus on singular applications of these herbs. Despite these differences, the shared ethnobotanical knowledge highlights the collective cultural importance of plant-based diabetes treatments in the Maghreb.

4. Future Directions and Research Opportunities

Future research on the antidiabetic effects of Moroccan medicinal plants should prioritize the standardization of extracts and dosages to ensure consistency in bioactive compound concentrations. Advanced techniques could elucidate the molecular mechanisms through which compounds like saponins and flavonoids exert their antidiabetic effects. Additionally, well-designed clinical trials are critical to evaluate the efficacy and safety of these plants in humans, considering various comorbidities. Investigating the synergistic effects of polyherbal formulations and potential drug–herb interactions is also essential for their safe and effective use.
Comprehensive safety profiling and toxicological assessments are necessary, especially for plants with known risks, such as N. oleander. Ethnopharmacological studies should continue to explore new species with antidiabetic potential, ensuring that sustainable practices are employed to conserve these valuable medicinal resources. Further research on isolating and characterizing specific bioactive compounds could lead to the development of novel pharmaceuticals. By addressing these research opportunities, the therapeutic potential of Moroccan medicinal plants for diabetes management could be fully realized, leading to the development of natural-based treatments for this widespread condition.

5. Conclusions and Implications for Healthcare Practice

The extensive use of Moroccan medicinal plants in the management of diabetes highlights their potential as alternative or complementary therapies for blood sugar regulation. This review has documented 344 medicinal plant species from 79 different families, with plants from the Compositae family being the most frequently used. Among these, ten of the most effective plants have been identified and reviewed for their in vitro and in vivo antidiabetic properties. However, while these plants show potential, their effectiveness and safety must be validated through standardized clinical trials. The variability in plant composition, potential toxicity, and interactions with conventional medications necessitate a cautious and well-informed approach in integrating these plants into mainstream healthcare.
For healthcare practitioners, understanding the benefits and risks associated with these medicinal plants is crucial for advising patients, especially those who may seek complementary therapies for diabetes management. Educating patients on the importance of evidence-based use and potential interactions with prescribed medications is essential to prevent adverse effects. Furthermore, ongoing research and collaboration between traditional healers and modern healthcare providers could facilitate the safe and effective incorporation of these plants into treatment regimens, offering patients more holistic and personalized care options.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Standl, E.; Khunti, K.; Hansen, T.B.; Schnell, O. The global epidemics of diabetes in the 21st century: Current situation and perspectives. Eur. J. Prev. Cardiol. 2019, 26, 7–14. [Google Scholar] [CrossRef]
  2. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27, 1047–1053. [Google Scholar] [CrossRef] [PubMed]
  3. Sun, H.; Saeedi, P.; Karuranga, S.; Pinkepank, M.; Ogurtsova, K.; Duncan, B.B.; Stein, C.; Basit, A.; Chan, J.C.; Mbanya, J.C.; et al. IDF Diabetes Atlas: Global, regional, and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022, 183, 109279. [Google Scholar] [CrossRef]
  4. Lefèbvre, P. La pandémie de diabète: Un fléau cardiovasculaire et une menace pour les systèmes de santé et l’économie mondiale. Médecine Mal. Métab. 2008, 2, 169–179. [Google Scholar] [CrossRef]
  5. Cosentino, F.; Grant, P.J.; Aboyans, V.; Bailey, C.J.; Ceriello, A.; Delgado, V.; Federici, M.; Filippatos, G.; Grobbee, D.E.; Hansen, T.B.; et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. 2020, 41, 255–323. [Google Scholar] [CrossRef] [PubMed]
  6. World Health Organization. Diabetes. 2023. Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes (accessed on 2 August 2024).
  7. Ogurtsova, K.; da Rocha Fernandes, J.D.; Huang, Y.; Linnenkamp, U.; Guariguata, L.; Cho, N.H.; Cavan, D.; Shaw, J.E.; Makaroff, L.E. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 2017, 128, 40–50. [Google Scholar] [CrossRef] [PubMed]
  8. Dhindsa, D.S.; Mehta, A.; Sandesara, P.B.; Thobani, A.; Brandt, S.; Sperling, L.S. Strategies for appropriate selection of SGLT2-i vs. GLP1-RA in persons with diabetes and cardiovascular disease. Curr. Cardiol. Rep. 2019, 21, 100. [Google Scholar] [CrossRef]
  9. Marouf, A.; Joël, R. La Botanique de A à Z; Edition Dunod: Paris, France, 2007; pp. 66–82. [Google Scholar]
  10. Chang, C.L.; Lin, Y.; Bartolome, A.P.; Chen, Y.C.; Chiu, S.C.; Yang, W.C. Herbal therapies for type 2 diabetes mellitus: Chemistry, biology, and potential application of selected plants and compounds. Evid. Based Complement. Altern. Med. 2013, 2013, 378657. [Google Scholar] [CrossRef]
  11. Eddouks, M.; Ouahidi, M.L.; Farid, O.; Moufid, A.; Khalidi, A.; Lemhadri, A. L’utilisation des plantes médicinales dans le traitement du diabète au Maroc. Phytothérapie 2007, 5, 194–203. [Google Scholar] [CrossRef]
  12. Giovannini, P.; Howes, M.J.R.; Edwards, S.E. Medicinal plants used in the traditional management of diabetes and its sequelae in Central America: A review. J. Ethnopharmacol. 2016, 184, 58–71. [Google Scholar] [CrossRef]
  13. Oridupa, O.; Saba, A. Diabetes mellitus in Nigeria and the on-going search for a cure from medicinal plants: A review. Afr. J. Diabetes Med. 2017, 25, 4–6. [Google Scholar]
  14. Jacob, B.; Narendhirakannan, R.T. Role of medicinal plants in the management of diabetes mellitus: A review. 3 Biotech 2019, 9, 4. [Google Scholar]
  15. Shen, Q.; Zhang, L.; Liao, Z.; Wang, S.; Yan, T.; Shi, P.U.; Liu, M.; Fu, X.; Pan, Q.; Wang, Y.; et al. The genome of Artemisia annua provides insight into the evolution of Compositae family and artemisinin biosynthesis. Mol. Plant 2018, 27, 776–788. [Google Scholar] [CrossRef] [PubMed]
  16. Bessada, S.M.; Barreira, J.C.; Oliveira, M.B.P. Compositae species with most prominent bioactivity and their potential applications: A review. Ind. Crop Prod. 2015, 76, 604–615. [Google Scholar] [CrossRef]
  17. Tahraoui, A.; El-Hilaly, J.; Israili, Z.H.; Lyoussi, B. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in South–Eastern Morocco (Errachidia province). J. Ethnopharmacol. 2007, 270, 105–117. [Google Scholar] [CrossRef]
  18. Amrani, F.; Rhallab, A.; Alaoui, T.; Badaoui, K.; Chakir, S. Étude ethnopharmacologique de quelques plantes utilisées dans le traitement du diabète dans la région de Meknès-Tafilalet (Maroc). Phytothérapie 2010, 8, 161–165. [Google Scholar] [CrossRef]
  19. Ghourri, M.; Zidane, L.; Douira, A. Usage des plantes médicinales dans le traitement du Diabète Au Sahara marocain (Tan-Tan). J. Anim. Plant Sci. 2013, 17, 2388–2427. [Google Scholar]
  20. Bousta, D.; Boukhira, S.; Aafi, A.; Ghanmi, M.; El-Mansouri, L. Ethnopharmacological study of anti-diabetic medicinal plants used in the middle-atlas region of Morocco (Sefrou region). Int. J. Pharm. Res. Health Sci. 2014, 2, 75–79. [Google Scholar]
  21. Benkhnigue, O.; Akka, F.B.; Salhi, S.; Fadli, M.; Douira, A.; Zidane, L. Catalogue des plantes médicinales utilisées dans le traitement du diabète dans la région d’Al Haouz-Rhamna (Maroc). J. Anim. Plant Sci. 2014, 23, 3539–3568. [Google Scholar]
  22. Alami, Z.; Aynaou, H.; Alami, B.; Hdidou, Y.; Latrech, H. Herbal medicines use among diabetic patients in oriental Morocco. J. Pharmacogn. Phytother. 2015, 7, 9–17. [Google Scholar]
  23. Orch, H.; Douira, A.; Zidane, L. Étude ethnobotanique des plantes médicinales utilisées dans le traitement du diabète, et des maladies cardiaques dans la région d’Izarène (Nord du Maroc). J. Appl. Biosci. 2015, 86, 7940–7956. [Google Scholar] [CrossRef]
  24. Hachi, M.; Ouafae, B.; Hachi, T.; Mohamed, E.B.; Imane, B.; Atmane, R.; Zidane, L. Contribution to the ethnobotanical study of antidiabetic medicinal plants of the Central Middle Atlas region (Morocco). Lazaroa 2016, 37, 1–11. [Google Scholar] [CrossRef]
  25. Barkaoui, M.; Katiri, A.; Boubaker, H.; Msanda, F. Ethnobotanical survey of medicinal plants used in the traditional treatment of diabetes in Chtouka Ait Baha and Tiznit (Western anti-atlas), Morocco. J. Ethnopharmacol. 2017, 198, 338–350. [Google Scholar] [CrossRef] [PubMed]
  26. Laadim, M.; Ouahidi, M.L.; Zidane, L.; El Hessni, A.; Ouichou, A.; Mesfioui, A. Ethnopharmacological survey of plants used for the treatment of diabetes in the town of Sidi Slimane (Morocco). J. Pharmacogn. Phytother. 2017, 9, 101–110. [Google Scholar]
  27. Mrabti, H.N.; Jaradat, N.; Kachmar, M.R.; Ed-Dra, A.; Ouahbi, A.; Cherrah, Y.; Faouzi, M.E.A. Integrative herbal treatments of diabetes in Beni Mellal region of Morocco. J. Integr. Med. 2019, 17, 93–99. [Google Scholar] [CrossRef]
  28. Skalli, S.; Hassikou, R.; Arahou, M. An ethnobotanical survey of medicinal plants used for diabetes treatment in Rabat, Morocco. Heliyon 2019, 5, e01421. [Google Scholar] [CrossRef] [PubMed]
  29. Mechchate, H.; Es-safi, I.; Bari, A.; Grafov, A.; Bousta, D. Ethnobotanical survey about the management of diabetes with medicinal plants used by diabetic patients in region of Fez Meknes, Morocco. J. Ethnobot. Res. Appl. 2020, 19, 1–28. [Google Scholar] [CrossRef]
  30. Chetoui, A.; Kaoutar, K.; Boutahar, K.; El Kardoudi, A.; BenChaoucha-Chekir, R.; Chigr, F.; Najimi, M. Herbal medicine use among Moroccan type 2 diabetes patients in the Beni Mellal-Khenifra region. J. Herb. Med. 2021, 29, 100480. [Google Scholar] [CrossRef]
  31. Hinad, I.; S’hih, Y.; Elhessni, A.; Mesfioui, A.; Laarbi Ouahidi, M. Medicinal plants used in the traditional treatment of diabetes in Ksar Elkebir Region. Pan Afr. Med. J. 2022, 42, 1–12. [Google Scholar] [CrossRef]
  32. Sekkat, Z.L.; Hassikou, R.; Souad, S. Ethnobotanical study on the use of medicinal plants among diabetic patients in the Rabat-Salé-Kénitra region, Morocco. Ethnobot. Res. Appl. 2023, 26, 1–44. [Google Scholar] [CrossRef]
  33. Ghabbour, I.; Ghabbour, N.; Khabbach, A.; Louahlia, S.; Hammani, K. Ethnobotanical statistics of disease groups treated by medicinal plants used in the province of Taza (northern Morocco). Ethnobot. Res. Appl. 2023, 26, 1–23. [Google Scholar] [CrossRef]
  34. Belhaj, S.; Chaachouay, N.; Zidane, L. Ethnobotanical and toxicology study of medicinal plants used for the treatment of diabetes in the High Atlas Central of Morocco. J. Pharm. Pharmacogn. Res. 2021, 9, 619–662. [Google Scholar] [CrossRef]
  35. Tahraoui, A.; El-Hilaly, J.; Ennabili, A.; Maache, S.; Laamech, J.; Lyoussi, B. Ethnobotanical Study of Medicinal Plants used by Traditional Health Practitioners to Manage Diabetes Mellitus in Safi and Essaouira Provinces (Central-Western Morocco). Trop. J. Nat. Prod. Res. 2023, 7, 2178–2201. [Google Scholar]
  36. Insaf, M.; Ghizlane, H.; Ghada, B.; Fadoua, E.; Samiha, K.; Mohamed, F. Plant-based Bioproducts for the Control of Diabetes and Hypertension in Tangier-Tetouan Region (Morocco). Trop. J. Nat. Prod. Res. 2023, 7, 4016–4025. [Google Scholar]
  37. Arraji, M.; Al Wachami, N.; Boumendil, K.; Chebabe, M.; Mochhoury, L.; Laamiri, F.Z.; Barkaoui, M.; Chahboune, M. Ethnobotanical survey on herbal remedies for the management of type 2 diabetes in the Casablanca-Settat region, Morocco. BMC Complement. Med. Ther. 2024, 24, 160. [Google Scholar] [CrossRef] [PubMed]
  38. Eddouks, M.; Ajebli, M.; Hebi, M. Ethnopharmacological survey of medicinal plants used in Daraa-Tafilalet region (Province of Errachidia), Morocco. J. Ethnopharmacol. 2017, 198, 516–530. [Google Scholar] [CrossRef]
  39. Fouad, Z.; Fatiha, E.A.; Larbi, E.G.; Lahcen, Z. Ethnobotanical survey of medicinal plants used in the traditional treatment of diabetes and gout in the north of Morocco (Tangier, Tetouan and Chefchaouen cities). Plant Arch. 2019, 19, 2731–2737. [Google Scholar]
  40. Hseini, S.; Kahouadji, A. Étude ethnobotanique de la flore médicinale dans la région de Rabat (Maroc occidental). Lazaroa 2007, 28, 79–93. [Google Scholar]
  41. Naceiri Mrabti, H.; Bouyahya, A.; Naceiri Mrabti, N.; Jaradat, N.; Doudach, L.; Faouzi, M.E.A. Ethnobotanical survey of medicinal plants used by traditional healers to treat diabetes in the Taza region of Morocco. Evid. Based Complement. Altern. Med. 2021, 2021, 5515634. [Google Scholar] [CrossRef]
  42. Teixidor-Toneu, I.; Martin, G.J.; Ouhammou, A.; Puri, R.K.; Hawkins, J.A. An ethnomedicinal survey of a Tashelhit-speaking community in the High Atlas, Morocco. J. Ethnopharmacol. 2016, 188, 96–270. [Google Scholar] [CrossRef]
  43. El Rhaffari, L.; Zaid, A. Pratique de la phytothérapie dans le sud-est du Maroc (Tafilalet): Un savoir empirique pour une pharmacopée rénovée. Sources Savoir Médicaments Future 2002, 1, 293–318. [Google Scholar]
  44. Hachi, M.; Hachi, T.; Belahbib, N.; Dahmani, J.; Zidane, L. Contribution a L’etude Floristique et Ethnobotanique de la Flore medicinale utilisee Au Niveau de la ville de Khenifra (MAROC)/Contribution to the study and Floristic Ethnobotany flora medicinal use at the City OF Khenifra (Morocco). Int. J. Innov. Appl. Stud. 2015, 27, 754. [Google Scholar]
  45. Chaachouay, N.; Benkhnigue, O.; Fadli, M.; El Ibaoui, H.; Zidane, L. Ethnobotanical and ethnopharmacological studies of medicinal and aromatic plants used in the treatment of metabolic diseases in the Moroccan Rif. Heliyon 2019, 5, e02191. [Google Scholar] [CrossRef] [PubMed]
  46. Katiri, A.; Barkaoui, M.; Msanda, F.; Boubaker, H. Ethnobotanical survey of medicinal plants used for the treatment of diabetes in the Tizi n’Test region (Taroudant Province, Morocco). J. Pharmacogn. Nat. Prod. 2017, 3, 1–10. [Google Scholar] [CrossRef]
  47. Fakchich, J.; Elachouri, M. Ethnobotanical survey of medicinal plants used by people in Oriental Morocco to manage various ailments. J. Ethnopharmacol. 2014, 154, 76–87. [Google Scholar]
  48. Benlamdini, N.; Elhafian, M.; Rochdi, A.; Zidane, L. Etude floristique et éthnobotanique de la flore médicinale du Haut Atlas oriental (Haute Moulouya). J. Appl. Biosci. 2014, 78, 6771–6787. [Google Scholar] [CrossRef]
  49. Hilah, F.E.; Dahmani, J.; Zidane, L. Ethnobotanical study of medicinal plants used to control diabetes in population of the central plateau, Morocco. Plant Arch. 2021, 21, 560–564. [Google Scholar]
  50. Bouyahya, A.; Abrini, J.; Et-Touys, A.; Bakri, Y.; Dakka, N. Indigenous knowledge of the use of medicinal plants in the North-West of Morocco and their biological activities. Eur. J. Integr. Med. 2017, 13, 9–25. [Google Scholar] [CrossRef]
  51. El Kourchi, C.; Belhoussaine, O.; Harhar, H.; Bouyahya, A.; Kotra, V.; Rehman, I.U.; Ming, L.C.; Lua, P.L.; Tabyaoui, M. Medicinal and aromatic plants traditionally used to treat metabolic diseases in the Rabat region, Morocco. J. Res. Pharm. 2024, 28, 1293–1315. [Google Scholar] [CrossRef]
  52. El Boullani, R.; Barkaoui, M.; Lagram, K.; El Finti, A.; Kamel, N.; El Mousadik, A.; Serghini, M.A.A.; Msanda, F. The use of plants in the traditional treatment of diabetes patients: Survey in southern Morocco. Not. Sci. Biol. 2022, 14, 27322. [Google Scholar] [CrossRef]
  53. El-Ghazouani, F.; El-Ouahmani, N.; Teixidor-Toneu, I.; Yacoubi, B.; Zekhnini, A. A survey of medicinal plants used in traditional medicine by women and herbalists from the city of Agadir, southwest of Morocco. Eur. J. Integr. Med. 2021, 42, 101284. [Google Scholar] [CrossRef]
  54. Taha, D.; Bourais, I.; El Hajjaji, S.; Bouyahya, A.; Khamar, H.; Iba, N. Traditional medicine knowledge of medicinal plants used in Laayoune boujdour sakia el hamra region, Morocco. J. Herbs Spices Med. Plants 2022, 28, 351–369. [Google Scholar] [CrossRef]
  55. International Diabetes Federation (IDF). Diabetes in Morocco. 2021. Available online: https://idf.org/our-network/regions-and-members/middle-east-and-north-africa/members/morocco/ (accessed on 5 August 2024).
  56. Lachguer, S.A.; Chakit, M.; Kossou, J.; Kachache, H.; Boujdi, R.; Bouziani, A.; Benkirane, H. Obesity and body composition determined by bioimpedance-metry in Moroccan adult population. Commun. Pract. 2024, 21, 393–400. [Google Scholar]
  57. International Diabetes Federation (IDF). IDF Diabetes Atlas 10th Edition. 2021. Available online: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf (accessed on 5 August 2024).
  58. International Diabetes Federation (IDF). IDF Diabetes Atlas 10th Edition. 2021. Available online: https://diabetesatlas.org/data/en/country/133/ma.html (accessed on 5 August 2024).
  59. Dinar, Y.; Belahsen, R. Diabetes mellitus in Morocco: Situation and challenges of diabetes care. J. Sci. Res. Rep. 2014, 3, 2477–2485. [Google Scholar] [CrossRef]
  60. Ministère Marocain de la Santé (MMS). Célébration de la Journée Mondiale de la Santé. 2016. Available online: https://www.sante.gov.ma/Documents/2016/04/Fiche%20Diab%C3%A8te%20Fran%C3%A7ais.pdf (accessed on 5 August 2024).
  61. Utz, B.; Assarag, B.; Lekhal, T.; Damme, W.V.; De Brouwere, V.D. Implementation of a new program of gestational diabetes screening and management in Morocco: A qualitative exploration of health workers’ perceptions. BMC Pregnancy Childbirth 2020, 20, 315. [Google Scholar] [CrossRef]
  62. Bouyahya, A.; El Omari, N.; Elmenyiy, N.; Guaouguaou, F.E.; Balahbib, A.; Belmehdi, O.; Salhi, N.; Imtara, H.; Mrabti, H.N.; El-Shazly, M.; et al. Moroccan antidiabetic medicinal plants: Ethnobotanical studies, phytochemical bioactive compounds, preclinical investigations, toxicological validations and clinical evidences; challenges, guidance and perspectives for future management of diabetes worldwide. Trends Food Sci. Techno. 2021, 115, 147–254. [Google Scholar]
  63. Idm’hand, E.; Msanda, F.; Cherifi, K. Ethnopharmacological review of medicinal plants used to manage diabetes in Morocco. Clin. Phytosci. 2020, 6, 18. [Google Scholar] [CrossRef]
  64. Rizvi, S.I.; Mishra, N. Traditional Indian medicines used for the management of diabetes mellitus. J. Diabetes Res. 2013, 2013, 712092. [Google Scholar] [CrossRef]
  65. Al-Asadi, J.N. Therapeutic uses of fenugreek (Trigonella foenum-graecum L.). Am. J. Soc. Issues Hum. 2014, 2, 21–36. [Google Scholar]
  66. Ocvirk, S.; Kistler, M.; Khan, S.; Talukder, S.H.; Hauner, H. Traditional medicinal plants used for the treatment of diabetes in rural and urban areas of Dhaka, Bangladesh–an ethnobotanical survey. J. Ethnobiol. EthnoMed. 2013, 9, 43. [Google Scholar] [CrossRef]
  67. Savo, V.; Giulia, C.; Maria, G.P.; David, R. Folk phytotherapy of the amalfi coast (Campania, Southern Italy). J. Ethnopharmacol. 2011, 135, 376–392. [Google Scholar] [CrossRef]
  68. Bakhtiar, Z.; Hassandokht, M.; Naghavi, M.R.; Mirjalili, M.H. Variability in proximate composition, phytochemical traits and antioxidant properties of Iranian agro-ecotypic populations of fenugreek (Trigonella foenum-graecum L.). Sci. Rep. 2024, 14, 87. [Google Scholar] [CrossRef]
  69. US Department of Agriculture (USDA). Spices, Fenugreek Seeds, FDC ID 171324. Food Data Central. 2019. Available online: https://fdc.nal.usda.gov/fdc-app.html#/food-details/171324/nutrients (accessed on 5 August 2024).
  70. Moradi, Z.; Zadeh, J.B. Fenugreek (Trigonella foenum-graecum L.) as a valuable medicinal plant. Int. J. Adv. Biol. Biomed. Res. 2013, 1, 922–931. [Google Scholar]
  71. Srinivasan, K. Fenugreek (Trigonella foenum-graecum): A review of health beneficial physiological effects. Food Rev. Int. 2006, 22, 203–224. [Google Scholar] [CrossRef]
  72. Wani, S.A.; Kumar, P. Fenugreek: A review on its nutraceutical properties and utilization in various food products. J. Saudi Soc. Agric. Sci. 2018, 17, 97–106. [Google Scholar] [CrossRef]
  73. Alu’datt, M.H.; Rababah, T.; Al-ali, S.; Tranchant, C.C.; Gammoh, S.; Alrosan, M.; Kubow, S.; Tan, T.C.; Ghatasheh, S. Current perspectives on fenugreek bioactive compounds and their potential impact on human health: A review of recent insights into functional foods and other high value applications. J. Food Sci. 2024, 89, 1835–1864. [Google Scholar] [CrossRef]
  74. Ciftci, O.N.; Przybylski, R.; Rudzinska, M.; Rudzinska, M.; Acharya, S. Characterization of fenugreek (Trigonella foenum-graecum) seed lipids. J. Am. Oil Chem. Soc. 2011, 88, 1603–1610. [Google Scholar] [CrossRef]
  75. Han, Y.; Nishibe, S.; Noguchi, Y.; Jin, Z. Flavonol glycosides from the stems of Trigonella foenum-graecum. Phytochemistry 2001, 58, 577–580. [Google Scholar] [CrossRef]
  76. Nagulapalli Venkata, K.C.; Swaroop, A.; Bagchi, D.; Bishayee, A. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Mol. Nutr. Food Res. 2017, 61, 1600950. [Google Scholar] [CrossRef]
  77. Sahu, P.K.; Cervera-Mata, A.; Chakradhari, S.; Patel, K.S.; Towett, E.K.; Quesada-Granados, J.J.; Martin-Ramos, P.; Rufian-Henares, J.A. Seeds as Potential Sources of Phenolic Compounds and Minerals for the Indian Population. Molecules 2022, 27, 3184. [Google Scholar] [CrossRef]
  78. Salam, S.G.A.; Rashed, M.M.; Ibrahim, N.A.; Rahim, E.A.A.; Aly, T.A.; Al-Farga, A. Phytochemical screening and in-vitro biological properties of unprocessed and household processed fenugreek (Trigonella foenum-graecum Linn.) seeds and leaves. Sci. Rep. 2023, 13, 7032. [Google Scholar] [CrossRef] [PubMed]
  79. Hamden, K.; Keskes, H.; Belhaj, S.; Mnafgui, K.; Feki, A.; Allouche, N. Inhibitory potential of omega-3 fatty and fenugreek essential oil on key enzymes of carbohydrate-digestion and hypertension in diabetes rats. Lipids Health Dis. 2011, 10, 226. [Google Scholar] [CrossRef] [PubMed]
  80. Rajhi, I.; Baccouri, B.; Rajhi, F.; Hammami, J.; Souibgui, M.; Mhadhbi, H.; Flamini, G. HS-SPME-GC–MS characterization of volatile chemicals released from microwaving and conventional processing methods of fenugreek seeds and flours. Ind. Crop Prod. 2022, 182, 114824. [Google Scholar] [CrossRef]
  81. Chaudhary, K.; Prasad, D.; Sandhu, B. Preliminary pharmacognostic and phytochemical studies on Nerium oleander Linn. (White cultivar). J. Pharmacogn. Phytochem. 2015, 4, 185–188. [Google Scholar]
  82. Balkan, I.A.; Doğan, H.; Zengin, G.; Colak, N.; Ayaz, F.A.; Gören, A.; Kırmızıbekmez, H.; Yeşilada, E. Enzyme inhibitory and antioxidant activities of Nerium oleander L. fl ower extracts and activity guided isolation of the active components. Ind. Crop Prod. 2018, 112, 24–31. [Google Scholar] [CrossRef]
  83. Patel, S.; Rauf, A.; Khan, H.; Khalid, S.; Mubarak, M.S. Potential health benefits of natural products derived from truffles: A review. Trends Food Sci. Technol. 2017, 70, 1–8. [Google Scholar] [CrossRef]
  84. Farooqui, S.; Tyagi, T. Nerium oleander: It’s application in basic and applied science: A Review. Int. J. Pharm. Pharm. Sci. 2018, 10, 1–4. [Google Scholar] [CrossRef]
  85. Garima, Z.; Amla, B. A review on chemistry and pharmacological activity of Nerium oleander L. J. Chem. Pharm. Res. 2010, 2, 351–358. [Google Scholar]
  86. Al-Snai, A.E. Pharmacological and therapeutic effects of Lippia nodiflora (Phyla nodiflora). IOSR J. Pharm. 2019, 9, 15–25. [Google Scholar]
  87. Atay Balkan, İ.; Gören, A.C.; Kırmızıbekmez, H.; Yeşilada, E. Evaluation of the in vitro anti-inflammatory activity of Nerium oleander L. flower extracts and activity-guided isolation of the active constituents. Rec. Nat. Prod. 2018, 12, 128–141. [Google Scholar] [CrossRef]
  88. Sinha, S.N.; Biswas, K. A concise review on Nerium oleander L.—An important medicinal plant. Trop. Plant Res. 2016, 3, 408–412. [Google Scholar]
  89. Singhal, K.G.; Gupta, G.D. Hepatoprotective and antioxidant activity of methanolic extract of flowers of Nerium oleander against CCl4–induced liver injury in rats. Asian Pac. J. Trop. Med. 2012, 5, 677–685. [Google Scholar] [CrossRef] [PubMed]
  90. Huang, L.; Ding, B.; Zhang, H.; Kong, B.; Xiong, Y.L. Textural and sensorial quality protection in frozen dumplings through the inhibition of lipid and protein oxidation with clove and rosemary extracts. J. Sci. Food Agric. 2019, 99, 4739–4747. [Google Scholar] [CrossRef] [PubMed]
  91. Peru Checklist. The Catalogue of the Flowering Plants and Gymnosperms of Peru; Missouri Botanical Garden: St. Louis, MO, USA, 2014. [Google Scholar]
  92. Carrubba, A.; Abbate, L.; Sarno, M.; Sunseri, F.; Mauceri, A.; Lupini, A.; Mercati, F. Characterization of Sicilian rosemary (Rosmarinus officinalis L.) germplasm through a multidisciplinary approach. Planta 2020, 251, 37. [Google Scholar] [CrossRef] [PubMed]
  93. USDA-ARS. Germplasm Resources Information Network (GRIN); National Germplasm Resources Laboratory: Beltsville, MD, USA, 2014. Available online: https://www.ars-grin.gov/ (accessed on 5 August 2024).
  94. Edinburgh, R.B.G. Flora Europea; Royal Botanic Garden Edinburgh: Edinburgh, UK, 2014. [Google Scholar]
  95. Wang, W.; Wu, N.; Zu, Y.G.; Fu, Y.J. Antioxidative activity of Rosmarinus officinalis L. essential oil compared to its main components. Food Chem. 2008, 108, 1019–1022. [Google Scholar] [CrossRef]
  96. Andrade, J.M.; Faustino, C.; Garcia, C.; Ladeiras, D.; Reis, C.P.; Rijo, P. Rosmarinus officinalis L.: An update review of its phytochemistry and biological activity. Future Science OA 2018, 4, FSO283. [Google Scholar] [CrossRef]
  97. Petersen, M.; Simmonds, M.S. Rosmarinic acid. Phytochemistry 2003, 62, 121–125. [Google Scholar] [CrossRef]
  98. Shi, J.; Lei, Y.; Shen, H.; Hong, H.; Yu, X.; Zhu, B.; Luo, Y. Effect of glazing and rosemary (Rosmarinus officinalis) extract on preservation of mud shrimp (Solenocera melantho) during frozen storage. Food Chem. 2019, 272, 604–612. [Google Scholar] [CrossRef]
  99. Herrero, M.; Plaza, M.; Cifuentes, A.; Ibanez, E. Green processes for the extraction of bioactives from Rosemary: Chemical and functional characterization via ultraperformance liquid chromatography-tandem mass spectrometry and in-vitro assays. J. Chromatogr. A. 2010, 1217, 2512–2520. [Google Scholar] [CrossRef]
  100. Hanson, J. Rosemary, the beneficial chemistry of a garden herb. Sci. Progress 2016, 99, 83–91. [Google Scholar] [CrossRef]
  101. Del Bano, M.J.; Lorente, J.; Castillo, J.; Benavente-García, O.; Marín, M.P.; Del Río, J.A.; Ortuno, A.; Ibarra, I. Flavonoid distribution during the development of leaves, flowers, stems, and roots of Rosmarinus officinalis postulation of a biosynthetic pathway. J. Agric. Food Chem. 2004, 52, 4987–4992. [Google Scholar] [CrossRef] [PubMed]
  102. Bai, N.; He, K.; Roller, M.; Lai, C.S.; Shao, X.; Pan, M.H.; Ho, C.T. Flavonoids and phenolic compounds from Rosmarinus officinalis. J. Agric. Food Chem. 2010, 58, 5363–5367. [Google Scholar] [CrossRef] [PubMed]
  103. Kompelly, A.; Kompelly, S.; Vasudha, B.; Narender, B. Rosmarinus officinalis L.: An update review of its phytochemistry and biological activity. J. Drug Deliv. Ther. 2019, 9, 323–330. [Google Scholar]
  104. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oil—A review. Food Chem. Toxicol. 2008, 46, 446–475. [Google Scholar] [CrossRef]
  105. Máthé, I.; Hohmann, J.; Janicsák, G.; Nagy, G.; Rédei, D. Chemical diversity of the biological active ingredients of Salvia offi cinalis and some closely related species. Acta Pharm. Hung. 2007, 77, 37–43. [Google Scholar]
  106. Bernotiené, G.; Nivinskiené, O.; Butkiené, R.; Mockuté, D. Essential oil composition variability in sage (Salvia officinalis L.). Chemija 2007, 18, 38–43. [Google Scholar]
  107. Hadri, A.; Gomez del Rio, M.; Sanz, J.; Coloma, A.; Idaomar, M.; Ozanas, B. Cytotoxic activity of α-humulene and transcario-phyllene from Salvia offi cinalis in animal and human tumor cells. An. R. Acad. Nac. Farm. 2010, 76, 343–356. [Google Scholar]
  108. Jug-Dujaković, M.; Ristić, M.; Pljevljakušić, D.; Dajić-Stevanović, Z.; Liber, Z.; Hančević, K.; Radić, T.; Šatović, Z. High diversity in indigenous populations of Dalmatian sage (Salvia officinalis L.) in essential oil composition. Chem. Biodivers. 2012, 9, 2309–2323. [Google Scholar] [CrossRef]
  109. Stešević, D.; Ristić, M.; Nikolić, V.; Nedović, M.; Caković, D.; Satovic, Z. Chemotype Diversity of Indigenous Dalmatian Sage (Salvia offi cinalis L.) Populations in Montenegro. Chem. Biodivers. 2014, 11, 101–114. [Google Scholar] [CrossRef]
  110. Politi, M.; Ferrante, C.; Menghini, L.; Angelini, P.; Flores, G.A.; Muscatello, B.; Braca, A.; De Leo, M. Hydrosols from Rosmarinus officinalis, Salvia officinalis, and Cupressus sempervirens: Phytochemical Analysis and Bioactivity Evaluation. Plants 2022, 11, 349. [Google Scholar] [CrossRef]
  111. Afonso, A.F.; Pereira, O.R.; Fernandes, Â.; Calhelha, R.C.; Silva, A.M.S.; Ferreira, I.C.F.R.; Cardoso, S.M. Phytochemical Composition and Bioactive Effects of Salvia africana, Salvia officinalis ‘Icterina’ and Salvia mexicana Aqueous Extracts. Molecules 2019, 24, 4327. [Google Scholar] [CrossRef] [PubMed]
  112. Pereira, R.; Catarino, M.D.; Afonso, A.F.; Silva, A.M.S.; Cardoso, S.M. Salvia elegans, Salvia greggii and Salvia officinalis Decoctions: Antioxidant Activities and Inhibition of Carbohydrate and Lipid Metabolic Enzymes. Molecules 2018, 23, 3169. [Google Scholar] [CrossRef] [PubMed]
  113. Silva, B.N.; Cadavez, V.; Caleja, C.; Pereira, E.; Calhelha, R.C.; Añibarro-Ortega, M.; Finimundy, T.; Kostić, M.; Soković, M.; Teixeira, J.A.; et al. Phytochemical Composition and Bioactive Potential of Melissa officinalis L.; Salvia officinalis L. and Mentha spicata L. Extracts. Foods 2023, 12, 947. [Google Scholar] [CrossRef]
  114. Spréa, R.M.; Caleja, C.; Pinela, J.; Finimundy, T.C.; Calhelha, R.C.; Kostić, M.; Sokovic, M.; Prieto, M.A.; Pereira, E.; Amaral, J.S.; et al. Comparative study on the phenolic composition and in vitro bioactivity of medicinal and aromatic plants from the Lamiaceae family. Food Res. Int. 2022, 161, 111875. [Google Scholar] [CrossRef] [PubMed]
  115. Maliki, I.; Es-safi, I.; El Moussaoui, A.; Mechchate, H.; El Majdoub, Y.O.; Bouymajane, A.; Cacciola, F.; Mondello, L.; Elbadaouia, K. Salvia officinalis and Lippia triphylla: Chemical characterization and evaluation of antidepressant-like activity. J. Pharm. Biomed. Anal. 2021, 203, 114207. [Google Scholar] [CrossRef]
  116. Bracci, T.; Busconi, M.; Fogher, C.; Sebastiani, L. Molecular studies in olive (Olea europaea L.): Overview on DNA markers applications and recent advances in genome analysis. Plant Cell Rep. 2011, 30, 449–462. [Google Scholar] [CrossRef]
  117. Ghanbari, R.; Anwar, F.; Alkharfy, K.M.; Gilani, A.-H.; Saari, N. Valuable Nutrients and Functional Bioactives in Different Parts of Olive (Olea europaea L.)—A Review. Int. J. Mol. Sci. 2012, 13, 3291–3340. [Google Scholar] [CrossRef]
  118. Kaskoos, R.A. Pharmacognostic specifications of leaves of Olea europaea collected from Iraq. Am. J. Phytomed. ClinTher. 2013, 2, 153–160. [Google Scholar]
  119. Ayoub, L.; Hassan, F.; Hamid, S.; Abdelhamid, Z.; Souad, A. Phytochemical screening, antioxidant activity and inhibitorypotential of Ficus carica and Olea europaea leaves. Bioinformation 2019, 15, 226–232. [Google Scholar] [CrossRef]
  120. Kiritsakis, A.K. Olive Oil from the Tree to the Table, 2nd ed.; Food & Nutrition Press, Inc.: Trumbull, CT, USA, 1998. [Google Scholar]
  121. Boudhrioua, N.; Bahloul, N.; Ben Slimen, I.; Kechaou, N. Comparison on the total phenol contents and the color of fresh and infrared dried olive leaves. Ind. Crops Prod. 2009, 29, 412–419. [Google Scholar] [CrossRef]
  122. Benavente-Garcia, O.; Castillo, J.; Lorente, J.; Ortuno, A. Del Rio JA. Antioxidant activity of phenolics extracted from Olea europea L. leaves. Food. Chem. 2000, 68, 457–462. [Google Scholar] [CrossRef]
  123. Haloui, E.; Marzouk, Z.; Marzouk, B.; Bouftira, I.; Bouraoui, A.; Fenina, N. Pharmacological Activities and Chemical Composition of the Olea europaea L. Leaf Essential Oils from Tunisia. J. Food Agric. Environ. 2010, 8, 204–208. Available online: https://www.wflpublisher.com/Abstract/1605 (accessed on 15 August 2024).
  124. Bouarroudj, K.; Tamendjari, A.; Larbat, R. Quality, composition and antioxidant activity of Algerian wild olive (Olea europaea L. subsp. Oleaster) oil. Ind. Crops Prod. 2016, 83, 484–491. [Google Scholar] [CrossRef]
  125. Šarolić, M.; Gugić, M.; Tuberoso, C.I.G.; Jerković, I.; Šuste, M.; Marijanović, Z.; Kuś, P.M. Volatile Profile, Phytochemicals and Antioxidant Activity of Virgin Olive Oils from Croatian Autochthonous Varieties Mašnjača and Krvavica in Comparison with Italian Variety Leccino. Molecules 2014, 19, 881–895. [Google Scholar] [CrossRef] [PubMed]
  126. Luo, H. Extraction of Antioxidant Compounds from Olive (Olea europaea) Leaf. Thesis Massey Univ. 2011, pp. 1–17. Available online: https://mro.massey.ac.nz/handle/10179/3481 (accessed on 15 August 2024).
  127. Khlif, I.; Jellali, K.; Michel, T.; Halabalaki, M.; Skaltsounis, A.L.; Allouche, N. Characteristics, Phytochemical Analysis and Biological Activities of Extracts from Tunisian Chetoui Olea europaea Variety. J. Chem. 2015, 2015, e418731. [Google Scholar] [CrossRef]
  128. Jurišić Grubešić, R.; Nazlić, M.; Miletić, T.; Vuko, E.; Vuletić, N.; Ljubenkov, I.; Dunkić, V. Antioxidant Capacity of Free Volatile Compounds from Olea europaea L. cv. Oblica Leaves Depending on the Vegetation Stage. Antioxidants 2021, 10, 1832. [Google Scholar]
  129. Alagna, F.; Geu-Flores, F.; Kries, H.; Panara, F.; Baldoni, L.; O’Connor, S.E.; Osbourn, A. Identification and Characterization of the Iridoid Synthase Involved in Oleuropein Biosynthesis in Olive (Olea europaea) Fruits. J. Biol. Chem. 2016, 291, 5542–5554. [Google Scholar] [CrossRef]
  130. Maalej, A.; Bouallagui, Z.; Hadrich, F.; Isoda, H.; Sayadi, S. Assessment of Olea europaea L. fruit extracts: Phytochemical characterization and anticancer pathway investigation. Biomed. Pharmacother. 2017, 90, 179–186. [Google Scholar]
  131. Gariboldi, P.; Jommi, G.; Verotta, L. Secoiridoids from Olea europaea. Phytochemistry 1986, 25, 865–869. [Google Scholar] [CrossRef]
  132. Castejón, M.L.; Montoya, T.; Alarcón-de-la-Lastra, C.; Sánchez-Hidalgo, M. Potential Protective Role Exerted by Secoiridoids from Olea europaea L. in Cancer, Cardiovascular, Neurodegenerative, Aging-Related, and Immunoinflammatory Diseases. Antioxidants 2020, 9, 149. [Google Scholar] [CrossRef]
  133. Kamran, M. Olive (Olea europaea L.) Leaf Biophenols as Nutraceuticals. Doctor of Philosophy. Charles Sturt University. 2016, Volume 292. Available online: https://researchoutput.csu.edu.au/ws/portalfiles/portal/92488706/Kamran_Muhammad_thesis.pdf. (accessed on 15 August 2024).
  134. Hadrich, F.; Bouallagui, Z.; Junkyu, H.; Isoda, H.; Sayadi, S. The α-Glucosidase and α-Amylase Enzyme Inhibitory of Hydroxytyrosol and Oleuropein. J. Oleo Sci. 2015, 64, 835–843. [Google Scholar] [CrossRef] [PubMed]
  135. Ghosia, L.; Khan, A.; Tila, H.; Hussain, A.; Khan, A. Evaluation of Plants Extracts for Proximate Chemical Composition, Antimicrobial and Antifungal Activities. Am. Eurasian J. Agric. Environ. Sci. 2014, 14, 964–970. [Google Scholar]
  136. Celik, H.; Nadaroglu, H.; Senol, M. Evaluation of antioxidant, antiradicalic and antimicrobial activities of olive pits (Olea europaea L.). Bulg. J. Agric. Sci. 2014, 20, 1392–1400. [Google Scholar]
  137. Guo, L.; Sun, Q.; Gong, S.; Bi, X.; Jiang, W.; Xue, W.; Fei, P. Antimicrobial Activity and Action Approach of the Olive Oil Polyphenol Extract against Listeria monocytogenes. Front. Microbiol. 2019, 10, 1586. [Google Scholar] [CrossRef] [PubMed]
  138. Coccia, A.; Bastianelli, D.; Mosca, L.; Monticolo, R.; Panuccio, I.; Carbone, A.; Calogero, A.; Lendaro, E. Extra Virgin Olive Oil Phenols Suppress Migration and Invasion of T24 Human Bladder Cancer Cells through Modulation of Matrix Metalloproteinase-2. Nutr. Cancer 2014, 66, 946–954. [Google Scholar] [CrossRef]
  139. Shabana, A.; El-Menyar, A.; Asim, M.; Al-Azzeh, H.; Al Thani, H. Cardiovascular benefits of black cumin (Nigella Sativa). Cardiovasc. Toxicol. 2013, 13, 9–21. [Google Scholar] [CrossRef]
  140. Kehili, N.; Saka, S.; Aouacheri, O. L’effet phytoprotecteur de la nigelle (Nigella Sativa) contre la toxicité induite par le cadmium chez les rats. Phytothérapie 2018, 16, 194–203. [Google Scholar] [CrossRef]
  141. Sahak, M.K.A.; Kabir, N.; Abbas, G.; Draman, S.; Hashim, N.H.; Hasan Adli, D.S. The role of Nigella Sativa and its active constituents in learning and memory. Evid. Based Complement. Altern. Med. 2016, 1, 6075679. [Google Scholar] [CrossRef]
  142. Dalli, M.; Azizi, S.; Benouda, H.; Azghar, H.A.; Tahri, M.; Boufalja, B.; Maleb, A.; Gseyra, N. Molecular Composition and Antibacterial Effect of Five Essential Oils Extracted from Nigella Sativa L. Seeds against Multidrug-Resistant Bacteria: A Comparative Study. Evid. Based Complement. Altern. Med. 2021, 2021, 6643765. [Google Scholar] [CrossRef]
  143. Kabir, Y.; Akasaka-Hashimoto, Y.; Kubota, K.; Komai, M. Volatile compounds of black cumin (Nigella Sativa L.) seeds cultivated in Bangladesh and India. Heliyon 2020, 6, e05343. [Google Scholar] [CrossRef]
  144. Dalli, M.; Daoudi, N.E.; Azizi, S.; Benouda, H.; Bnouham, M.; Gseyra, N. Chemical composition analysis using HPLC-UV/GC-MS and inhibitory activity of different Nigella Sativa fractions on pancreatic α-amylase and intestinal glucose absorption. BioMed Res. Int. 2021, 2021, 9979419. [Google Scholar] [CrossRef] [PubMed]
  145. Parveen, A.; Farooq, M.A.; Kyunn, W.W. A new oleanane type saponin from the aerial parts of Nigella Sativa with anti-oxidant and anti-diabetic potential. Molecules 2020, 25, 2171. [Google Scholar] [CrossRef] [PubMed]
  146. Atta-ur-Rahman, S.M. Isolation and structure determination of nigellicine, a novel alkaloid from the seeds of Nigella Sativa. Tetrahedron Lett. 1985, 26, 2759–2762. [Google Scholar] [CrossRef]
  147. Atta-ur-Rahman, S.M.; Zaman, K. Nigellimine: A new isoquinoline alkaloid from the seeds of Nigella Sativa. J. Nat. Prod. 1992, 55, 676–678. [Google Scholar] [CrossRef]
  148. Atta-ur-Rahman, S.M.; Hasan, S.S.; Choudhary, M.I.; Ni, C.Z.; Clardy, J. Nigellidine—A new indazole alkaloid from the seeds of Nigella Sativa. Tetrahedron Lett. 1995, 36, 1993–1996. [Google Scholar] [CrossRef]
  149. Makkar, H.P.S.; Siddhuraju, P.; Becker, K. Plant Secondary Metabolites; Humana Press: Totowa, NJ, USA, 2007. [Google Scholar]
  150. Al-Jassir, M. Chemical composition and microflora of black cumin (Nigella Sativa L.) seeds growing in Saudi Arabia. Food Chem. 1992, 45, 239–242. [Google Scholar] [CrossRef]
  151. Usmani, A.; Almoselhy, R.I. Current trends in Nigella Sativa L. (Black seed) from traditional to modern medicine with advances in extraction, formulation, quality control, regulatory status, and pharmacology. Int. J. Pharm. Chem. 2024, 11, 11–23. [Google Scholar] [CrossRef]
  152. Cheikh-Rouhoua, S.; Besbes, S.; Lognay, G.; Blecker, C.; Deroanne, C.; Attia, H. Sterol composition of black cumin (Nigella Sativa L.) and Aleppo pine (Pinus halepensis Mill.) seed oils. J. Food Compos. Anal. 2008, 21, 162–168. [Google Scholar] [CrossRef]
  153. Mehta, B.K.; Verma, M.; Gupta, M. Novel lipid constituents identified in seeds of Nigella Sativa (Linn). J. Braz. Chem. Soc. 2008, 19, 458–462. [Google Scholar] [CrossRef]
  154. Bourgou, S.; Ksouri, R.; Bellila, A.; Skandrani, I.; Falleh, H.; Marzouk, B. Phenolic composition and biological activities of Tunisian Nigella Sativa L. shoots and roots. Comptes Rendus Biol. 2008, 331, 48–55. [Google Scholar] [CrossRef]
  155. Nickavar, B.; Mojab, F.; Javidnia, K.; Amoli, M.A. Chemical composition of the fixed and volatile oils of Nigella Sativa L. from Iran. Z. Natur. forsch. C. J. Biosci. 2003, 58, 629–631. [Google Scholar] [CrossRef] [PubMed]
  156. Morikawa, T.; Xu, F.; Ninomiya, K.; Matsuda, H.; Yoshikawa, M. Nigellamines A3, A4, A5, and C, new dolabellane-type diterpene alkaloids, with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin. Chem. Pharm. Bull. 2004, 52, 494–497. [Google Scholar] [CrossRef] [PubMed]
  157. Butt, A.S.; Nisar, N.; Ghani, N.; Altaf, I.; Mughal, T.A. Isolation of thymoquinone from Nigella Sativa L. and Thymus vulgaris L.; and its anti-proliferative effect on HeLa cancer cell lines, Trop. J. Pharm. Res. 2019, 18, 37–42. [Google Scholar] [CrossRef]
  158. MatthauS, B.; ÖzCaN, M.M. Fatty acids, tocopherol, and sterol contents of some Nigella species seed oil. Czech J. Food Sci. 2011, 29, 145–150. [Google Scholar] [CrossRef]
  159. Hussain, S.; Rukhsar, A.; Iqbal, M.; ul Ain, Q.; Fiaz, J.; Akhtar, N.; Afzal, M.; Ahmad, N.; Ahmad, I.; Mnif, W.; et al. Phytochemical Profile, Nutritional and Medicinal Value of Nigella Sativa. Biocatal. Agric. Biotechnol. 2024, 60, 103324. [Google Scholar] [CrossRef]
  160. Dabeek, W.M.; Marra, M.V. Dietary quercetin and kaempferol: Bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients 2019, 11, 2288. [Google Scholar] [CrossRef]
  161. David, A.V.A.; Arulmoli, R.; Parasuraman, S. Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn. Rev. 2016, 10, 84–89. [Google Scholar]
  162. Prima, S.R.; Julianti, E.; Fidrianny, I. Update review: Etnopharmacological, bioactivity and phytochemical of Allium cepa L. Pharmacia 2023, 70, 717–724. [Google Scholar]
  163. Han, M.H.; Lee, W.S.; Jung, J.H.; Jeong, J.H.; Park, C.; Kim, H.J.; Kim, G.S.; Jung, J.M.; Kwon, T.K.; Kim, G.Y.; et al. Polyphenols isolated from Allium cepa L. induces apoptosis by suppressing IAP-1 through inhibiting PI3K/Akt signaling pathways in human leukemic cells. Food Chem. Toxicol. 2013, 62, 382–389. [Google Scholar] [CrossRef]
  164. Sato, A.; Zhang, T.; Yonekura, L.; Tamura, H. Antiallergic activities of eleven onions (Allium cepa) were attributed to quercetin 4′-glucoside using QuEChERS method and Pearson’s correlation coefficient. J. Funct. Foods 2015, 14, 581–589. [Google Scholar] [CrossRef]
  165. Celano, R.; Docimo, T.; Piccinelli, A.L.; Gazzerro, P.; Tucci, M.; Di Sanzo, R.; Carabetta, S.; Campone, L.; Russo, M.; Rastrelli, L. Onion peel: Turning a food waste into a resource. Antioxidants 2021, 10, 304–321. [Google Scholar] [CrossRef] [PubMed]
  166. Vu, N.K.; Kim, C.S.; Ha, M.T.; Ngo, Q.M.T.; Park, S.E.; Kwon, H.; Lee, D.; Choi, J.S.; Kim, J.A.; Min, B.S. Antioxidant and antidiabetic activities of flavonoid derivatives from the outer skins of Allium cepa L. J. Agric. Food Chem. 2020, 68, 8797–8811. [Google Scholar] [CrossRef] [PubMed]
  167. Kumar, V.P.; Prashanth, K.H.; Venkatesh, Y.P. Structural analyses and immunomodulatory properties of fructo-oligosaccharides from onion (Allium cepa). Carbohydr. Polym. 2015, 117, 115–122. [Google Scholar] [CrossRef] [PubMed]
  168. Gîtin, L.; Dinică, R.; Neagu, C.; Dumitrascu, L. Sulfur compounds identification and quantification from Allium spp. fresh leaves. J. Food Drug Anal. 2014, 22, 425–430. [Google Scholar] [CrossRef]
  169. Abdelrahman, M.; Mahmoud, H.Y.; El-Sayed, M.; Tanaka, S.; Tran, L.S. Isolation and characterization of Cepa2, a natural alliospiroside A, from shallot (Allium cepa L. Aggregatum group) with anticancer activity. Plant Physiol. Biochem. 2017, 116, 167–173. [Google Scholar] [CrossRef]
  170. Ifesan, B. Chemical composition of onion peel (Allium cepa) and its ability to serve as a preservative in cooked beef. Int. J. Soc. Res. Methodol. 2017, 7, 25–34. [Google Scholar]
  171. Stoica, F.; Condurache, N.N.; Horincar, G.; Constantin, O.E.; Turturică, M.; Stănciuc, N.; Aprodu, I.; Croitoru, C.; Râpeanu, G. Value-added crackers enriched with red onion skin anthocyanins entrapped in different combinations of wall materials. Antioxidants 2022, 11, 1048. [Google Scholar] [CrossRef]
  172. Albishi, T.; John, J.A.; Al-Khalifa, A.S.; Shahidi, F. Antioxidative phenolic constituents of skins of onion varieties and their activities. J. Funct. Foods 2013, 5, 1191–1203. [Google Scholar] [CrossRef]
  173. Kuete, V. Allium cepa. In Medicinal Spices and Vegetables from Africa; Elsevier Inc.: Amsterdam, The Netherlands, 2017; pp. 353–361. [Google Scholar]
  174. Lee, S.U.; Lee, J.H.; Choi, S.H.; Lee, J.S.; Ohnisi-Kameyama, M.; Kozukue, N.; Levin, C.E.; Friedman, M. Flavonoid content in fresh, home-processed, and light-exposed onions and in dehydrated commercial onion products. J. Agric. Food Chem. 2008, 56, 8541–8548. [Google Scholar] [CrossRef]
  175. Sagar, N.A.; Pareek, S.; Gonzalez-Aguilar, G.A. Quantification of flavonoids, total phenols and antioxidant properties of onion skin: A comparative study of fifteen Indian cultivars. J. Food Technol. 2020, 57, 2423–2432. [Google Scholar] [CrossRef]
  176. Yang, D.; Dunshea, F.R.; Suleria, H.A.R. LC-ESI-QTOF/MS characterization of Australian herb and spices (garlic, ginger, and onion) and potential antioxidant activity. J. Food Process. Preserv. 2020, 44, e14497. [Google Scholar] [CrossRef]
  177. Ramos, A.F.; Takaishi, Y.; Shirotori, M.; Kawaguchi, Y.; Tsuchiya, K.; Shibata, H.; Higuti, T.; Tadokoro, T.; Takeuchi, M. Antibacterial and antioxidant activities of quercetin oxidation products from yellow onion (Allium cepa) skin. J. Agric. Food Chem. 2006, 54, 3551–3557. [Google Scholar] [CrossRef] [PubMed]
  178. Benítez, V.; Mollá, E.; Martín-Cabrejas, M.A.; Aguilera, Y.; López-Andréu, F.J.; Cools, K.; Terry, L.A.; Esteban, R.M. Characterization of industrial onion wastes (Allium cepa L.): Dietary fibre and bioactive compounds. Plant Foods Hum. Nutr. 2011, 66, 48–57. [Google Scholar] [CrossRef] [PubMed]
  179. Sharma, K.; Mahato, N.; Nile, S.H.; Lee, E.T.; Lee, Y.R. Economical and environmentally-friendly approaches for usage of onion (Allium cepa L.) waste. Food Funct. 2016, 7, 3354–3369. [Google Scholar] [CrossRef] [PubMed]
  180. Putnik, P.; Gabric, D.; Roohinejad, S.; Barba, F.J.; Granato, D.; Mallikarjunan, K.; Kovacevic, D.B. An overview of organosulfur compounds from Allium spp.: From processing and preservation to evaluation of their bioavailability, antimicrobial, and anti-inflammatory properties. Food Chem. 2019, 276, 680–691. [Google Scholar] [CrossRef]
  181. Réggami, Y.; Benkhaled, A.; Boudjelal, A.; Berredjem, H.; Amamra, A.; Benyettou, H.; Larabi, N.; Senator, A.; Siracusa, L.; Ruberto, G. Artemisia herba-alba aqueous extract improves insulin sensitivity and hepatic steatosis in rodent model of fructose-induced metabolic syndrome. Arch. Physiol. Biochem. 2021, 127, 541–550. [Google Scholar] [CrossRef]
  182. Younsi, F.; Trimech, R.; Boulila, A.; Ezzine, O.; Dhahri, S.; Boussaid, M.; Messaoud, C. Essential oil and phenolic compounds of Artemisia herba alba (Asso.): Composition, Antioxidant, Antiacetylcholinesterase, and Antibacterial Activities. Int. J. Food Prop. 2016, 19, 1425–1438. [Google Scholar] [CrossRef]
  183. Mohammed, M.J.; Anand, U.; Altemimi, A.B.; Tripathi, V.; Guo, Y.; Pratap-Singh, A. Phenolic composition, antioxidant capacity and antibacterial activity of white wormwood (Artemisia herba-alba). Plants 2021, 10, 164. [Google Scholar] [CrossRef]
  184. Ouguirti, N.; Bahri, F.; Bouyahyaoui, A.; Wanner, J. Chemical characterization and bioactivities assessment of Artemisia herba-alba Asso essential oil from South-western Algeria. Nat. Volatiles Essent. Oils 2021, 8, 27–36. [Google Scholar] [CrossRef]
  185. Mrabti, H.N.; El Hachlafi, N.; Al-Mijalli, S.H.; Jeddi, M.; Elbouzidi, A.; Abdallah, E.M.; Flouchi, R.; Assaggaf, H.; Qasem, A.; Zengin, G.; et al. Phytochemical profile, assessment of antimicrobial and antioxidant properties of essential oils of Artemisia herba-alba Asso.; and Artemisia dracunculus L.: Experimental and computational approaches. J. Mol. Struct. 2023, 1294, 136479. [Google Scholar] [CrossRef]
  186. Amor, G.; Caputo, L.; La Storia, A.; De Feo, V.; Mauriello, G.; Fechtali, T. Chemical composition and antimicrobial activity of Artemisia herba-alba and Origanum majorana essential oils from Morocco. Molecules 2019, 24, 4021. [Google Scholar] [CrossRef] [PubMed]
  187. El Ouahdani, K.; Es-Safi, I.; Mechchate, H.; Al-Zahrani, M.; Qurtam, A.A.; Aleissa, M.; Bari, A.; Bousta, D. Thymus algeriensis and Artemisia herba-alba essential oils: Chemical analysis, antioxidant potential and in vivo anti-inflammatory, analgesic activities, and acute toxicity. Molecules 2021, 26, 6780. [Google Scholar] [CrossRef] [PubMed]
  188. Benabdallah, A.; Betina, S.; Bouchentouf, S.; Boumendje, M.; Bechkr, S.; Bensouic, C.; Nicoli, F.; Vergine, M.; Negro, C. Chemical profiling, antioxidant, enzyme inhibitory and in silico modeling of Rosmarinus officinalis L. and Artemisia herba alba Asso. essential oils from Algeria. S. Afr. J. Bot. 2022, 147, 501–510. [Google Scholar]
  189. Almi, D.; Sebbane, H.; Lahcene, S.; Habera, F.; Laoudi, K.; Mati, A. Antibacterial and antioxidant activities of various extracts and essential oil from dried leaves of Artemisia herba-alba Asso of Tamanrasset (South Algeria). Int. J. Minor Fruits Med. Aromat. Plants 2022, 8, 47–55. [Google Scholar] [CrossRef]
  190. Bourgou, S.; Tammar, S.; Salem, N.; Mkadmini, K.; Msaada, K. Phenolic composition, essential oil, and antioxidant activity in the aerial part of Artemisia herba alba from several provenances: A comparative study. Int. J. F. Prop. 2016, 19, 549–563. [Google Scholar] [CrossRef]
  191. Benmeziane, B.; Haddadin, M.; AL-Domi, H. Extraction yield, phytochemicals analysis, and certain in vitro biological activities of Artemisia herba alba extracts. Jordan J. Agric. Sci. 2023, 19, 125–141. [Google Scholar] [CrossRef]
  192. Zhao, H.; Dong, J.; Lu, J.; Chen, J.; Li, Y.; Shan, L. Effects of extraction solvent mixtures on antioxidant activity evaluation and their extraction capacity and selectivity for free phenolic compounds in Barley (Hordeum vulgare L.). J. Agri. Food Chem. 2006, 54, 7277–7286. [Google Scholar] [CrossRef]
  193. Ashraf, A.; Sarfraz, A.; Rashid, A.; Shahid, M. Antioxidant, antimicrobial, antitumor, and cytotoxic activities of an important medicinal plant (Euphorbia royleana) from Pakistan. J. Food Drug Anal. 2015, 23, 109–115. [Google Scholar]
  194. Ashraf, A.; Sarfraz, A.R.; Mahmood, A. Phenolic compounds characterization Artemisia rutifolia spreng from Pakistani flora and their relationships with antioxidant and antimicrobial attributes. Int. J. F. Prop. 2017, 20, 2538–2549. [Google Scholar] [CrossRef]
  195. Morales-González, J.A.; Madrigal-Bujaidar, E.; Sánchez-Gutiérrez, M.; Izquierdo-Vega, J.A.; Carmen Valadez-Vega, M.D.; ÁlvarezGonzález, I.; Morales-González, A.; Madrigal-Santillán, E. Garlic (Allium sativum L.): A brief review of its antigenotoxic effects. Foods 2019, 8, E343. [Google Scholar] [CrossRef]
  196. Varga-Visi, E.; Jócsák, I.; Ferenc, B.; Végvári, G. Effect of crushing and heating on the formation of volatile organosulfur compounds in garlic. CYTA J. Food 2019, 17, 796–803. [Google Scholar] [CrossRef]
  197. Al-Snafi, A. Pharmacological effects of Allium species grown in Iraq. An overview. Int. J. Pharm. Health Care Res. 2013, 1, 132–147. [Google Scholar]
  198. Zeng, Y.; Li, Y.; Yang, J.; Pu, X.; Du, J.; Yang, X.; Yang, T.; Yang, S. Therapeutic role of functional components in Alliums for preventive chronic disease in human being. Evid. Based Complement. Altern. Med. 2017, 2017, 9402849. [Google Scholar] [CrossRef] [PubMed]
  199. Tran, G.B.; Dam, S.M.; Le, N.T.T. Amelioration of single clove black garlic aqueous extract on dyslipidemia and hepatitis in chronic carbon tetrachloride intoxicated swiss albino mice. Int. J. Hepatol. 2018, 2018, 9383950. [Google Scholar] [CrossRef]
  200. Liu, Y.; Yan, J.; Han, X.; Hu, W. Garlic-derived compound S-allylmercaptocysteine (SAMC) is active against anaplastic thyroid cancer cell line 8305C (HPACC). Technol. Health Care 2015, 23, S89–S93. [Google Scholar] [CrossRef] [PubMed]
  201. Țigu, A.B.; Moldovan, C.S.; Toma, V.-A.; Farcaș, A.D.; Moț, A.C.; Jurj, A.; Fischer-Fodor, E.; Mircea, C.; Pârvu, M. Phytochemical analysis and in vitro effects of Allium fistulosum L. and Allium sativum L. extracts on human normal and tumor cell lines: A comparative study. Molecules 2021, 26, 574. [Google Scholar] [CrossRef] [PubMed]
  202. Akbarpour, A.; Kavoosi, B.; Hosseinifarahi, M.; Tahmasebi, S.; Gholipour, S. Evaluation of yield and phytochemical content of different Iranian garlic (Allium sativum L.) ecotypes. Int. J. Hortic. Sci. Technol. 2021, 8, 385–400. [Google Scholar]
  203. Efiong, E.E.; Akumba, L.P.; Chukwu, E.C.; Olusesan, A.I.; Obochi, G. Comparative qualitative phytochemical analysis of oil, juice and dry forms of garlic (Allium sativum) and different varieties of onions (Allium cepa) consumed in Makurdi metropolis. Int. J. Plant Physiol. Biochem. 2020, 12, 9–16. [Google Scholar]
  204. Knoss, W. Marrubium vulgare (White Horehound): In vitro culture, and the production of diterpene marrubiin and other secondary metabolites. In Medicinal and Aromatic Plants XI. Biotechnology in Agriculture and Forestry; Bajaj, Y.P.S., Ed.; Springer: Berlin/Heidelberg, Germany, 1999; Volume 43, pp. 274–289. [Google Scholar]
  205. Aćimović, M.; Jeremić, K.; Salaj, N.; Gavarić, N.; Kiprovski, B.; Sikora, V.; Zeremski, T. Marrubium vulgare L.: A Phytochemical and pharmacological overview. Molecules 2020, 25, 2898. [Google Scholar] [CrossRef]
  206. Amessis-Ouchemoukh, N.; Abu-Reidah, I.M.; Quirantes-Piné, R.; Madani, K.; Segura-Carretero, A. Phytochemical profiling, in vitro evaluation of total phenolic contents and antioxidant properties of Marrubium vulgare (horehound) leaves of plants growing in Algeria. Ind. Crops Prod. 2014, 61, 120–129. [Google Scholar] [CrossRef]
  207. Ahmed, B.; Masoodi, M.H.; Siddique, A.H.; Khan, S. A new monoterpene acid from Marrubium vulgare with potential antihepatotoxic activity. Nat. Prod. Res. 2010, 24, 1671–1680. [Google Scholar] [CrossRef]
  208. Verma, A.; Masoodi, M.; Ahmed, B. Lead findings from whole plant of Marrubium vulgare L. with hepatoprotective potentials through in silico methods. Asian Pac. J. Trop. Biomed. 2012, 2, S1308–S1311. [Google Scholar] [CrossRef]
  209. Neamah, S.I.; Sarhan, I.A.; Al-Shayea, O.N. Extraction and evaluation of the anti-inflammatory activity of six compounds of Marrubium vulgare L. Biosci. Res. 2018, 15, 2393–2400. [Google Scholar]
  210. Knoss, W.; Zapp, J. Accumulation of furanic labdane diterpenes in Marrubium vulgare and Leonorus cardiaca. Planta Med. 1998, 64, 357–361. [Google Scholar] [CrossRef] [PubMed]
  211. Shaheen, F.; Rasool, S.; Shah, Z.A.; Soomro, S.; Jabeen, A.; Mesaik, M.A.; Choudhary, M.I. Chemical constituents of Marrubium vulgare as potential inhibitors of nitric oxide and respiratory burst. Nat. Prod. Commun. 2014, 9, 903–906. [Google Scholar] [CrossRef]
  212. Piozzi, F.; Bruno, M.; Rosselli, S.; Maggio, A. The diterpenoids of the genus Marrubium (Lamiaceae). Nat. Prod. Commun. 2006, 1, 585–592. [Google Scholar] [CrossRef]
  213. Ghedadba, N.; Hambaba, L.; Fercha, N.; Houas, B.; Abdessemed, S.; Mokhtar, S.M.O. Assessment of hemostatic activity of the aqueous extract of leaves of Marrubium vulgare L.; a Mediterranean Lamiaceae Algeria. Int. J. Health Sci. 2016, 2, 253–258. [Google Scholar]
  214. Boudjelal, A.; Henchiri, C.; Siracusa, L.; Sari, M.; Ruberto, G. Compositional analysis and in vivo anti-diabetic activity of wild Algerian Marrubium vulgare L. infusion. Fitoterapia 2012, 83, 286–292. [Google Scholar] [CrossRef]
  215. Paunovic, V.; Kostic, M.; Djordjevic, S.; Zugic, A.; Djalinac, N.; Gasic, U.; Trajkovic, V.; Harhaji-Trajkovic, J. Marrubium vulgare ethanolic extract induces proliferation block, apoptosis and cytoprotective autophagy in cancer cells in vitro. Cell. Mol. Biol. 2016, 62, 108–114. [Google Scholar] [PubMed]
  216. Dewick, M.P. Medicinal Natural Products: A Biosynthetic Approach, 3rd ed.; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2009; ISBN 978-0-470-74168-9. [Google Scholar]
  217. Boulila, A.; Sanaa, A.; Salem, I.B.; Rokbeni, N.; M’rabet, Y.; Hosni, K.; Fernandez, X. Antioxidant properties and phenolic variation in wild populations of Marrubium vulgare L. (Lamiaceae). Ind. Crops Prod. 2015, 76, 616–622. [Google Scholar] [CrossRef]
  218. Popoola, O.K.; Elbagory, A.M.; Ameer, F.; Hussein, A. Marrubiin. Molecules 2013, 18, 9049–9060. [Google Scholar] [CrossRef] [PubMed]
  219. Karunanithi, P.S.; Dhanlta, P.; Addison, J.B.; Tong, S.; Fiehn, O.; Zerbe, P. Functional characterization of the cytochrome P450 monooxygenase CYP71AU87 indicates a role in marrubiin byosynthesis in the medicinal plant Marrubium vulgare. BMC Plant Biol. 2019, 19, 114. [Google Scholar] [CrossRef] [PubMed]
  220. Demiroz Akbulut, T.; Aydin Kose, F.; Demirci, B.; Baykan, S. Chemical profile and cytotoxicity evaluation of aerial parts of Marrubium vulgare L. from different locations in Turkey. Chem. Biodivers. 2023, 20, e202201188. [Google Scholar] [CrossRef]
  221. Guedri Mkaddem, M.; Zrig, A.; Ben Abdallah, M.; Romdhane, M.; Okla, M.K.; Al-Hashimi, A.; Alwase, Y.A.; Hegab, M.Y.; Madany, M.M.Y.; Hassan, A.H.A. Variation of the chemical composition of essential oils and total phenols content in natural populations of Marrubium vulgare L. Plants 2022, 11, 612. [Google Scholar] [CrossRef]
  222. Rezgui, M.; Majdoub, N.; Mabrouk, B.; Baldisserotto, A.; Bino, A.; Kaab, L.B.B. Antioxidant and antifungal activities of marrubiin, extracts and essential oil from Marrubium vulgare L. against pathogenic dermatophyte strains. J. Mycol. Med. 2020, 30, 100927. [Google Scholar] [CrossRef] [PubMed]
  223. Abadi, A.; Hassani, A. Chemical composition of Marrubium vulgare L. essential oil from Algeria. Int. Lett. Chem. Phys. Astron. 2013, 8, 210–214. [Google Scholar] [CrossRef]
  224. Zawiślak, G. The chemical composition of the essential oil of Marrubium vulgare L. from Poland. Farmacia 2012, 60, 287–292. [Google Scholar]
  225. Zarai, Z.; Kadri, A.; Ben Chobba, I.; Ben Mansour, R.; Bekir, A.; Mejdoub, H.; Gharsallah, N. The in-vitro evaluation of antibacterial, antifungal and cytotoxic properties of Marrubium vulgare L. essential oil grown in Tunisia. Lipids Health Dis. 2011, 21, 161. [Google Scholar] [CrossRef]
  226. Michalak, M.; Stryjecka, M.; Zagórska-Dziok, M.; Żarnowiec, P. Biological Activity of Horehound (Marrubium vulgare L.) Herb Grown in Poland and Its Phytochemical Composition. Pharmaceuticals 2024, 17, 780. [Google Scholar] [CrossRef]
  227. Tlili, H.; Hanen, N.; Ben Arfa, A.; Neffati, M.; Boubakri, A.; Buonocore, D.; Dossena, M.; Verri, M.; Doria, E. Biochemical profile and in vitro biological activities of extracts from seven folk medicinal plants growing wild in southern Tunisia. PLoS ONE 2019, 14, e0213049. [Google Scholar] [CrossRef]
  228. Benhaddou-Andaloussi, A.; Martineau, L.; Vuong, T.; Meddah, B.; Madiraju, P.; Settaf, A.; Haddad, P.S. The in vivo antidiabetic activity of Nigella Sativa is mediated through activation of the AMPK pathway and increased muscle Glut4 content. Evid. Based Complement. Altern. Med. 2011, 1, 538671. [Google Scholar] [CrossRef]
  229. Liu, I.M.; Tzeng, T.F.; Liou, S.S.; Lan, T.W. Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats. Life Sci. 2007, 81, 1479–1488. [Google Scholar] [CrossRef] [PubMed]
  230. Malviya, N.; Jain, S.; Malviya, S.A.P.N.A. Antidiabetic potential of medicinal plants. Acta Pol. Pharm. 2010, 67, 113–118. [Google Scholar] [PubMed]
  231. Salehi, B.; Ata, A.; Anil Kumar, N.V.; Sharopov, F.; Ramírez-Alarcón, K.; Ruiz-Ortega, A.; Abdulmajid Ayatollahi, S.; Valere Tsouh Fokou, P.; Kobarfard, F.; Amiruddin Zakaria, Z.; et al. Antidiabetic potential of medicinal plants and their active components. Biomolecules 2019, 9, 551. [Google Scholar] [CrossRef]
  232. Nakhaee, A.; Sanjari, M. Evaluation of effect of acarbose consumption on weight losing in non-diabetic overweight or obese patients in Kerman. J. Res. Med. Sci. 2013, 18, 391. [Google Scholar] [PubMed]
  233. Kast, R. Acarbose related diarrhea: Increased butyrate upregulates prostaglandin E. Inflamm. Res. 2002, 51, 117–118. [Google Scholar] [CrossRef] [PubMed]
  234. Apostolidis, E.; Kwon, Y.I.; Shetty, K. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov. Food Sci. Emerg. Technol. 2007, 8, 46–54. [Google Scholar] [CrossRef]
  235. Inbaraj, S.D.; Muniappan, M. Correlation between the in-vitro and in-vivo antihyperglycemic effect of Ocimum Sanctum, Trigonella Foenum graecum and Curcuma longa. Pharmacogn. J. 2020, 12, 369–376. [Google Scholar] [CrossRef]
  236. Neagu, E.; Paun, G.; Albu, C.; Apreutesei, O.T.; Radu, G.L. In vitro Assessment of the Antidiabetic and Anti-Inflammatory Potential of Artemisia absinthium, Artemisia vulgaris and Trigonella foenum-graecum Extracts Processed Using Membrane Technologies. Molecules 2023, 28, 7156. [Google Scholar] [CrossRef]
  237. Laila, O.; Murtaza, I.; Muzamil, S.; Ali, S.I.; Ali, S.A.; Paray, B.A.; Gulnaz, A.; Vladulescu, C.; Mansoor, S. Enhancement of nutraceutical and anti-diabetic potential of fenugreek (Trigonella foenum-graecum). Sprouts with natural elicitors. Saudi Pharm. J. 2023, 31, 1–13. [Google Scholar] [CrossRef]
  238. Mowla, A.; Alauddin, M.; Rahman, M.A.; Ahmed, K. Antihyperglycemic effect of Trigonella foenum-graecum (fenugreek) seed extract in alloxan-induced diabetic rats and its use in diabetes mellitus: A brief qualitative phytochemical and acute toxicity test on the extract. Afr. J. Tradit. Complement. Altern. Med. 2009, 6, 255–261. [Google Scholar] [CrossRef] [PubMed]
  239. Xue, W.L.; Li, X.S.; Zhang, J.; Liu, Y.H.; Wang, Z.L.; Zhang, R.J. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac. J. Clin. Nutr. 2007, 16, 422–426. [Google Scholar]
  240. Abdelatif, A.M.; Ibrahim, M.Y.; Mahmoud, A.S. Antidiabetic effects of fenugreek (Trigonella foenum-graecum) seeds in the domestic rabbit (Oryctolagus cuniculus). Res. J. Med. Plant 2012, 6, 449–455. [Google Scholar] [CrossRef]
  241. Kumar, G.S.; Shetty, A.K.; Sambaiah, K.; Salimath, P.V. Antidiabetic property of fenugreek seed mucilage and spent turmeric in streptozotocin-induced diabetic rats. Nutr. Res. 2005, 25, 1021–1028. [Google Scholar] [CrossRef]
  242. Baset, M.E.; Ali, T.I.; Elshamy, H.; El Sadek, A.M.; Sami, D.G.; Badawy, M.T.; Abou-Zekry, S.S.; Heiba, H.H.; Saadeldin, M.K.; Abdellatif, A. Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration-an animal study. Int. J funct. Nutr. 2020, 1, 2–9. [Google Scholar] [CrossRef]
  243. Haeri, M.R.; Limaki, H.K.; White, C.J.B.; White, K.N. Non-insulin dependent anti-diabetic activity of (2S, 3R, 4S) 4-hydroxyisoleucine of fenugreek (Trigonella foenum graecum) in streptozotocin-induced type I diabetic rats. Phytomedicine 2012, 19, 571–574. [Google Scholar] [CrossRef]
  244. Priya, V.; Jananie, R.K.; Vijayalakshmi, K. Antidiabetic effect of Trigonella foenum graecum in diabetic rats-an in vivo study. Pharm. Sci. Monitor. 2012, 3, 204. [Google Scholar]
  245. Kumar, P.; Kale, R.K.; McLean, P.; Baquer, N.Z. Antidiabetic and neuroprotective effects of Trigonella foenum-graecum seed powder in diabetic rat brain. Prague Med. Rep. 2012, 113, 33–43. [Google Scholar] [CrossRef]
  246. Sudha, P.; Zinjarde, S.S.; Bhargava, S.Y.; Kumar, A.R. Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants. BMC Complem. Altern. Med. 2011, 11, 5. [Google Scholar]
  247. Ishikawa, A.; Yamashita, H.; Hiemori, M.; Inagaki, E.; Kimoto, M.; Okamoto, M.; Tsuji, H.; Memon, A.N.; Mohammadi, A.; Natori, Y. Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J. Nutr. Sci. Vitaminol. 2007, 53, 166–173. [Google Scholar] [CrossRef]
  248. Dey, P.; Saha, M.R.; Chowdhuri, S.R.; Sen, A.; Sarkar, M.P.; Haldar, B.; Chaudhuri, T.K. Assessment of anti-diabetic activity of an ethnopharmacological plant Nerium oleander through alloxan induced diabetes in mice. J. Ethnopharmcol. 2015, 161, 128–137. [Google Scholar] [CrossRef] [PubMed]
  249. Magdalene, M.; Kavitha, S.; Priya, V.V.; Gayathri, R. Evaluation of antidiabetic effect of Nerium oleander flowers-An in vitro study. Drug Invent. Today 2019, 12, 1313. [Google Scholar]
  250. Mwafy, S.N.; Yassin, M.M. Antidiabetic activity evaluation of glimepiride and Nerium oleander extract on insulin, glucose levels and some liver enzymes activities in experimental diabetic rat model. Pak. J. Biol. Sci. 2011, 14, 984–990. [Google Scholar] [CrossRef] [PubMed]
  251. Battal, A.; Dogan, A.; Uyar, A.; Demir, A.; Keleş, Ö.F.; Celik, I.; Baloglu, M.C.; Aslan, A. Exploring of the ameliorative effects of Nerium (Nerium oleander L.) ethanolic flower extract in streptozotocin induced diabetic rats via biochemical, histological and molecular aspects. Mol. Biol. Rep. 2023, 50, 4193–4205. [Google Scholar] [CrossRef] [PubMed]
  252. Bas, A.L.; Demirci, S.; Yazihan, N.; Uney, K.; Ermis Kaya, E. Nerium oleander distillate improves fat and glucose metabolism in high-fat diet-fed streptozotocin-induced diabetic rats. Int. J. Endocrinol. 2012, 2012, 947187. [Google Scholar] [CrossRef]
  253. Sikarwar, M.S.; Patil, M.B.; Kokate, C.K.; Sharma, S.; Bhat, V. Antidiabetic activity of Nerium indicum leaf extract in alloxan-induced diabetic rats. J. Young Pharma. 2009, 1, 330–335. [Google Scholar] [CrossRef]
  254. Sharma, A.D.; Kaur, I.; Kaur, J.; Chauhan, A. Chemical profiling and in-vitro anti-oxidant, anti-diabetic, anti-inflammatory, anti-bacterial and anti-fungal activities of essential oil from Rosmarinus officinalis L. Not. Sci. Biol. 2024, 16, 11756. [Google Scholar] [CrossRef]
  255. Gholam, H.A.; Falah, H.; Sharififar, F.; Mirtaj, A.S. The inhibitory effect of some Iranian plants extracts on the α glucosidase. Iran. J. Basic Med. Sci. 2008, 11, 1–9. [Google Scholar]
  256. McCue, P.P.; Shetty, K. Inhibitory effects of rosmarinic acid extracts on porcine pancreatic amylase in vitro. Asia Pac. J. Clin. Nutr. 2004, 13, 101–106. [Google Scholar]
  257. Belmouhoub, M.; Bribi, N.; Iguer-ouada, M. A-glucosidase inhibition and antihyperglycemic activity of flavonoids rich fractions of Rosmarinus officinalis in normal and streptozotocin diabetic mice. Orient. Pharm. Exp. Med. 2017, 17, 29–39. [Google Scholar] [CrossRef]
  258. Koga, K.; Shibata, H.; Yoshino, K.; Nomoto, K. Effects of 50% ethanol extract from rosemary (Rosmarinus officinalis) on α-glucosidase inhibitory activity and the elevation of plasma glucose level in rats, and its active compound. J. Food Sci. 2006, 71, S507–S512. [Google Scholar] [CrossRef]
  259. Kabubii, Z.N.; Mbaria, J.M.; Mathiu, P.M.; Wanjohi, J.M.; Nyaboga, E.N. Diet supplementation with rosemary (Rosmarinus officinalis L.) leaf powder exhibits an antidiabetic property in streptozotocin-induced diabetic male wistar rats. Diabetology 2024, 5, 12–25. [Google Scholar] [CrossRef]
  260. Benkhedir, A.; Boussekine, S.; Saker, H.; Gasmi, S.; Benali, Y. Beneficial effects of Rosmarinus officinalis and Thymus numidicus on key enzymes of carbohydrate metabolism in alloxan-induced diabetic rats. J. Microbiol. Biotechnol. Food Sci. 2023, 12, e9507. [Google Scholar] [CrossRef]
  261. Khalil, O.A.; Ramadan, K.S.; Danial, E.N.; Alnahdi, H.S.; Ayaz, N.O. Antidiabetic activity of Rosmarinus officinalis and its relationship with the antioxidant property. Afri. J. Pharm. Pharmacol. 2012, 6, 1031–1036. [Google Scholar]
  262. Al-Jamal, A.R.; Alqadi, T. Effects of rosemary (Rosmarinus officinalis) on lipid profile of diabetic rats. Jordan J. Biol. Sci. 2011, 4, 199–204. [Google Scholar]
  263. Alnahdi, H.S. Effect of Rosmarinus officinalis extract on some cardiac enzymes of streptozotocin-induced diabetic rats. J. Health Sci. 2012, 2, 33–37. [Google Scholar] [CrossRef]
  264. Emam, M.A. Comparative evaluation of antidiabetic activity of Rosmarinus officinalis L. and Chamomile recutita in streptozotocin induced diabetic rats. Agric. Biol. J. Am. 2012, 3, 247–252. [Google Scholar] [CrossRef]
  265. Soliman, G.Z. Effect of Rosmarinus officinalis on lipid profile of streptozotocin-induced diabetic rats. Egypt. J. Hosp. Med. 2013, 53, 809–815. [Google Scholar] [CrossRef]
  266. Ramadan, K.S.; Khalil, O.A.; Danial, E.N.; Alnahdi, H.S.; Ayaz, N.O. Hypoglycemic and hepatoprotective activity of Rosmarinus officinalis extract in diabetic rats. J. Physiol. Biochem. 2013, 69, 779–783. [Google Scholar] [CrossRef]
  267. Nazem, F.; Farhangi, N.; Neshat-Gharamaleki, M. Beneficial effects of endurance exercise with Rosmarinus officinalis labiatae leaves extract on blood antioxidant enzyme activities and lipid peroxidation in streptozotocin-induced diabetic rats. Can. J. Diabetes 2015, 39, 229–234. [Google Scholar] [CrossRef]
  268. Header, E.; ElSawy, N.; El-Boshy, M.; Basalamah, M.; Mubarak, M.; Hadda, T.B. POM analyses of constituents of Rosmarinus officinalis and their synergistic effect in experimental diabetic rats. J. Bioanal. Biomed. 2015, 7, 18–23. [Google Scholar]
  269. Runtuwene, J.; Cheng, K.C.; Asakawa, A.; Amitani, H.; Amitani, M.; Morinaga, A.; Takimoto, Y.; Kairupan, B.H.R.; Inui, A. Rosmarinic acid ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of PEPCK and GLUT4. Drug Des. Devel. Ther. 2016, 10, 2193–2202. [Google Scholar] [PubMed]
  270. Azevedo, M.F.; Lima, C.F.; Fernandes-Ferreira, M.; Almeida, M.J.; Wilson, J.M.; Pereira-Wilson, C. Rosmarinic acid, major phenolic constituent of Greek sage herbal tea, modulates rat intestinal SGLT1 levels with effects on blood glucose. Mol. Nutr. Food Res. 2011, 55, S15–S25. [Google Scholar] [CrossRef] [PubMed]
  271. Bakırel, T.; Bakırel, U.; Keleş, O.Ü.; Ülgen, S.G.; Yardibi, H. In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J. Ethnopharmacol. 2008, 116, 64–73. [Google Scholar] [CrossRef] [PubMed]
  272. Kensara, O.; ElSawy, N.; Altaf, F.; Header, E. Hypoglycemic and hepato-protective effects of Rosmarinus officinalis in experimental diabetic Rats. UQU Med. J. 2010, 1, 98–113. [Google Scholar]
  273. Tavafi, M.; Ahmadvand, H.; Tamjidipoor, A. Rosmarinic acid ameliorates diabetic nephropathy in uninephrectomized diabetic rats. Iran. J. Basic Med. Sci. 2011, 14, 275–283. [Google Scholar]
  274. Al-Mijalli, S.H.; Assaggaf, H.; Qasem, A.; El-Shemi, A.G.; Abdallah, E.M.; Mrabti, H.N.; Bouyahya, A. Antioxidant, antidiabetic, and antibacterial potentials and chemical composition of Salvia officinalis and Mentha suaveolens grown wild in Morocco. Adv. Pharmacol. Pharm. Sci. 2022, 2022, 2844880. [Google Scholar] [CrossRef]
  275. Chehade, S.; Kobeissy, M.; Kanaan, H.; Haddad, M. Comparison between the chemical compositions and the in-vitro antidiabetic and anti-inflammatory activities of Salvia Libanotica’ and Salvia officinalis’ leaves essential oils. Eur. J. Pharm. Med. Res. 2022, 93, 34–43. [Google Scholar]
  276. Hamza, A.A.; Ksiksi, T.S.; Shamsi, O.A.A.; Balfaqh, S.A. α-glucosidase inhibitory activity of common traditional medicinal plants used for diabetes mellitus. J. Dev. Drugs 2015, 4, 1000144. [Google Scholar] [CrossRef]
  277. Kwon, Y.I.I.; Vattem, D.A.; Shetty, K. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac. J. Clin. Nutr. 2006, 15, 107. [Google Scholar]
  278. Mahdi, S.; Azzi, R.; Lahfa, F.B. Evaluation of in vitro α-amylase and α-glucosidase inhibitory potential and hemolytic effect of phenolic enriched fractions of the aerial part of Salvia officinalis L. Diabetes Metab. Syndr. Clin. Res. Rev. 2020, 14, 689–694. [Google Scholar] [CrossRef] [PubMed]
  279. Moradabadi, L.; Kouhsari, S.M.; Sani, M.F. Hypoglycemic effects of three medicinal plants in experimental diabetes: Inhibition of rat intestinal α-glucosidase and enhanced pancreatic Insulin and cardiac Glut-4 mRNAs expression. Iran. J. Pharm. Res. 2013, 12, 387. [Google Scholar] [PubMed]
  280. Bouteldja, R.; Doucene, R.; Aggad, H.; Abdi, F.Z.; Belkhodja, H.; Belal, A.; Abdali, M.; Zidane, K. Phytochemical screening, acute toxicity and antidiabetic activity of ethanolic extract of Salvia officinalis L. in Wistar Rat. Agric. Conspec. Sci. 2023, 88, 351–357. [Google Scholar]
  281. Eidi, A.; Eidi, M. Antidiabetic effects of sage (Salvia officinalis L.) leaves in normal and streptozotocin-induced diabetic rats. Diabetes Metab. Syndr. Clin. Res. Rev. 2009, 3, 40–44. [Google Scholar] [CrossRef]
  282. Khashan, K.T.; Al-Khefaji, K.A. Effects of Salvia officinalis L. (sage) leaves extracts in normal and alloxan-induced diabetes in white rats. Int. J. Sci. Eng. Res. 2015, 6, 20–28. [Google Scholar]
  283. Alarcon-Aguilar, F.J.; Roman-Ramos, R.; Flores-Saenz, J.L.; Aguirre-Garcia, F. Investigation on the hypoglycaemic effects of extracts of four Mexican medicinal plants in normal and Alloxan-diabetic mice. Phytother. Res. 2002, 16, 383–386. [Google Scholar] [CrossRef]
  284. Mbiti, K.F.; Mwendia, M.C.; Mutai, K.J.; Matasyoh, C.J. Hypoglycaemic effects of Salvia officinalis extracts on alloxan-induced diabetic Swiss albino mice. J. Med. Plants Res. 2020, 14, 518–525. [Google Scholar]
  285. Salah, M.M.A.L.C.; Hussein, M.; Rana, I.; Khalid, L.B. Effect of Salvia officinalis L. (Sage) aqueous extract on liver and testicular function of diabetic albino male rats. J. Babylon Univ. Pure Appl. Sci. 2016, 24, 83–90. [Google Scholar]
  286. Eidi, M.; Eidi, A.; Zamanizadeh, H. Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2005, 100, 310–313. [Google Scholar] [CrossRef]
  287. Gourich, A.A.; Touijer, H.; Drioiche, A.; Asbabou, A.; Remok, F.; Saidi, S.; Siddique, F.; Ailli, A.; Bourhia, M.; Salamatullah, A.M.; et al. Insight into biological activities of chemically characterized extract from Marrubium vulgare L. in vitro, in vivo and in silico approaches. Front. Chem. 2023, 11, 1238346. [Google Scholar] [CrossRef]
  288. Aazza, S.; El-Guendouz, S.; da Graça Miguel, M. Antioxidant and α-amylase Inhibition activities of six plants used in the management of diabetes in Morocco. Lett. Appl. Nanosci. 2023, 13, 17. [Google Scholar]
  289. Elberry, A.A.; Harraz, F.M.; Ghareib, S.A.; Gabr, S.A.; Nagy, A.A.; Abdel-Sattar, E. Methanolic extract of Marrubium vulgare ameliorates hyperglycemia and dyslipidemia in streptozotocin-induced diabetic rats. Int. J. Diabetes Mellit. 2015, 3, 37–44. [Google Scholar] [CrossRef]
  290. Elmhdwi, M.F.; Muktar, M.A.; Attitalla, I.H. Hypoglycemic effects of Marrubium vulgare (Rubia) in experimentally induced autoimmune diabetes mellitus. Int. Res. J. Biochem. Bioinform. 2014, 44, 42–54. [Google Scholar]
  291. Ghlissi, Z.; Atheymen, R.; Sahnoun, Z.; Zeghal, K.; Mnif, H.; Hakim, A. The effect of Marrubium vulgare L on hyperglycemia-mediated oxidative damage in the hepatic and renal tissues of diabetic rats. Int. J. Pharma Chem. Res. 2015, 1, 97–106. [Google Scholar]
  292. Vergara-Galicia, J.; Aguirre-Crespo, F.; Tun-Suarez, A.; Aguirre-Crespo, A.; Estrada-Carrillo, M.; Jaimes-Huerta, I.; Flo-res-Flores, A.; Estrada-Soto, S.; Ortiz-Andrade, R. Acute hypoglycemic effect of ethanolic extracts from Marrubium vulgare. Phytopharmacology 2012, 3, 54–60. [Google Scholar]
  293. Eidi, A.; Eidi, M.; Darzi, R. Antidiabetic effect of Olea europaea L. in normal and diabetic rats. Phytother. Res. 2009, 23, 347–350. [Google Scholar] [CrossRef] [PubMed]
  294. Choudhury, M.E.; Mostofa, M.; Awal, M.A. Antidiabetic effects of Azadirachta indica, Trigonella foenum graecum, Olea europea and Glibenclamide in experimentally diabetic induced rat. J. Bangladesh Agril Univ. 2005, 3, 277–282. [Google Scholar]
  295. Wainstein, J.; Ganz, T.; Boaz, M.; Bar Dayan, Y.; Dolev, E.; Kerem, Z.; Madar, Z. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J. Med. Food 2012, 15, 605–610. [Google Scholar] [CrossRef] [PubMed]
  296. El-Amin, M.; Virk, P.; Elobeid, M.A.; Almarhoon, Z.M.; Hassan, Z.K.; Omer, S.A.; Merghani, N.M.; Daghestani, M.H.; Al-Olayan, E.M. Anti-diabetic effect of Murraya koenigii (L) and Olea europaea (L) leaf extracts on streptozotocin induced diabetic rats. Pak. J. Pharm. Sci. 2013, 26, 359–365. [Google Scholar]
  297. Moghadam, M.G.; Masomi, Y.; Razavian, M.; Moradi, M. The effect of oral consumption of olive leaves on serum glucose level and lipid profile of diabetic rats. J. Basic Clin. Pathophysiol. 2013, 1, 37–42. [Google Scholar]
  298. Kaeidi, A.; Esmaeili-Mahani, S.; Sheibani, V.; Abbasnejad, M.; Rasoulian, B.; Hajializadeh, Z.; Afrazi, S. Olive (Olea europaea L.) leaf extract attenuates early diabetic neuropathic pain through prevention of high glucose-induced apoptosis: In vitro and in vivo studies. J. Ethnopharmacol. 2011, 136, 188–196. [Google Scholar] [CrossRef] [PubMed]
  299. Sangi, S.M.A.; Sulaiman, M.I.; Abd El-wahab, M.F.; Ahmedani, E.I.; Ali, S.S. Antihyperglycemic effect of thymoquinone and oleuropein, on streptozotocin-induced diabetes mellitus in experimental animals. Pharmacogn. Mag. 2015, 11, S251. [Google Scholar] [CrossRef] [PubMed]
  300. Laaboudi, W.; Ghanam, J.; Ghoumari, O.; Sounni, F.; Merzouki, M.; Benlemlih, M. Hypoglycemic and hypolipidemic effects of phenolic olive tree extract in streptozotocin diabetic rats. Int. J. Pharm. Pharma. Sci. 2016, 8, 287–291. [Google Scholar] [CrossRef]
  301. Afify, A.E.M.M.R.; El-Beltagi, H.S.; Fayed, S.A.; El-Ansary, A.E. Hypoglycemic and iron status ameliorative effects of Olea europea CV.‘Picual’ leaves extract in streptozotocin induced diabetic rats. Fresen. Environ. Bull. 2017, 26, 6898–6908. [Google Scholar]
  302. Al-Attar, A.M.; Alsalmi, F.A. Effect of Olea europaea leaves extract on streptozotocin induced diabetes in male albino rats. Saudi J. Biol. Sci. 2019, 26, 118–128. [Google Scholar] [CrossRef] [PubMed]
  303. Guex, C.G.; Reginato, F.Z.; de Jesus, P.R.; Brondani, J.C.; Lopes, G.H.H.; de Freitas Bauermann, L. Antidiabetic effects of Olea europaea L. leaves in diabetic rats induced by high-fat diet and low-dose streptozotocin. J. Ethnopharmacol. 2019, 235, 1–7. [Google Scholar] [CrossRef] [PubMed]
  304. Al-Shudiefat, A.A.R.; Alturk, H.; Al-Ameer, H.J.; Zihlif, M.; Alenazy, M. Olive leaf extract of Olea europaea reduces blood glucose level through inhibition of as160 in diabetic rats. Appl. Sci. 2023, 13, 5939. [Google Scholar] [CrossRef]
  305. Mansour, H.M.; Zeitoun, A.A.; Abd-Rabou, H.S.; El Enshasy, H.A.; Dailin, D.J.; Zeitoun, M.A.; El-Sohaimy, S.A. Antioxidant and anti-diabetic properties of olive (Olea europaea) leaf extracts: In vitro and in vivo evaluation. Antioxidants 2023, 12, 1275. [Google Scholar] [CrossRef] [PubMed]
  306. Sato, H.; Genet, C.; Strehle, A.; Thomas, C.; Lobstein, A.; Wagner, A.; Mioskowski, C.; Auwerx, J.; Saladin, R. Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem. Biophys. Res. Commun. 2007, 362, 793–798. [Google Scholar] [CrossRef]
  307. Jemai, H.; El Feki, A.; Sayadi, S. Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. J. Agric. Food Chem. 2009, 57, 8798–8804. [Google Scholar] [CrossRef]
  308. Mousa, H.M.; Farahna, M.; Ismail, M.S.; Al-Hassan, A.A.; Ammar, A.S.; Abdel-Salam, A.M. Anti-diabetic effect of olive leaves extract in alloxan-diabetic rats. J. Agric. Vet. Sci. 2014, 7, 183–192. [Google Scholar] [CrossRef]
  309. Benhabyles, N.; Arab, K.; Bouchenak, O.; Baz, A. Phytochemical screening, hypoglycemic and antihyperglycemic effect of flavonoids from the leaves of Algerian Olea europaea L. in normal and alloxan-induced diabetic rats. Int. J. Pharmacol. 2015, 11, 477–483. [Google Scholar] [CrossRef]
  310. Qadir, N.M.; Ali, K.A.; Qader, S.W. Antidiabetic effect of oleuropein from Olea europaea leaf against alloxan induced type 1 diabetic in rats. Braz. Arch. Biol. Technol. 2016, 59, e16150116. [Google Scholar] [CrossRef]
  311. Farah, H.S. Hypoglycemic, hypolipidemic and antioxidant activities of ethanolic extract of Olea europaea Linn. Int. J. Novel Res. Life Sci. 2015, 2, 33–37. [Google Scholar]
  312. Al-Azzawie, H.F.; Alhamdani, M.S.S. Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits. Life Sci. 2006, 78, 1371–1377. [Google Scholar] [CrossRef] [PubMed]
  313. AlShaal, S.; Karabet, F.; Daghestani, M. Evaluation the antioxidant activity of Syrian ficus and olive leaf extracts and their inhibitory effects on α-glucosidase in vitro. Mor. J. Chem. 2020, 8, 235–243. [Google Scholar]
  314. Loizzo, M.R.; Lecce, G.D.; Boselli, E.; Menichini, F.; Frega, N.G. Inhibitory activity of phenolic compounds from extra virgin olive oils on the enzymes involved in diabetes, obesity and hypertension. J. Food Biochem. 2011, 35, 381–399. [Google Scholar] [CrossRef]
  315. Khlif, I.; Hamden, K.; Damak, M.; Allouche, N. A new triterpene from Olea europea stem with antidiabetic activity. Chem. Nat. Compd. 2012, 48, 799–802. [Google Scholar] [CrossRef]
  316. Alhodieb, F.S. In vitro hypoglycemic effects of black seed (Nigella Sativa). NeuroQuantology 2022, 20, 425. [Google Scholar]
  317. Meddah, B.; Ducroc, R.; El Abbes Faouzi, M.; Eto, B.; Mahraoui, L.; Benhaddou-Andaloussi, A.; Martineau, L.C.; Cherrah, Y.; Haddad, P.S. Nigella Sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J. Ethnopharmacol. 2009, 121, 419–424. [Google Scholar] [CrossRef]
  318. Houcher, Z.; Boudiaf, K.; Benboubetra, M.; Houcher, B. Effects of methanolic extract and commercial oil of Nigella sativa L. on blood glucose and antioxidant capacity in alloxan-induced diabetic rats. Pteridines 2007, 18, 8–18. [Google Scholar] [CrossRef]
  319. Akhtar, M.T.; Ilyas, H.F.; Shaukat, U.A.; Qadir, R.; Masood, S.; Batool, S.; Zahoor, S.; Saadia, M. Comparative study of hypoglycaemic and antioxidant potential of methanolic seed extract and oil of Nigella Sativa on alloxanized diabetic rabbits. Pak. J. Pharm. Sci. 2022, 35, 1755–1760. [Google Scholar]
  320. Chisom, S.A.; Chinyere, S.N.; Andrew, C.N. Evaluation of the effect of black seed (Nigella Sativa) on oxidative stress markers of Alloxan–induced diabetic wistar rat. IAA J. Biol. Sci. 2022, 8, 164–177. [Google Scholar]
  321. Sutrisna, E.; Azizah, T.; Wahyuni, S. Potency of Nigella Sativa linn. seed as antidiabetic (preclinical study). Res. J. Pharm. Technol. 2022, 15, 381–384. [Google Scholar] [CrossRef]
  322. Abbasnezhad, A.; Niazmand, S.; Mahmoudabady, M.; Rezaee, S.A.; Soukhtanloo, M.; Mosallanejad, R.; Hayatdavoudi, P. Nigella sativa L. seed regulated eNOS, VCAM-1 and LOX-1 genes expression and improved vasoreactivity in aorta of diabetic rat. J. Ethnopharmacol. 2019, 228, 142–147. [Google Scholar] [CrossRef]
  323. Hannan, J.M.A.; Ansari, P.; Haque, A.; Sanju, A.; Huzaifa, A.; Rahman, A.; Ghosh, A.; Azam, S. Nigella Sativa stimulates insulin secretion from isolated rat islets and inhibits the digestion and absorption of (CH2O) n in the gut. Biosci. Rep. 2019, 39, BSR20190723. [Google Scholar] [CrossRef]
  324. Sadiq, N.; Subhani, G.; Fatima, S.A.; Nadeem, M.; Zafer, S.; Mohsin, M. Antidiabetic effect of Nigella Sativa compared with metformin on blood glucose levels in streptozotocin induced diabetic albino wistar rats. Int. J. Basic Clin. Pharmacol. 2021, 10, 361–367. [Google Scholar] [CrossRef]
  325. Tariq, S.M.; Khan, K.; Sadiq, M.M.; Pooja, S.; Suyog, S.; Devendra, S.K. Nigella Sativa’s effect on biochemical as well as anthropometric parameters in diabetic rats on high fat diet. J. Med. Sci. Health 2023, 9, 16–22. [Google Scholar] [CrossRef]
  326. Khan, S.S.; Zaidi, K.U. Protective effect of Nigella Sativa seed extract and its bioactive compound thymoquinone on streptozotocin-induced diabetic rats. Cardiovasc. Hematol. Agents Med. Chem. 2024, 22, 51–59. [Google Scholar] [CrossRef]
  327. Fararh, K.M.; Atoji, Y.; Shimizu, Y.; Shiina, T.; Nikami, H.; Takewaki, T. Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Res. J. Vet. Sci. 2004, 77, 123–129. [Google Scholar] [CrossRef]
  328. Abdelrazek, H.M.; Kilany, O.E.; Muhammad, M.A.; Tag, H.M.; Abdelazim, A.M. Black seed thymoquinone improved insulin secretion, hepatic glycogen storage, and oxidative stress in streptozotocin-induced diabetic male wistar rats. Oxid. Med. Cell. Longev. 2018, 2018, 8104165. [Google Scholar] [CrossRef] [PubMed]
  329. Le, P.M.; Benhaddou-Andaloussi, A.; Elimadi, A.; Settaf, A.; Cherrah, Y.; Haddad, P.S. The petroleum ether extract of Nigella Sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J. Ethnopharmacol. 2004, 94, 251–259. [Google Scholar] [CrossRef] [PubMed]
  330. Dong, J.; Liang, Q.; Niu, Y.; Jiang, S.; Zhou, L.I.; Wang, J.; Ma, C.; Kang, W. Effects of Nigella Sativa seed polysaccharides on type 2 diabetic mice and gut microbiota. Int. J. Biol. Macromol. 2020, 159, 725–738. [Google Scholar] [CrossRef]
  331. Kim, S.H.; Jo, S.H.; Kwon, Y.I.; Hwang, J.K. Effects of onion (Allium cepa L.) extract administration on intestinal α-glucosidases activities and spikes in postprandial blood glucose levels in sd rats model. Int. J. Mol. Sci. 2011, 12, 3757–3769. [Google Scholar] [CrossRef] [PubMed]
  332. Lee, S.K.; Hwang, J.Y.; Kang, M.J.; Kim, Y.M.; Jung, S.H.; Lee, J.H.; Kim, J.I. Hypoglycemic effect of onion skin extract in animal models of diabetes mellitus. Food Sci. Biotech. 2008, 17, 130–134. [Google Scholar]
  333. Amba, E.; Ramya, R.; Lakshmi, A.; Sandhya, S.; Suganya, P.; Pratibha, R. Quantification of the anti-diabetic effect of Allium cepa. Cureus 2024, 16, e59174. [Google Scholar] [CrossRef]
  334. Gois Ruivo da Silva, M.; Skrt, M.; Komes, D.; Poklar Ulrih, N.; Pogačnik, L. Enhanced yield of bioactivities from onion (Allium cepa L.) skin and their antioxidant and anti-α-amylase activities. Int. J. Mol. Sci. 2020, 21, 2909. [Google Scholar] [CrossRef]
  335. Yang, S.J.; Paudel, P.; Shrestha, S.; Seong, S.H.; Jung, H.A.; Choi, J.S. In vitro protein tyrosine phosphatase 1B inhibition and antioxidant property of different onion peel cultivars: A comparative study. Food Sci. Nutr. 2019, 7, 205–215. [Google Scholar] [CrossRef]
  336. Nile, A.; Gansukh, E.; Park, G.S.; Kim, D.H.; Nile, S.H. Novel insights on the multi-functional properties of flavonol glucosides from red onion (Allium cepa L) solid waste–In vitro and in silico approach. Food Chem. 2021, 335, 127650. [Google Scholar] [CrossRef]
  337. El-Soud, N.A.; Khalil, M. Antioxidative effects of Allium cepa essential oil in streptozotocin induced diabetic rats. Maced. J. Med. Sci. 2010, 3, 344–351. [Google Scholar] [CrossRef]
  338. Abouzed, T.K.; del Mar Contreras, M.; Sadek, K.M.; Shukry, M.; Abdelhady, D.H.; Gouda, W.M.; Abdo, W.; Nasr, N.E.; Mekky, R.H.; Segura-Carretero, A.; et al. Red onion scales ameliorated streptozotocin-induced diabetes and diabetic nephropathy in Wistar rats in relation to their metabolite fingerprint. Diabetes Res. Clin. Pract. 2018, 140, 253–264. [Google Scholar] [CrossRef] [PubMed]
  339. Jung, J.Y.; Lim, Y.; Moon, M.S.; Kim, J.Y.; Kwon, O. Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats. Nutr. Metab. 2011, 8, 18. [Google Scholar] [CrossRef] [PubMed]
  340. Islam, M.S.; Choi, H.; Loots, D.T. Effects of dietary onion (Allium cepa L.) in a high-fat diet streptozotocin-induced diabetes rodent model. Ann. Nutr. Metab. 2008, 53, 6–12. [Google Scholar] [CrossRef] [PubMed]
  341. Ozougwu, J.C. Anti-diabetic effects of Allium cepa (onions) aqueous extracts on alloxan-induced diabetic Rattus novergicus. J. Med. Plants Res. 2011, 5, 1134–1139. [Google Scholar]
  342. El-Demerdash, F.M.; Yousef, M.I.; Abou El-Naga, N.I. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem. Toxicol. 2005, 43, 57–63. [Google Scholar] [CrossRef] [PubMed]
  343. Gholamali, A.J.; Maleki, M.; Motadayen, M.H.; Sirus, S. Effect of fenugreek, onion and garlic on blood glucose and histopathology of pancreas of alloxan-induced diabetic rats. Indian J. Med. Sci. 2005, 59, 64–69. [Google Scholar]
  344. Panda, N.; Panigrahi, S.P.; Gupta, M.K.; Kumari, A.; Mehta, D.; Goswami, T.D.; Das, G.N.; Gangopadhyay, A. Phytochemical screening and pharmacological study of antidiabetic potential and bioactive compounds present in Allium sativum. J. Chem. Health Risks 2024, 14, 2646–2654. [Google Scholar]
  345. El Mahi, F.; Hasib, A.; Boulli, A.; Boussadda, L.; Abidi, O.; Aabdousse, J.; Khiraoui, A.; Ourouadi, S. In vitro and in vivo antidiabetic effect of the aqueous extract of garlic (Allium sativum L.) compared to glibenclamide on biochemical parameters in alloxan-induced diabetic mice. Int. J. Pharm. Sci. Rev. Res. 2023, 80, 106–113. [Google Scholar] [CrossRef]
  346. Ahmed, M.U.; Ibrahim, A.; Dahiru, N.J.; Mohammed, H.U.S. A amylase inhibitory potential and mode of inhibition of oils from Allium sativum (garlic) and Allium cepa (onion). Clin. Med. Insights Endocrinol. Diabetes 2020, 13, 1179551420963106. [Google Scholar] [CrossRef]
  347. Yan, J.K.; Wang, C.; Yu, Y.B.; Wu, L.X.; Chen, T.T.; Wang, Z.W. Physicochemical characteristics and in vitro biological activities of polysaccharides derived from raw garlic (Allium sativum L.) bulbs via three-phase partitioning combined with gradient ethanol precipitation method. Food Chem. 2021, 339, 128081. [Google Scholar] [CrossRef]
  348. Wongsa, P.; Bhuyar, P.; Tongkoom, K.; Spreer, W.; Müller, J. Influence of hot-air drying methods on the phenolic compounds/allicin content, antioxidant activity and α-amylase/α-glucosidase inhibition of garlic (Allium sativum L.). Eur. Food Res. Technol. 2023, 249, 523–535. [Google Scholar] [CrossRef]
  349. Sujithra, K.; Srinivasan, S.; Indumathi, D.; Vinothkumar, V. Allyl methyl sulfide, an organosulfur compound alleviates hyperglycemia mediated hepatic oxidative stress and inflammation in streptozotocin-induced experimental rats. Biomed. Pharmacother. 2018, 107, 292–302. [Google Scholar] [CrossRef] [PubMed]
  350. Eidi, A.; Eidi, M.; Esmaeili, E. Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine 2006, 13, 624–629. [Google Scholar] [CrossRef] [PubMed]
  351. Drobiova, H.; Thomson, M.; Al-Qattan, K.; Peltonen-Shalaby, R.; Al-Amin, Z.; Ali, M. Garlic increases antioxidant levels in diabetic and hypertensive rats determined by a modified peroxidase method. Evid. Based Complement. Altern. Med. 2011, 2011, 703049. [Google Scholar] [CrossRef]
  352. Xie, C.; Gao, W.; Li, X.; Luo, S.; Wu, D.; Chye, F.Y. Garlic (Allium sativum L.) polysaccharide ameliorates type 2 diabetes mellitus (T2DM) via the regulation of hepatic glycogen metabolism. NFS J. 2023, 31, 19–27. [Google Scholar] [CrossRef]
  353. Mohamed, J.; Ainane, T. In vitro antidiabetic activity of essential oil of two species of Artemisia: Artemisia herba-alba asso and Artemisia ifranensis. Pharm. Online 2021, 3, 812–820. [Google Scholar]
  354. Awad, N.E.; Seida, A.A.; El-Khayat, Z.; Shaffie, N.; Abd El-Aziz, A.M. Hypoglycemic activity of Artemisia herba-alba (Asso.) used in Egyptian traditional medicine as hypoglycemic remedy. J Appl. Pharm. Sci. 2012, 2, 30–39. [Google Scholar]
  355. Tastekin, D.; Atasever, M.; Adiguzel, G.; Keles, M.; Tastekin, A. Hypoglycaemic effect of Artemisia herba-alba in experimental hyperglycaemic rats. Bull Vet. Inst. Pulawy. 2006, 50, 235–238. [Google Scholar]
  356. Boudjelal, A.; Siracusa, L.; Henchiri, C.; Sarri, M.; Abderrahim, B.; Baali, F.; Ruberto, G. Antidiabetic effects of aqueous infusions of Artemisia herba-alba and Ajuga iva in alloxan-induced diabetic rats. Planta Medica. 2015, 81, 696–704. [Google Scholar] [CrossRef]
  357. Iriadam, M.; Musa, D.; Gumushan, H.; Baba, F. Effects of two Turkish medicinal plants Artemisia herba-alba and Teucrium polium on blood glucose levels and other biochemical parameters in rabbits. J. Cell. Mol. Biol. 2006, 5, 19–24. [Google Scholar]
  358. Abdallah, H.M.; Abdel-Rahman, R.F.; Jaleel, G.A.A.; El-Kader, H.A.M.A.; El-Marasy, S.A. Pharmacological effects of ethanol extract of Artemisia herba alba in streptozotocin-induced type 1 diabetes mellitus in rats. Biochem. Pharmacol. 2015, 4, 1–13. [Google Scholar] [CrossRef]
  359. El-Marasy, S.A.; Zaki, E.R.; Abdallah, H.M.; Arbid, M.S. Therapeutic effects of aqueous, methanol and ethanol extracts of Egyptian Artemisia herba-alba in STZ-induced diabetic neuropathy in rats. J. Appl. Pharm. Sci. 2017, 7, 180–187. [Google Scholar]
  360. Ahmad, Z.A.K.; Abdul-Hussian, B.A. Effect of Artemisia herb on induced hyperglycemia in wistar rats. Al-Qadisiyah J. Vet. Med. Sci. 2016, 15, 63–69. [Google Scholar]
  361. Hamza, N.; Berke, B.; Cheze, C.; Le Garrec, R.; Lassalle, R.; Agli, A.N.; Robinson, P.; Gin, H.; Moore, N. Treatment of high fat diet induced type 2 diabetes in C57BL/6J mice by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J. Ethnopharmacol. 2011, 133, 931–933. [Google Scholar] [CrossRef]
  362. Mansi, K.; Amneh, M.; Nasr, H. The hypolipidemic effects of Artemisia sieberi (A. herba-alba) in alloxan induced diabetic rats. Int. J. Pharmacol. 2007, 3, 487–491. [Google Scholar] [CrossRef]
  363. Declaration of Amnesty, Abdul Razak Hamoui, Asad al Abdulla. Effect of watery extract of Artemisia herba alba on blood glucose level and body weight in alloxan-diabetic rabbits. Assiut Vet. Med. J. 2010, 56, 1–11. [CrossRef]
  364. El Ansari, N.; Chadli, A.; El Aziz, S.; El Mghari, G.; El Achhab, Y.; Seqat, M.; Nejjari, C. Observational study of patients in morocco with uncontrolled type 2 diabetes treated with metformin and/or sulfonylurea with or without insulin. J. Endocrinol. Metab. 2015, 5, 321–327. [Google Scholar] [CrossRef]
  365. Triad, A.C. Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk. Clevel. Clin. J. Med. 2009, 76, S20–S27. [Google Scholar]
  366. Kasilo, O.M.; Nikiema, J.B. World Health Organization perspective for traditional medicine. In Novel Plant Bioresources: Applications in Food, Medicine and Cosmetics; John Wiley & Sons: Hoboken, NJ, USA, 2014; pp. 23–42. [Google Scholar]
  367. Aboufaras, M.; Selmaoui, K.; Ouzennou, N. Use of complementary traditional phytotherapy to manage cancer in Morocco: A decade-long review of ethnopharmacological studies. J. Herb. Med. 2021, 29, 100494. [Google Scholar] [CrossRef]
  368. Hamza, N.; Berke, B.; Umar, A.; Cheze, C.; Gin, H.; Moore, N. A review of Algerian medicinal plants used in the treatment of diabetes. J. Ethnopharmacol. 2019, 238, 111841. [Google Scholar] [CrossRef]
  369. Wannes, W.A.; Marzouk, B. Research progress of Tunisian medicinal plants used for acute diabetes. J. Acute Dis. 2016, 5, 357–363. [Google Scholar] [CrossRef]
  370. Abogmaza, F.A.; Keer, F.K.; Takrizzah, A.A.; Yahya, E.B. A Review on the Medicinal and Aromatic Plants Growing in Libya and Their Therapeutic Properties. Int. Res. J. Sci. Technol. 2020, 2, 327–334. [Google Scholar] [CrossRef]
  371. Al-Traboulsi, M.; Alaib, M.A. A Survey of Medicinal Plants of Wadi Al-Kouf in Al-Jabal Al-Akhdar, Libya. Nat. Croat. Period. Musei Hist. Nat. Croat. 2021, 30, 389–404. [Google Scholar] [CrossRef]
  372. Hamden, K.; Jaouadi, B.; Carreau, S.; Bejar, S.; Elfeki, A. Inhibitory effect of fenugreek galactomannan on digestive enzymes related to diabetes, hyperlipidemia, and liver-kidney dysfunctions. Biotechnol. Bioprocess Eng. 2010, 15, 407–413. [Google Scholar] [CrossRef]
  373. Hachouf, M.; Aouacheri, O.; Saka, S.; Marzocchi, A.; Tenore, G.C. Phytochemical, biochemical and physiological assessment of the protective effect of local Trigonella foenum graecum in rats administered a β-cell toxicant. Chem. Biodiversity 2024, e202401183. [Google Scholar] [CrossRef] [PubMed]
  374. Ghlissi, Z.; Hamden, K.; Saoudi, M.; Sahnoun, Z.; Zeghal, K.M.; El Feki, A.; Hakim, A. Effect of Nigella sativa seeds on reproductive system of male diabetic rats. Afr. J. Pharm. Pharmacol. 2012, 6, 1444–1450. [Google Scholar]
  375. Belmouhoub, M.; Tacherfıout, M.; Boukhalfa, F.; Khodja, Y.K.; Bachir-Bey, M. Traditional medicinal plants used in the treatment of diabetes: Ethnobotanical and ethnopharmacological studies and mechanisms of action. Int. J. Plant Based Pharm. 2022, 2, 145–154. [Google Scholar] [CrossRef]
  376. Belhadj, S.; Hentati, O.; Hammami, M.; Hadj, A.B.; Boudawara, T.; Dammak, M.; Zouari, S.; El Feki, A. Metabolic impairments and tissue disorders in alloxan-induced diabetic rats are alleviated by Salvia officinalis L. essential oil. Biomed. Pharmacother. 2018, 108, 985–995. [Google Scholar] [CrossRef]
Figure 1. The botanical families used for diabetes management in Morocco.
Figure 1. The botanical families used for diabetes management in Morocco.
Diseases 12 00246 g001
Figure 2. The distribution of plants species families per Moroccan regions.
Figure 2. The distribution of plants species families per Moroccan regions.
Diseases 12 00246 g002
Figure 3. The distribution of plants species per Moroccan regions.
Figure 3. The distribution of plants species per Moroccan regions.
Diseases 12 00246 g003
Figure 4. The distribution of plants species origin per Moroccan regions.
Figure 4. The distribution of plants species origin per Moroccan regions.
Diseases 12 00246 g004
Figure 5. The distribution of the percentage of different parts used for diabetes management in Morocco.
Figure 5. The distribution of the percentage of different parts used for diabetes management in Morocco.
Diseases 12 00246 g005
Figure 6. The distribution of the percentage of different preparation methods used for diabetes management in Morocco.
Figure 6. The distribution of the percentage of different preparation methods used for diabetes management in Morocco.
Diseases 12 00246 g006
Figure 7. Most useful medicinal plants for diabetes management. (A) T. foenum-graecum, (B) N. oleander, (C) S. officinalis, (D) O. europeae, (E) N. sativa, and (F) M. vulgare.
Figure 7. Most useful medicinal plants for diabetes management. (A) T. foenum-graecum, (B) N. oleander, (C) S. officinalis, (D) O. europeae, (E) N. sativa, and (F) M. vulgare.
Diseases 12 00246 g007
Figure 8. Chemical structures of the known natural compounds useful against diabetes.
Figure 8. Chemical structures of the known natural compounds useful against diabetes.
Diseases 12 00246 g008
Table 2. The origins of Moroccan medicinal plants used in the treatment of diabetes.
Table 2. The origins of Moroccan medicinal plants used in the treatment of diabetes.
Family NameScientific NameOrigin
AizoaceaeOpophytum theurkauffii Maire L.Spontaneous
AlliaceaeAllium cepa L.Cultivated
Allium sativum L.Cultivated
Allium ampeloprasum var. porrumCultivated
AloeaceaeAloe vera (L.) Burm.f.Cultivated
AmaranthaceaeAnabasis aretioides Moq. & Coss. ex BungeSpontaneous
Beta vulgaris L.Cultivated
Spinacia oleracea L.Cultivated
AnacardiaceaePistacia atlantica Desf.Spontaneous
Pistacia lentiscus L.Spontaneous
Searsia albida (Schousb.) MoffettSpontaneous
ApiaceaeAmmodaucus leucotrichus Coss.Spontaneous
Ammi majus L.Spontaneous
Ammi visnaga (L.) Lam.Spontaneous
Anethum foeniculum L.Cultivated
Apium graveolens L.Cultivated
Carum carvi L.Cultivated
Coriandrum sativum L.Cultivated
Cuminum cyminum L.Cultivated
Daucus carota L.Cultivated
Eryngium ilicifolium Lam.Spontaneous
Ferula communis L.Spontaneous
Foeniculum vulgare Mill.Cultivated
Pastinaca sativa L.Cultivated
Petroselinum crispum (Mill.) FussCultivated
Petroselinum sativum HoffmCultivated
Pimpinella anisum L.Cultivated
Ptychotis verticillata DubyCultivated
Ridolfia segetum (L.) MorisSpontaneous
ApocynaceaeApteranthes europaea (Guss.) Murb.Spontaneous
Calotropis procera (Aiton) Dryand.Spontaneous
Caralluma europaea (Guss.) N.E.Br.Spontaneous
Nerium oleander L.Spontaneous
Periploca laevigata subsp. Angustifolia (Labill.) Markgr.Spontaneous
ArecaceaeChamaerops humilis L.Spontaneous
Hyphaene thebaica (L.) Mart.Spontaneous
Phoenix dactylifera L.Cultivated
AristolochiaceaeAristolochia baetica L.Spontaneous
Aristolochia longa subsp. Fontanesii Boiss. & Reut.Spontaneous
AsparagaceaeAgave americana L.Cultivated
Asparagus albus L.Spontaneous
Asparagus officinalis L.Cultivated
AsteraceaeAchillea odorata L.Spontaneous
Achillea santolinoides Lag.Spontaneous
Anacyclus pyrethrum (L.) Lag.Spontaneous
Antennaria dioica (L.) GaertnSpontaneous
Anvillea garcinii subsp. Radiata (Coss. & Durieu) Anderb.Spontaneous
Artemisia abrotanum L.Cultivated
Artemisia absinthium L.Cultivated
Artemisia arborescens (Vaill.) L.Spontaneous
Artemisia atlantica Coss. & DurieuSpontaneous
Artemisia campestris L.Spontaneous
Artemisia herba-alba AssoSpontaneous
Artemisia herba alba Assac.Spontaneous
Artemisia mesatlantica MaireEndemic
Artemisia reptans C. Sm. ex LinkSpontaneous
Atractylis gummifera Salzm. ex L.Spontaneous
Calendula arvensis Bieb.,Spontaneous
Centaurea maroccana BalSpontaneous
Chamaemelum mixtum (L.) AlloniSpontaneous
Chamaemelum nobile (L.) All.Spontaneous
Chrysanthemum coronarium L.Spontaneous
Cichorium intybus L.Cultivated
Cladanthus arabicus (L.) Cass.Spontaneous
Cladanthus scariosus (Ball) Oberpr. & VogtSpontaneous
Cynara cardunculus L.Cultivated
Cynara cardunculus subsp. scolymus (L.)Cultivated
Cynara humilis L.Spontaneous
Dittrichia viscosa (L.) GreuterSpontaneous
Echinops spinosissimus TurraSpontaneous
Helianthus annuus L.Cultivated
Inula conyza (Griess.) DC.Spontaneous
Inula helenium L.Cultivated
Lactuca sativa L.Cultivated
Launaea arborescens (Batt.) Murb.Spontaneous
Matricaria chamomilla L.Spontaneous
Pallenis spinosa (L.) Cass.Spontaneous
Saussurea costus (Falc.) LipschitzSpontaneous
Scolymus hispanicus L.Spontaneous
Scorzonera undulata VahlSpontaneous
Seriphidium herba-albaSpontaneous
Sonchus arvensis L.Spontaneous
Sonchus asper (L.) HillSpontaneous
Sonchus tenerrimus L.Spontaneous
Stevia rebaudiana Willd.Cultivated
Silybum marianum L.Spontaneous
Tanacetum vulgare L.Spontaneous
Taraxacum campylodes G.E. HaglundSpontaneous
Warionia saharae Benthem ex Benth. & Coss.Spontaneous
BerberidaceaeBerberis vulgaris subsp. Australis (Boiss.) HeywoodSpontaneous
BrassicaceaeAnastatica hierochuntica L.Spontaneous
Brassica napus L.Cultivated
Brassica nigra (L.) K. KochCultivated
Brassica oleracea L.Cultivated
Brassica rapa L.Cultivated
Diplotaxis pitardiana MaireSpontaneous
Eruca vesicaria (L.) Cav.Spontaneous
Lepidium sativum L.Cultivated
Nasturtium officinale R.Br.Spontaneous
Ptilotrichum spinosum (L.) Boiss.Spontaneous
Raphanus raphanistrum subsp. sativus (L.)Cultivated
BurseraceaeBoswellia sacra Flueck.Imported
Commiphora myrrha (Nees) Engl.Cultivated
BuxaceaeBuxus balearica Lam.Cultivated
Buxus sempervirens L.Cultivated
CactaceaeOpuntia ficus indica (L.) Mill.Spontaneous/Cultivated
CapparaceaeCapparis decidua (Forssk.) Edgew.Cultivated
Capparis spinosa L.Spontaneous
Maerua crassifolia Forssk.Cultivated
CaryophyllaceaeHerniaria glabra var. hirsuta (L.) KuntzeSpontaneous
Paronychia argentea Lam.Spontaneous
Silene vivianii Steud.Spontaneous
Corrigiola telephiifolia Pourr.Spontaneous
CannabaceaeCannabis sativa L.Spontaneous/Cultivated
CistaceaeCistus albidus L.Spontaneous
Cistus creticus L.Spontaneous
Cistus laurifolius L.Spontaneous
Cistus salviifolius L.Spontaneous
Cistus ladanifer L.Spontaneous
ChenopodiaceaeAtriplex halimus L.Spontaneous
Chenopodium ambrosioides L.Spontaneous
Hammada scoparia (Pomel) IljinSpontaneous
Salsola tetragona DelileSpontaneous
Suaeda mollis Dest.,Spontaneous
ColchicaceaeAndrocymbium gramineum (Cav.) J.F. Macbr.Spontaneous
ConvolvulaceaeIpomoea batatas (L.)Cultivated
CucurbitaceaeBryonia dioica Jacq.Spontaneous
Citrullus colocynthis (L.) Schrad.Spontaneous
Citrullus vulgaris Schard.Cultivated
Cucumis sativus L.Cultivated
Cucumis melo var. flexuosus L.Cultivated
Cucurbita maxima DuchesneCultivated
Cucurbita pepo L.Cultivated
CupressaceaeJuniperus phoenicea L.Imported
Juniperus thurifera LSpontaneous
Juniperus oxycedrus L.Imported
Tetraclinis articulata (Vahl) Mast.Spontaneous
CynomoriaceaeCynomorium coccineum L.Spontaneous
CyperaceaeBolboschoenus maritimus (L.) PallaSpontaneous
Cyperus longus L.Imported
Cyperus rotundus L.Spontaneous
DracaenaceaeDracaena draco subsp. ajgal Benabid & CuzinCultivated
EphedraceaeEphedra alata Decne.Spontaneous
Ephedra altissima Desf.Spontaneous
Ephedra fragilis Desf.Spontaneous
EquisetaceaeEquisetum ramosissimum DesfSpontaneous
EricaceaeArbutus unedo L.Spontaneous
Vaccinium myrtillus L.Cultivated
EuphorbiaceaeEuphorbia officinarum subsp. echinus (Hook. f. & Coss.) VindtSpontaneous
Euphorbia officinarum L.Spontaneous
Euphorbia peplis L.Spontaneous
Euphorbia resinifera O. BergEndemic
Mercurialis annua L.Spontaneous
Ricinus communis L.Spontaneous
FagaceaeQuercus coccifera L.Spontaneous
Quercus suber L.Spontaneous
Quercus ilex L.Imported
GentianaceaeCentaurium erythraea RafnSpontaneous
Centaurium spicatum (L.) FritschCultivated
GeraniaceaePelargonium odoratissimumCultivated
Pelargonium roseum Willd.Cultivated
IridaceaeCrocus sativus L.Cultivated
JuglandaceaeJuglans regia L.Cultivated
JuncaceaeJuncus maritimus Lam.Cultivated
LamiaceaeAjuga iva (L.) Schreb.Spontaneous
Ballota hirsuta BenthSpontaneous
Calamintha officinalis Moench.Spontaneous
Calamintha nepeta subsp. Spruneri (Boiss.) NymanSpontaneous
Calamintha alpina L.Spontaneous
Clinopodium alpinum (L.) KuntzeSpontaneous
Clinopodium nepeta subsp. glandulosum (Req.) GovaertsSpontaneous
Lavandula angustifolia MillSpontaneous
Lavandula dentata L.Spontaneous
Lavandula maroccana Murb.Endemic
Lavandula multifida L.Spontaneous
Lavandula stoechas L.Spontaneous
Marrubium vulgare L.Spontaneous
Mentha pulegium L.Spontaneous
Melissa officinalis L.Spontaneous
Mentha spicata L.Spontaneous
Mentha piperita L.Cultivated
Mentha suaveolens Ehrh.Spontaneous
Ocimum basilicum L.Cultivated
Origanum compactum Benth.Spontaneous
Origanum elongatum (Bonnet) Emb. & MaireSpontaneous
Origanum majorana L.Spontaneous
Origanum vulgare L.Spontaneous
Rosmarinus officinalis L.Imported
Salvia officinalis L.Cultivated
Salvia hispanica L.Cultivated
Teucrium polium L.Spontaneous
Thymus broussonetii Boiss.Endemic
Thymus algeriensis Boiss. & Reut.Spontaneous
Thymus maroccanus Ball.Endemic
Thymus munbyanus Boiss. & ReutSpontaneous
Thymus satureioides Coss.Endemic
Thymus vulgaris L.Spontaneous
Thymus zygis L.Spontaneous
LauraceaeCinnamomum cassia (L.) J. PreslImported
Cinnamomum verum J. PreslCultivated
Laurus nobilis L.Spontaneous
Persea americana Mill.Cultivated
LeguminosaeAcacia gummifera Willd.Endemic
Acacia nilotica (L.) DelileCultivated
Acacia senegal (L.) Willd.Cultivated
Acacia tortilis (Forssk.) HayneSpontaneous
Acacia albida DelileCultivated
Anagyris foetida L.Cultivated
Arachis hypogaea L.Cultivated
Cassia absus L.Imported
Cassia fistula L.Cultivated
Ceratonia siliqua L.Imported
Cicer arietinum L.Cultivated
Cytisus battandieri MaireCultivated
Glycine max (L.) Merr.Cultivated
Glycyrrhiza glabra L.Imported
Lupinus albus L.Spontaneous
Lupinus angustifolius L.Spontaneous
Lupinus luteus L.Spontaneous
Lupinus pilosus L.Spontaneous
Medicago sativa L.Cultivated
Ononis natrix L.Spontaneous
Ononis tournefortii Coss.Spontaneous
Phaseolus aureus Roxb.Cultivated
Phaseolus vulgaris L.Cultivated
Retama monosperma (L.) Boiss.Spontaneous
Retama raetam (Forssk.) WebbSpontaneous
Retama sphaerocarpa (L.) Boiss.Spontaneous
Senna alexandrina Mill.Cultivated
Trigonella foenum-graecum L.Spontaneous
Vicia faba L.Spontaneous
Vicia sativa L.Spontaneous
Vigna radiata (L.) R. WilczekCultivated
Vigna unguiculata (L.) WalpCultivated
Urginea maritima (L.) BakerCultivated
LinaceaeLinum usitatissimum L.Cultivated
LythraceaeLawsonia inermis L.Spontaneous
Punica granatum L.Cultivated
MalvaceaeAbelmoschus esculentus (L.) MoenchCultivated
Hibiscus sabdariffa L.Spontaneous
MoraceaeFicus abelii MiqCultivated
Ficus carica L.Spontaneous/Cultivated
Ficus dottata Gasp.Cultivated
Morus alba L.Spontaneous
Morus nigra L.Spontaneous
MoringaceaeMoringa oleifera Lam.Cultivated
MusaceaeMusa paradisiaca L.Cultivated
MyristicaceaeMyristica fragrans Houtt.Cultivated
MyrtaceaeEucalyptus camaldulensis Dehnh.Cultivated
Eucalyptus globulus Labill.Imported
Eugenia caryophyllata ThunbCultivated
Jasminum fruticans L.Spontaneous
Myrtus communis L.Imported
Syzygium aromaticum (L.) Merr. & L. M. PerryCultivated
NitrariaceaePeganum harmala L.Spontaneous
OleaceaeFraxinus angustifolia VahlSpontaneous
Fraxinus excelsior var. acuminata SchurCultivated
Olea europaea L.Spontaneous/Cultivated
Olea europaea subsp. maroccana (Greuter & Burdet) Spontaneous/Cultivated
Olea europea L. subsp. europaea var. sylvestris (Mill) Lehr,Cultivated
Olea oleaster Hoffm. & Link.Spontaneous
PapaveraceaeFumaria officinalis L.Spontaneous
Papaver rhoeas L.Spontaneous
Plantago ovata Forssk.Spontaneous
PedaliaceaeSesamum indicum L.Imported
PlantaginaceaeGlobularia alypum L.Spontaneous
Globularia repens Lam.Spontaneous
PlumbaginaceaeLimonium sinuatum (L.) Mill.Spontaneous
PoaceaeAvena sativa L.Cultivated
Avena sterilis L.Cultivated
Castellia tuberculosa (Moris) BorSpontaneous
Cynodon dactylon (L.) Pers.Spontaneous
Hordeum vulgare L.Cultivated
Lolium perenne L.Cultivated
Lolium multiflorum Lam.Spontaneous
Lolium rigidum GaudinSpontaneous
Panicum miliaceum L.Spontaneous
Panicum turgidum Forssk.Spontaneous
Pennisetum glaucum (L.) R.Br.Spontaneous
Phalaris canariensis L.Spontaneous
Phalaris paradoxa L.Spontaneous
Polypogon monspeliensis (L.) DesfSpontaneous
Sorghum bicolor (L.) MoenchSpontaneous
Triticum durum Desf.Cultivated
Triticum aestivum L.Cultivated
Triticum turgidum L.Spontaneous
Zea mays L.Cultivated
PolygonaceaeEmex spinosa (L.) Campd.Spontaneous
Portulaca oleracea L.Spontaneous
RanunculaceaeNigella Sativa L.Spontaneous
ResedaceaeReseda lanceolata Lag.Spontaneous
RhamnaceaeZiziphus lotus (L.) Lam.Spontaneous
Ziziphus jujube MillSpontaneous
RosaceaeCydonia oblonga Mill.Cultivated
Chaenomeles sinensis (Dum.Cours.) KoehneCultivated
Crataegus monogyna Jacq.Cultivated
Eriobotrya japonica (Thunb.) Lindl.Cultivated
Fragaria vesca L.Cultivated
Malus communis (L.) Poir.Cultivated
Prunus armeniaca L.Cultivated
Prunus dulcis (Mill.) D.A. WebbSpontaneous
Prunus cerasus L.Cultivated
Rubus fruticosus var. vulgaris (Weihe & NeesSpontaneous
Rubus fruticosus var. ulmifolius, (Schott)Spontaneous
RubiaceaeRubia tinctorum L.Spontaneous
Coffea arabica L.Cultivated
RutaceaeCitrus medica var. limon L.Cultivated
Citrus paradisi Macfad.Cultivated
Citrus sinensis (L.) OsbeckCultivated
Citrus aurantium L.Imported
Ruta graveolens L.Spontaneous
Ruta chalepensis L.Spontaneous
Ruta montana L.Spontaneous
SalicaceaeSalix alba L.Cultivated
SalvadoraceaeSalvadora persica L.Cultivated
SantalaceaeViscum album LSpontaneous
SapotaceaeArgania spinosa (L.) SkeelsCultivated
SchisandraceaeIllicium verum Hook.f.Cultivated
SolanaceaeCapsicum annuum L.Cultivated
Datura stramonium L.Spontaneous/Cultivated
Lycopersicon esculentum Mill.Cultivated
Nicotiana tabacum L.Cultivated
Solanum americanum Mill.Spontaneous/Cultivated
Solanum melongena L.Cultivated
Withania frutescens (L.) PauquyCultivated
TaxaceaeTaxus baccata L.Spontaneous
TheaceaeCamellia sinensis (L.) KuntzeImported
ThymelaeaceaeThymelaea hirsuta (L.) Endl.Spontaneous
Thymelaea tartonraira (L.) All.Spontaneous
Thymelaea virgata (Desf.) Endl.Endemic
Aquilaria malaccensis LamCultivated
UrticaceaeUrtica dioica L.Spontaneous
Urtica pilulifera L.Spontaneous
Urtica urens L.Spontaneous
Urtica membranacea Poir. ex SavignySpontaneous
ValerianaceaeNardostachys jatamansi (D. Don) DC.Imported
VerbenaceaeAloysia citriodora PalauCultivated
Verbena officinalis L.Spontaneous/Cultivated
VitaceaeVitis vinifera L.Spontaneous/Cultivated
XanthorrhoeaceaeAsphodelus microcarpus Salzm. & Viv.Spontaneous
Asphodelus tenuifolius Cav.Spontaneous
ZingiberaceaeZingiber officinale Roscoe.Cultivated
Curcuma longa L.Cultivated
ZygophyllaceaeTetraena gaetula (Emb. & Maire) Beier & ThulinEndemic
Zygophyllum gaetulum Emb. & MaireSpontaneous
Table 3. Plants used by Moroccan diabetic patients for type 1, type 2, or gestational diabetes mellitus.
Table 3. Plants used by Moroccan diabetic patients for type 1, type 2, or gestational diabetes mellitus.
Scientific NameType 1 DiabetesType 2 DiabetesGestational Diabetes Mellitus
Allium cepa L.++-
Allium sativum L.++-
Allium ampeloprasum var. porrum-+-
Aloe vera (L.) Burm.f.-+-
Beta vulgaris L.-+-
Pistacia atlantica Desf.-+-
Pistacia lentiscus L.+--
Ammi visnaga (L.) Lam.++-
Anethum foeniculum L.-+-
Apium graveolens L.++-
Carum carvi L.-++
Coriandrum sativum L.++-
Cuminum cyminum L.-+-
Foeniculum vulgare Mill.++-
Petroselinum crispum (Mill.) Fuss++-
Pimpinella anisum L.-++
Ridolfia segetum (L.) Moris+--
Caralluma europaea (Guss.) N.E.Br.++-
Nerium oleander L.++-
Chamaerops humilis L.-+-
Phoenix dactylifera L.--+
Asparagus albus L.+--
Achillea odorata L.+--
Achillea santolinoides Lag.-+-
Artemisia absinthium L.++-
Artemisia campestris L.-+-
Artemisia herba-alba Asso+++
Artemisia mesatlantica Maire-+-
Chamaemelum mixtum (L.) Alloni-+-
Chamaemelum nobile (L.) All.++-
Chrysanthemum coronarium L.+--
Cladanthus arabicus (L.) Cass.+--
Cynara cardunculus L.++-
Cynara cardunculus subsp. scolymus (L.)++-
Dittrichia viscosa (L.) Greuter+--
Lactuca sativa L.-+-
Matricaria chamomilla L.--+
Pallenis spinosa (L.) Cass.+--
Saussurea costus (Falc.) Lipschitz-+-
Scolymus hispanicus L.-+-
Sonchus asper (L.) Hill-+-
Sonchus tenerrimus L.-+-
Silybum marianum L.-+-
Tanacetum vulgare L.+--
Berberis vulgaris subsp. Australis (Boiss.) Heywood-+-
Anastatica hierochuntica L.-++
Brassica oleracea L.-++
Brassica rapa L.+--
Eruca vesicaria (L.) Cav.+--
Lepidium sativum L.+++
Raphanus raphanistrum subsp. sativus (L.)+++
Boswellia sacra Flueck.++-
Opuntia ficus indica (L.) Mill.-+-
Capparis spinosa L.++-
Cistus laurifolius L.+--
Cistus ladanifer L.+--
Atriplex halimus L.-+-
Chenopodium ambrosioides L.,++-
Ipomoea batatas (L.)-+-
Bryonia dioica Jacq.-+-
Citrullus colocynthis (L.) Schrad.++-
Citrullus vulgaris Schard.++-
Cucumis sativus L.-+-
Cucurbita maxima Duchesne+--
Cucurbita pepo L.-+-
Juniperus phoenicea L.++-
Juniperus oxycedrus L.++-
Tetraclinis articulata (Vahl) Mast.++-
Cyperus longus L.+--
Cyperus rotundus L.-+-
Equisetum ramosissimum Desf+--
Arbutus unedo L.+--
Euphorbia officinarum subsp.echinus-+-
Euphorbia officinarum L.++-
Euphorbia peplis L.--+
Euphorbia resinifera O. Berg++-
Mercurialis annua L.++-
Quercus suber L.-+-
Quercus ilex L.+--
Centaurium spicatum (L.) Fritsch+--
Pelargonium roseum Willd.+--
Crocus sativus L.-++
Juglans regia L.++-
Ajuga iva (L.) Schreb.--+
Ballota hirsuta Benth+--
Calamintha officinalis Moench.+--
Calamintha alpina L-+-
Lavandula angustifolia Mill-+-
Lavandula dentata L.-+-
Lavandula maroccana Murb.+--
Lavandula multifida L.++-
Lavandula stoechas L.--+
Marrubium vulgare L.+++
Mentha pulegium L.++-
Melissa officinalis L.+--
Mentha spicata L.++-
Mentha suaveolens Ehrh.++-
Ocimum basilicum L.--+
Origanum compactum Benth.-+-
Origanum elongatum (Bonnet) ++-
Origanum majorana L.++-
Origanum vulgare L++-
Rosmarinus officinalis L.+++
Salvia officinalis L.++-
Teucrium polium L.++-
Thymus broussonetii Boiss.+--
Thymus maroccanus Ball.++-
Thymus satureioides Coss.++-
Thymus vulgaris L.-+-
Cinnamomum cassia (L.) J. Presl+--
Cinnamomum verum J. Presl++-
Laurus nobilis L.-+-
Persea americana Mill.++-
Acacia gummifera Willd.-+-
Acacia nilotica (L.) Delile-+-
Acacia senegal (L.) Willd.-++
Acacia tortilis (Forssk.) Hayne-+-
Acacia albida Delile-+-
Anagyris foetida L.-+-
Arachis hypogaea L.-+-
Cassia absus L.+--
Cassia fistula L.-+-
Ceratonia siliqua L.++-
Cicer arietinum L.+--
Glycine max (L.) Merr.+--
Glycyrrhiza glabra L++-
Lupinus albus L.++-
Lupinus angustifolius L.-+-
Lupinus luteus L.-+-
Medicago sativa L.+--
Ononis natrix L.-+-
Phaseolus aureus Roxb.-+-
Phaseolus vulgaris L.++-
Retama monosperma (L.) Boiss.-+-
Retama raetam (Forssk.) Webb-+-
Trigonella foenum-graecum L.+++
Vicia faba L.+--
Vigna radiata (L.) R. Wilczek-+-
Linum usitatissimum L.++-
Punica granatum L.-+-
Abelmoschus esculentus (L.) Moench++-
Hibiscus sabdariffa L.+--
Ficus carica L.++-
Ficus dottata Gasp.--+
Morus alba L.-+-
Morus nigra L.-+-
Myristica fragrans Houtt.-+-
Eucalyptus camaldulensis Dehnh.-+-
Eucalyptus globulus Labill.+--
Eugenia caryophyllata Thunb+--
Jasminum fruticans L.++-
Myrtus communis L.-+-
Syzygium aromaticum L.++-
Peganum harmala L.-+-
Olea europaea L.+++
Olea europaea subsp. maroccana++-
O. europea L. subsp. europaea var. sylvestris ++-
O. oleaster Hoffm. & Link.+--
Fumaria officinalis L.+--
Plantago ovata Forssk.-+-
Sesamum indicum L.+++
Globularia alypum L.+--
Avena sativa L.++-
Avena sterilis L.+--
Castellia tuberculosa Moris+--
Hordeum vulgare L.++-
Lolium perenne L.--+
Lolium rigidum Gaudin-+-
Panicum miliaceum L.-+-
Pennisetum glaucum L.-+-
Phalaris canariensis L.-+-
Sorghum bicolor L.-+-
Triticum durum Desf.++-
Triticum aestivum L.-+-
Triticum turgidum L.-+-
Portulaca oleracea L.+--
Nigella Sativa L.++-
Ziziphus lotus L.-+-
Ziziphus jujube Mill-+-
Chaenomeles sinensis Dum.Cours.-+-
Eriobotrya japonica Thunb.-+-
Malus communis L.+--
Prunus armeniaca L.+--
Prunus dulcis Mill.-+-
Rubus fruticosus var. vulgaris-+-
Rubus fruticosus var. ulmifolius, (Schott)--+
Rubia tinctorum L.-+-
Coffea arabica L.++-
Citrus medica var. limon L.+++
Citrus paradisi Macfad.++-
Citrus sinensis L.-+-
Citrus aurantium L.++-
Ruta graveolens L.+--
Ruta chalepensis L.-+-
Ruta montana L.++-
Salvadora persica L.-+-
Viscum album L.-+-
Argania spinosa L.++-
Illicium verum Hook.f.-+-
Capsicum annuum L.-+-
Lycopersicon esculentum Mill.++-
Solanum melongena L.++-
Withania frutescens L.+--
Taxus baccata L.+--
Camellia sinensis L.++-
Thymelaea hirsuta L.++-
Thymelaea tartonraira L.-+-
Thymelaea virgata Desf.+--
Aquilaria malaccensis Lam++-
Urtica urens L.+--
Nardostachys jatamansi D. Don+--
Aloysia citriodora Palau-++
Verbena officinalis L.+--
Vitis vinifera L.-+-
Aloe succotrina Lam.+-+
Asphodelus microcarpus Salzm. & Viv.--+
Asphodelus tenuifolius Cav.--+
Zingiber officinale Roscoe.++-
Curcuma longa L.-+-
Tetraena gaetula Emb. & Maire--+
Zygophyllum gaetulum Emb. &Maire++-
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Boutaj, H. A Comprehensive Review of Moroccan Medicinal Plants for Diabetes Management. Diseases 2024, 12, 246. https://doi.org/10.3390/diseases12100246

AMA Style

Boutaj H. A Comprehensive Review of Moroccan Medicinal Plants for Diabetes Management. Diseases. 2024; 12(10):246. https://doi.org/10.3390/diseases12100246

Chicago/Turabian Style

Boutaj, Hanane. 2024. "A Comprehensive Review of Moroccan Medicinal Plants for Diabetes Management" Diseases 12, no. 10: 246. https://doi.org/10.3390/diseases12100246

APA Style

Boutaj, H. (2024). A Comprehensive Review of Moroccan Medicinal Plants for Diabetes Management. Diseases, 12(10), 246. https://doi.org/10.3390/diseases12100246

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop